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ABSTRACT
Osteopetrosis is a metabolic bone disease in mammals characterized by a generalized
skeletal scerosis caused by reduced bone resorption. This reduce bone resorption is
manifested in afficed animals by abnormal bone shap, reduced or absent marrow
cavities, extramedullary hemopoiesis, abnormal mineral homeostasis and absent or
delayed tooth eruption. The available osteopetrotic animal mutations have been a
constant source of fruitfl investigations concerning the systemic regulation of
osteolastogenesis and bone metablism. Tooth eruption, on the other hand, is a loalized
manifestation of the timely activation of bone resorption and bone formation on opposite
sides of an erupting tooth. Its rate- limiting step is the speed of bone resorption to form
the eruption pathway. In this dissertation, we used two osteopetrotic rat mutations,
toothless (to and microphthalmia blanc (mi, to investigate the abnormal development
of osteoclasts and tooth eruption in mutant rats with an emphasis on the role of systemic
and local factors. The significant contributions to this work are listed below.
1. In the toothless rat, a mutation lacking erupted dentition due to severely reduce
bone resorption, colony-stimulating factor-1 (CSF-1) promoted tooth eruption but this
was delayed compared to normal rats. Eruption was accmpanied by changes in the
populations of tartrate-resistant acid phosphatase-positive (TRAP+) mononuclear cells
in the dental follicle and TRAP+ osteoclasts on adjacent alveolar bone surfaces. These
cell populations were dramatically increased in treated mutants compared to untreated 
rats, but the timing of their aparance was delayed compared to normallittermates.
This lag in the aparance of osteolasts and their precursors correspnded to the delay
in eruption of first molars in treated 11 rats.
2. CSF-1 also acclerated the eruption of molars in normal rats. CSF-1 increased
the number of TRAP+ mononuclear cells in the dental follcle and TRAP+ osteolasts on
adjacent alveolar bone surfaces, but had no effect on the timing of their appearance in
normal rats.
3. Our data revealed a differential effect on tooth eruption of the growth factors
CSF-1 and epidermal growth factor (EGF). CSF-1 acclerated eruption of molars in
normal n ts, but had no effect on incisor eruption. On the other hand, EGF accelerated
incisor eruption; but did not affect molar eruption in normal rats.
4. We have describe the mecanism for the transient, mild form of osteopetrosis
inherited by mi rats. Mutant animals possess a typical sclerosis at birth, which
diminished--but was not resolved--during the first postnatal month. These
characteristics are caused by early reductions in osteoast number and function which
improve to normal levels by 4 weeks. Osteolast numbers were severely reduced in 
rats between birth and 2 weeks, but improved to near normal levels by 4 weeks.
Neonatal abnormaliies in osteoclast function included reduced staining for the functional
enzymes TRAP and TrATPase, decreased levels of mRNA for both TrATPase and CAli, and
inabilty to form a well-developed ruffled border. None of these defects were apparent
after the first postnatal month.
5. Finally, we have shown that the dental abnormalities caused by the mild,
transient form of osteopetrosis in mi rats are limited to incisor defects and delayed
eruption of all teeth. Histologic and radiographic examination of mutant incisors
revealed that, contrary to the situation in normal rats, the apex of the incisors of 
rats failed to extend past the first molar region to the third molar. The incisor apex of
newbrn mi rats was misshap due to ankylosis of incisor matrices with alveolar
bone. This ankylosis was temporary, being resolved by the third postnatal day. The
delayed eruption of incisors in mi rats and abnormal shape and oclusion of these teeth
in older animals is a consequence of the temporary ankylosis in newborn rats.
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CHAPTER I
INTRODUCTION
PART A:
The Structure of Osteoclasts
The osteoclast (literally "bone-breaker") is the major cell responsible for bone matrix
degradation and was originally described by KOllker (1873). Under the light
microscope, osteoclasts are easily identified and appear as large (SO-100J.m) cells
with several centrally located nuclei, often with prominent nucleoli and a strongly
basophilc, frothy cytoplasm. Although they appear infrequently in normal adult bone,
osteoclasts are usually found attached to mineralized surfaces, especially endosteal or
trabecular surfaces between the calcified matrix and bone marrow. Active osteoclasts
reside within a region of excavated bone known as Howship s lacuna, produced by
extensive matrix degradation. In addition, osteoclasts take on a number of cell shapes
ranging from plump cells facing straight bone surfaces to elongate cells wrapped around
the end of a spicule of trabecular bone.
The distinctive ultrastructural features of osteoclasts are highly-developed,
perinuclear Golgi complexes, abundant mitochondria, various Iysosomes, and free
ribosomes. These featurE;s are represented in Figure 1. In fact, the ratio of
mitochondria to cytoplasmic area is larger than any other cell type in the body (Holtrop
1991). The ultrastructural hallmark of active osteoclasts is the ruffled border, a
uniquely polarized apical membrane surface comprised of deep infoldings of the plasma
membrane (Sctt and Pease 1956). This membrane ruffling produces an immense
surface area between the cell and extracellular matrix, thus providing an ideal exchange
region for bone degradation. The degradation of bone surfaces opposite the ruffled border
that results from the release of lytic enzymes (Lucht and Norgaard 1976) and acid by
the ruffled border (Baron et al. 1985) is evident by the frayed appearance of collagen
fibers there and the presence of mineralized particles seen between membrane
infoldings (Holtrop 1991). In addition, the cytoplasm of the ruffled border region being
highly vesicular is a source of membrane for the rapid expansion of the ruffled border
(Vaananen et ai. 1989). Ruffled borders are always circumscribed by an area known as
the clear zone, an organelle-free region of cytoplasm containing numerous
contractile/attachment filaments (also called sealing zone). A microfilament network
consisting of a vinculin-talin double circle surrounding F-actin has been shown to be
associated with resorption lacunae (Holtrop and King 1977; Lakkakorpi et al. 1989;
Lakkakorpi and Vaananen 1991). It is likely that this specialized cytoplasmic region
limits the acidic environment necessary for mineral degradation by sealing off the area
under the ruffled border from extracellular spaces (Schenk et al. 1967; Lakkakorpi and
Vaananen 1991). This microfiament structure corresponds roughly to the edges of
resorbing lacunae of active osteoclasts, and is dispersed by inhibitors of osteoclastic
bone resorption. such as calcitonin (Lakkakorpi and VaanAnen 1990).
Part B:
The Origin of Osteoclasts
Osteoclasts are derived from hemopoietic precursors
The observation that osteoclasts are usually found on mineralized bone surfaces
in close associ tion with marrow is both functional and developmental in nature. The
former observation, that osteoclasts degrade bone matrix, was realized long ago;
however, the origin of the osteoclast eluded researchers until recently. Among the first
evidence for a hemopoietic origin of osteoclasts came from the pioneering work of Donald
Walker (Walker 1972, 1973). Walker made use of inbred strains of rodents with
congenital osteopetrosis, a metabolic bone disease characterized by reduced bone
resorption due to interceptions in osteoclast function. When lethally-irradiated mutants
were joined to normal littermates by skin flaps to establish a common circulation, they
were cured of the disease. Furthermore, their osteoclasts were derived from their
normal sibling. In an extension of this work, Walker repeatedly cured mice of
osteopetrosis with spleen and bone marrow transplantations and likewise, transmitted
osteopetrosis to normal littermates via transplantation of mutant spleen or marrow
(Walker 1973, 1975a, c). In similar parabiosis experiments, GOthlin and Ericsson
(1973) assessed the origin of bone cells in developing fracture calluses. To do so, they
joined inbred rats and delivered a dose of radiation sufficient" to destroy all hemopoietic
tissue in one rat while the other animal was shielded. The cross-circulation was
temporarily blocked, and tritiated thymidine was injected into the shielded rat. Electron
microscopic and autoradiographic examination of osteoclasts and other bone cells of the
fracture calluses in both animals revealed that both osteoblasts and giant cells were
labeled in the shielded animal while labeling was confined to osteoclasts in the irradiated
sibling. These experiments indicated that osteoclasts could be replaced with cells
derived from the bloodstream and formed the foundation for our current concept of the
hemopoietic origin of osteoclasts.
Walker s observations were confirmed in other laboratories through
1. chick/quail transplantation experiments (Kahn and Sim"1ons 1975; Jotereau and Le
Douarin 1978), 2. co-cultures of osteoclast-free bone with nonadherent bone marrow
cells (Ko and Bernard 1981; Schneider and Relfson 1988b), and 3. cell suspension
transplantation studies (Schneider and Byrnes 1983; Schneider and Relfson 1988a):
1. Chick/quail transplantation experiments have provided scientists with a useful tool
for constructing chimeras, since the cells from chickens and quails can be easily
distinguished by their characteristic interphase nuclear morphology. When bone
rudiments of one species were grafted onto the chorioallantoic membrane of the other and
allowed to differentiate (endochondral bone formation), the osteoclasts present in the
resultant later stage long bones were invariably of recipient origin, while osteoblasts
were donor-derived. 2. Osteoclast-free bone formation assays: Osteoclast-free bone
can be derived from either preculturing fetal mouse calvaria rudiments or by taking
advantage of periosteum and perichondrium-free fetal long bone rudiments; in either
case ossification proceeds with the development of osteoblasts in the absence of
osteoclasts. When these rudiments are co-cultured with appropriate cell suspensions,
for example spleen or marrow, osteoclasts formed: 3. Using density gradients and
fluorescent activated-cell-sorting techniques, hemopoietic stem cells were enriched and
transplanted to donor rats. These isolated progenitor cells, especially those of CFU-
and CFU-GM, differentiated into osteoclasts in the host or fused with pre-existing host
osteolasts. Taken together, these experiments provide strong evidence that osteoclasts
can be replaced and replenished by the blood stream via precursor cells present in the
skeleton and extraskeletal hemopoietic tissues.
Characteristics of osteoclast precursors
It is now generally believed that osteoclasts form by the fusion of mononuclear
precursors present in blood and marrow. Mononuclear phagocytes have long been
considered as candidates for osteoclast progenitors, since they can dissolve both bone
mineral nd organic matrix under appropriate conditions (Holtrop et al. 1982;
Teitelbaum et al. 1979), and respond to many factors either present in bone matrix
and/or known to influence bone resorption, including bone mineral itself, osteocalcin,
type I collagen, and PTH (Minkin et al. 1977; Malone et al. 1982; Mundy et al. 1978).
Histochemical and ultrastructural examinations of these mononuclear phagocytes,
osteoclasts, and presumptive osteoclast precursors have revealed both similarities and
differences between presumptive preosteoclasts and mononuclear cells of the
macrophage lineage (Horton and Helfrich 1992). Both have Fc and C3 receptors,
characteristic of macrophages and nonspecific-esterase (NSE), a marker for
mononuclear phagocytes (Pierce and Lindskog 1986; Baron et al. 1986). However
preosteoclasts express greater amounts of acid phosphatases--especially tartrate-
resistant acid phosphatase--and NADH dehydrogenase, but lower levels of fluoride-
inhibited non-specific esterase activity than multinucleated giant cells (Zheng et al.
1991). In addition, phagocytic mononuclear macrophages do not respond to calcitonin
nor do they develop ruffled borders (Teitelbaum 1979; Mundy 1983). It has been
observed that mononuclear cells with ultrastructural features of preosteoclasts,
including abundant mitochondria and Iysosomes and extensive Golgi complexes, fuse with
avian osteoclasts attached to bone surfaces (Fukushima et al. 1991). These cells also
have numerous small vesicles containing alkaline p-Nppase, a marker for the basal
ruffled border. Indeed, mononuclear osteoclasts can resorb bone (Domon and Wakita
1991). Recently, a number of laboratories have shown that mouse peripheral blood
monocytes, chicken bone marrow mononuclear phagocytes, and alveolar macrophages
fuse with cultured osteoclasts or form syncytia by fusing with themselves in vitro
(Zambonin-Zallone and Teti 1985; Zambonin-Zallone et al. 1984; Helfrich et aL 1986;
Udagawa et al. 1990). However, these studies have been questioned since it is difficult
to obtain pure populations of the cells in question. In addition, other studies have
indicated that mature monocytes and macrophages cannot fuse to form osteoclasts
(Burger et al. 1982; Takahashi et al. 1991). These data indicate that osteoclasts and
macrophages share a common lineage and that osteoclasts arise from mononuclear
progenitors before commitment to the macrophage lineage.
Reaulation of osteoclastoaenesis
Recent investigations concerning the development of osteoclasts have relied
primarily on the use of long-term marrow or stromal cell cultures. These studies have
provided additional evidence for the hemopoietic origin of the osteoclast and shed light on
the factors influencing their development and function. Factors which have been shown
to stimulate osteoclast formation in stromal or marrow cell cultures include the growth
factors macrophage colony-stimulating factor (M-CSF or colony-stimulating factor-
CSF-1), granulocyte-macrophage colony-stimulating factor (GM-CSF), and
granulocyte colony stimulating factor (G-CSF) (Kodama et al. 1991; Takahashi et al.
1991); cytokines including interleukin 1 (IL-1), interleukin 3 (IL-3) , interleukin 6
(IL-6), and tumor necrosis factor (TNF) (Kurihara and Roodman 1990; Hagenaars et
al. 1991; Barton and Meyer 1989; Kurihara et al. 1990; Pfeilschifter et aL 1989);
and the calcitropic hormones such as 1,2S-dihydroxyvitamin D3 and the parathyroid
hormone (PTH) family of molecules (Akatsu et al. 1989; Udagawa et al. 1990).
Numerous factors which inhibit the formation of osteoclasts in have also been
identified in long-term marrow cell cultures, for example estrogen, TGF-B, PGE2, INF-
alpha and gamma, and IL-4 (Jilka et al. 1992; chenu et al. 1988; Kurihara and
Roodman 1990; Shioi et al. 1991). However, it is noteworthy that the specific
conditions necessary for generating osteoclasts inmm remain undefined (Flanagan et
al. 1992). Furthermore, these studies are selective in approach, primarily testing the
effects of known factors (growth factors, hormones, cytokines, colony-stimulating
factors) on the formation of osteoclasts in . In order to identify and understand the
factors/signals which are operative during in osteoclastogenesis, non-selective
approaches must be utilzed. In addition, the possible role of those factors influencing
osteoclast development and/or function in must be examined and verified in
In mu hybridization and antibody blockade provide useful tools for such investigations.
The cells which form under culture conditions have many of the features of
osteoclasts. These include ultrastructural and histochemical features, responsiveness to
calcitonin, and abilty to resorb devitalized bone (Skj0dt and Russell 1992). Although
there is litle doubt that some osteoclasts form in long-term marrow/stromal cell
cultures, up to 4 weeks is often necessary to produce them. Macrophage polykaryons,
which do not resorb bone, often form spontaneously in cell cultures, especially . in the
presence of factors commonly in these systems, such as 1,2S-dihydroxyvitamin D3
(Schlesinger et a1.1984; Sutton and Weiss 1966). Consequently, caution must be used
when interpreting data f om in osteoclast-generating cultures, especially when
attempting to correlate multinuclear cell number with osteoclast formation or activity.
For example, osteoclastic markers such as tartrate-resistant acid phosphatase . (TRAP)
do not always apply to the in state, since TRAP may be expressfid by monocytes
and/or macrophages, which resemble osteoclasts in culture (Horton and Helfrich
1992). In addition, TRAP is expressed by hairy leukemia cells and macrophages derived
from a variety of tissues (Ketcham et al. 1985; Robinson and Glew 1980; Snipes et al.
1986). Therefore, the only verifiable criterion for assessing in 
osteoclastogenesis
at this time lies in determining that the cell(s) in question are capable of resorbing a
mineralized matrix (Hattersley and Chambers 1989).
The role of the hemopoietic Qrowth factor CSF 1 in osteoclastoQenesis
One example of discrepancies between in and in data concerning the
generation of osteoclasts comes from recent experiments about colony-stimulating
factor-1 (CSF-1 or M-CSF). CSF-1 is one of a family of factors known to stimulate
growth and differentiation of hemopoietic cells. The primary function of CSF-1 is to
stimulate the proliferation, differentiation, function, and survival of cells of the
mononuclear phagocyte system (Stanley and Heard 1977; Stanley et al. 1983). CSF-
is produced by stromal or connective tissue cells including monocytes, keratinocytes,
fibroblasts, endothelial cells and osteoblasts (Horowitz and . Jilka 1992) and is encoded
by a single gene (about 21 kb) composed of at least 10 exons (Ladner et al. 1987).
Post-transcriptional modifications of the primary mRNA transcript produce multiple
mature mRNAs which encode both a soluble form and at least 3 distinct membrane-bound
forms of the factor. The soluble form of CSF-1 is derived from a 554 amino acid
precursor that is processed to yield two subunits of approximately 223 amino acids.
These smaller subunits form homodimers to yield the soluble form of CSF-1, which is
secreted by the cell (Ladner et aI1987). The membrane-bound forms of cSF-1 share a
common arrangement which includes a short carboxy terminal intracellular tail, a
series of hydrophobic amino acids which serve as the transmembrane segment, a
sequence corresponding to the actual soluble factor, and an aminoterminal signal peptide
(Kawasaki et al. 1985; Rajavashisth et al. 1987). Consequently, the membrane-bound
forms are transported to the plasma membrane where they are expressed as integral
membrane glycoproteins. The proto-oncoene
(Rothwell and Rohrschneider 1987).
fms encoes the receptor for CSF-
Numerous studies have provided conflicting evidence for the role of CSF-1 is
bone cell function, but recent observations suggest that CSF-1 plays an important role
in osteoclastogenesis. CSF-1 stimulates the formation of osteoclast-like cells in organ
cultures of emcryonic mouse calvaria and weakly adherent bone marrow cells (Burger
et al. 1982), suggesting that osteoclasts share a common lineage with phagocytic
macrophages. CSF-1 enhances osteoclast formation in long-term marrow cell cultures,
presumably by inducing proliferation from precursors and 1 ,2S-dihydroxyvitamin D-
mediated fusion of precursors (MacDonald et al. 1986). These data support the concept
that CSF-1 influences osteoclast formation from mononuclear precursors. On the
contrary, Shinar et al. (1990) reported that CSF-1 had no effect on osteoclast
formation in long-term marrow cultures, but actually reduced the number of TRAP+
mononuclear and multinuclear cells. Nevertheless, additional studies using long-term
marrow and stromal cell cultures have led some investigators to conclude that CSF-1 in
necessary for proliferation and differentiation of osteoclast precursors (Tanaka et al.
1993). These studies ilustrate conflicts in the role of CSF-1 in osteoclastogenesis in
Recent studies in the QJ mouse and the 1l rat, osteopetrotic mutations with few
osteoclasts, reduced numbers of macrophages and monocytes, and resistance to cure by
stem cell replacement .(Marks and Lane 1976; Marks et al. 1984; Wiktor-Jedrzejczak
et al. 1982, 1990; Marks 1977b; Seifert et al. 1988b) have provided compellng
evidence for the importance of CSF-1 in osteoclast development and function. The
mutation responsible for the disease in QJ mice is located in the coding region of the
CSF-1 gene (Yoshida et al. 1990) and injections of CSF-1 are reported to cure the
disease in QR mice (Felix et al. 1990a; Kodama et al. 1991). Similarly, injections of
CSF-1 improve the skeletal manifestations of osteopetrosis in 11 rats, although some
skeletal sclerosis persists even with prolonged treatment (Marks et al. 1992; lizuka et
al. 1992; Marks et al. 1993). In either case, treatment with CSF-1 increases
osteoclast numbers and increases bone resorption. Indeed, a single dose of CSF-1 is
sufficient to cause a temporary elevation in osteoclast numbers in the skeleton of 
mice (Kodama et al. 1993). The residual metaphyseal sclerosis which persists in 
rats treated with CSF-1 is probably due to a failure to restore subepiphyseal osteoclasts
(Marks et al. 1993). Despite the reported effects of CSF-1 on QR mice by other
investigators, Sundquist and others (1993) have shown that, after prolonged CSF-
treatment, metaphyseal sclerosis persists in these mice. In addition, they report that
macrophages are deficient and osteoclasts are maldistributed in the metaphyseal regions
of CSF-1 treated QR mice. Furthermore, no subepiphyseal osteoclasts were observed.
These authors have postulated that the residual metaphyseal sclerosis and failure to
restore subepiphyseal osteoclasts in QR mice is caused by the failure to restore the cell-
bound form of CSF-1 on local cells. This concept is supprted by the observation that
cells known to produce CSF-1, namely osteoblasts and endothelial cells, are present in
the subepiphyseal region and osteoclasts are absent from this region despite the
administration of secreted CSF-1. Therefore, CSF 1 treatment of either osteopetrotic
mutation improves--but does not cure--the manifestations of the disease. The similar
skeletal responses of these two osteopetrotic mutations to exogenous CSF-1 suggest that
redundant and related mechanisms for osteoclastogenesis exist in . This concept is
supported by the observation that some--albeit few--osteoclasts are present in both
mutations prior to treatment.
Part C:
The Function of Osteoclasts
In order to resorb bone, newly formed or quiescent osteoclasts must be activated.
It is generally thought that this process is influenced by factors produced by the local
environment in- response to systemic signals (1,2S-dihydroxyvitamin D3, PTH) or
local factors such as matrix components, cytokines, or growth factors produced by cells
in the microenvironment. Activating factors stimulate bone resorption by influencing
cellular events such a adhesion to bone, formation of a ruffled border, release of acid
hydrolases in the ruffled border region, and production of superoxide radicals.
Osteoclast attachment to bone is mediated by the integrin superfamily of adhesion
molecules and plays an integral role in the resorbing process (Horton and Davies 1989;
Oldberg et al. 1988a,b). Bone contains numerous matrix proteins that contain Arg-
Gly-Asp (RGD) sequences, such as type I collagen , osteopontin, bone sialoprotein,
thrombospondin, and fibronectin (Bernard et al. 1983; Oldberg et al. 1986; Oldberg et
al. 1988; Lawler and Haynes 1986). These proteins faciltate adhesion of both
osteoblasts and osteoclasts in culture (Dedhar et al. 1987; Gehron Robey et al. 1989;
Helfrich et al. 1992), apparently by interactions with the vitronectin receptor. Indeed,
peptides containing the RGD sequence inhibit bone resorption (Lakkakorpi et al. 1991).
The vitronectin receptor (alpha-v, beta-3) has been localized to the plasma membrane
of osteoclasts (Horton 1988; Davies et al. 1989) and antibodies to this integrin inhibit
bone resorption (Chambers et al. 1986; Horton et al. 1991). Although it is tempting to
suggest that the vitronectin receptor plays an important role in maintaining the tight
attachment (seal zone) of osteoclasts to bone during resorption, recent evidence suggests
that the protein mediates osteoclast attachment and migration. The receptor is not 
found
, .
in association with the clear/sealing zone, but is localized in the ruffled border and the
basolateral membrane of osteoclasts (Lakkakorpi et al. 1991).
The process by which osteoclasts resorb bone ocurs in two phases and is
ilustrated in Figure 1. During the first phase of resorption, inorganic matrix is
dissolved, a process which takes about 2 hours to reach peak activity in freshly isolated
chicken osteociasts (Blair et al. 1986). During this process, degradation of bone
mineral is faciltated by the acidic microenvironment present in the resorption lacuna
under the osteoclast. The acidity of this region has been demonstrated by acridine orange
staining and by direct micropuncture techniques (Baron et al. 1985; Anderson et al.
1986; Silver et al. 1988). The protons necessary for the generation of this acidic
mileu are provided by either intracellular or membrane-associated carbonic anhydrase
isoenzyme II and delivered to the extracellular space by vacuolar-type H+ ATPase
proton pumps in the ruffled border region (Baron et al. 1985; Sundquist et al. 1990;
Sundquist 1993). Numerous observations support the role of carbonic anhydrase in
bone resorption. First, carbonic anhydrase is influenced by calcitropic hormones.
Calcitonin reduces carbonic anhydrase activity and reduces bone resorption in isolated
osteoclasts, while PTH increases carbonic anhydrase II (CAli) activity (Anderson t al.
1982). Second, inhibition of carbonic anhydrase II activity by drugs reduces bone
resorption in organ culture (Minkin and Jennings 1972) and responsiveness to PTH in
(Waite et al. 1970; Waite 1972). Third, congenital defects in carbonic anhydrase
are associated with reduced bone resorption (osteopetrosis) (Sly et al. 1983; Gay
1992) .
In order to regulate intracellular pH, the osteoclast possesses a
chloride/bicarbonate exchanger in the basolateral membrane (Teti et al. 1989).
Inhibition of this chloride/bicarbonate exchanger reduces bone resorption, indicating
that this exchanger is coupled with bone resorption (Hall and Chambers 1989). In
addition, the basolateral membrane of osteoclasts has numerous Na+- ATPases
which, like the chloride/bicarbnate exchanger, are coupled to bone resorption (Baron
et al. 1986; Krieger and Tashjian 1981).
Degradation of the organic portion of bone matrix is dependent upon exocytosis
and endocytosis at the ruffled border (Lucht and Norgaard 1976) and takes 12-24 hours
in freshly isolated chicken osteoclasts (Blair et al. 1986). High concentrations of
lysosomal enzymes have been observed in the ruffled border and the extracellular space
adjacent to the ruffled border (Baron et al. 1988). Among these enzymes are various
cysteine proteinases and acid hydrolases, including tartrate-resistant acid phosphatase
(TRAP), an enzyme observed in the granules and vesicles of rat osteoclasts and linked to
actively resorbing osteoclasts (HammarstrOm et al. 1971; Chambers et al. 1987).
Tartrate-resistant acid ATPase is also present in active osteoclasts (Andersson and
Marks 1989). Evidence for the role of these enzymes in the degradation of organic
matrix during bone resorption comes from the observation that both TRAP and TrATPase
exhibit phosphoprotein phosphatase activity with the bone matrix proteins osteopontin,
osteonectin, and bone sialoprotein II as substrates (Ek-Rylander et al. 1991).
Osteoclasts also produce and secrete cysteine proteinases capable of solubilzing
collagen, including cathepsin B, L, and D (Rifkin et al. 1991; Goto et al. 1992).
Furthermore, it has been proposed that collagenase, produced by the osteoblast
and stored in the bony matrix, could playa role in bone resorption (Chambers et al.
1985). Collagenase is present in bone matrix and contributes to the removal of non-
mineralized collagen during PTH-stimulated bone resorption in cultured calvaria
(Delaisse and Vaes 1992). This activity is prevented by inhibitors of collagenase, but
not by calcitonin, indicating that the activity is independent of osteoclasts. Although it is
generally agreed that the concerted effects of collagenase and the lysosomal enzymes and
cysteine proteases produced by the osteoclast are responsible for the removal of organic
matrix during bone resorption, the source of collagenase remained a mystery untU
recently. Many investigators speculated that procllagenase is secreted by osteoblasts,
incorporated into bone matrix, and activated by the acidic microenvironment of the
resorption lacuna (Delaisse and Vaes 1992; Vaes et al. 1992). It was also considered
possible that cysteine proteinases activate collagenase from its inactive zymogen I since
cathepsin B is known to activate procllagenase (Eechout and Vaes 1977). However,
Delaisse and others (1993) have recently demonstrated the presence of procollagenase
in the subosteoclastic bone resorbing compartment and in osteoclasts of mice, rats and
rabbits. The perinuclear Golgi distribution of this enzyme in both active and quiescent
osteoclasts, together with the observation that mRNA encoing for procollagenase is
present in odontoclasts (Okamura 1992; Okamura et al. 1993) strongly suggest that
procollagenase is produced and secreted by osteoclasts during matrix dissolution.
Recent evidence supports a role for oxygen-derived radicals such as the
superoxide anion in bone resorption. Superoxide anions are found in the resorption
lacuna and are believed to aid the process of bone resorption by enhancing matrix
degradation (Key et al. 1990; Garrett et al. 1990). In addition, superoxide dismutase,
the enzyme responsible for converting superoxide anions into hydrogen peroxide
(H202), has been identiied in the osteoclast membrane (Oursler and Osdoby 1990).
Indeed, H202 stimulates bone resorption at nanomolar concentrations (Bax et al. 1992).
These authors speculate that the stimulatory effects of H202 are brought about by
enhanced osteoclast motilty, similar to the effects of PTH (Chambers 1982).
The identification of functional markers is a paramount concern to distinguish
osteoclasts and their precursors from cells of other/similar lineages like macrophages.
Mononuclear precursors to osteoclasts have been observed at the bone surface and
express ultrastructural and histochemical features of osteoclasts, including Golgi
complexes, mitochondria, polysomes and cytoplasmic extensions (Baron et al. 1986).
One useful marker is carbonic anhydrase isoenzyme-2 (CA II), an enzyme present in the
ruffled border of active osteoclasts and responsible for the delivery of H+ to the
resorption site. Similarly, tartrate-resistant acid phosphatase (TRAP) and acid ATPase
(TrATPase) have been implicated in acid production by the osteoclast. As mentioned
above for TRAP, these latter markers are not absolute because cells other than
osteoclasts can produce them, in and in (Marks and Chambers 1991;
Hattersley and Chambers 1989).
The above data concerning osteolast morphology, development, and function
summarize the current understanding of osteoclast biology and ilustrate its derivation
largely from cultures of isolated osteoclasts and reconstituted marrow/stromal cell
systems. How these data relate to in events is, for the most part, unknown. What is
the origin and regulation of the specific mononuclear precursors of osteoclasts? What
factors determine the tissue and site-specificity of osteoclasts and their subsequent
activation? What causes resorption to stop and what is the lifespan of an osteoclast?
Many of these issues can be addressed in by the use of specific mutations or analyses
of events during tooth eruption. These opportunities are described below.
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Part D:
Osteopetrosi so-Opportunities
for Studying Systemic Osteoclast Development and Function
9steopetrosis is a rare metabolic bone disease in mammals characterized by a
general skeletal sclerosis caused by reduced bone resorption (Marks 1987a, 1989;
Osier and Marks 1992). Because these mutations interrupt the development or function
of osteoclasts, they represent reproducible models in which to study the systemic and
local factors essential for osteoclast differentiation and function (Marks and Walker
1976; Marks 1992). In addition, because osteoclasts fail to develop in certain skeletal
sites in different osteopetrotic mutations, these mutants offer models in which to
explore the emerging site-specificities of osteoclast development and function.
While spontaneous mutations have been documented in cattle (Gopal et al. 1980;
Zetterholm 1972), dogs (Lees and Sautter 1979), deer (Smits and Bubenik 1990), and
humans (Loria-Cortes et al. 1977), the nine distinct mutations found in common
laboratory animals (mice, rats, and rabbits) have been most studied. These animal
mutations with osteopetrosis have been useful in the study of osteoclast development and
function, and are listed with their distinguishing characteristics in Table 1. These
mutations are congenital, inherited as an autosomal recessive trait. Consequently, all
possess a characteristic skeletal sclerosis at birth, which persists in the severe forms
of the disease, but may gradually diminish in milder mutations. The four mouse
mutations are on different chromosomes and two of these, grey-lethal (gl) and
osteosclerosis ( , are lethal and afflicted individuals die within the first 3-4 weeks
of life. The four mutations in the rat are not alleles (Moutier et al. 1989, 1976). One
mutation, osteopetrotic (.Q is lethal, while both the incisors-absent (ia) and
microphthalmia blanc (m. are mild mutations capable of normal lifespans (Marks and
McGuire 1988).
The general skeletal manifestations of osteopetrosis are remarkably similar.
Because the disease is invariably caused by reduced bo e resorption , any process
dependent on bone resorption is compromised. All mutants have a generalized sclerosis
detectable radiographically at birth due to absent or delayed marrow cavity formation.
Indeed, individual mutations cannot be distinguished from each other radiographically at
that time. The ends of long bones lack the external modeling present in normal animals
and exhibit a characteristic blunting commonly referred to as "club-shaped." Delay 
failure of tooth eruption is common among the osteopetroses, ranging from complete lack
of erupted dentition in the most severe forms of the disease (lizuka et al. 1992) to
delays in incisor and/or molar eruption in the less severe ones (Marks 1981). These
abnormalities in bone modeling, tooth eruption, and marrow cavity development are the
distinct consequences of reductions in bone resorption. Rates of bone resorption have
been' measured in four mutations and range from undetectable in the toothless (.t) rat
(Raisz et al. 1981) to 70% of normal siblings in 1a rats (Marks 1973). Other values
include ..10% normal for microphthalmic (mi mice (Marks 1977a) and 50-60%
normal in .Q mice (Reitter et al. 1989).
Despite the marked similarities observed at the tissue level, there exists a
remarkable heterogeneity among the osteopetroses with respect to osteoclast morphology
and function (Seifert et al. 1993). While the number of osteoclasts is reduced in most
mutations, numbers of osteoclasts per unit area of skeleton are elevated in the ia rat and
.Q mouse (Marks et al. 1984). Ruffled borders, the specialized membrane responsible
for delivering protons and enzymes to the resorption compartment during bone
resorption, ar absent or poorly developed in most mutations (Marks 1984). However,
those few osteoclasts in the skeleton of 2Q mice have extensive ruffled borders (Marks
1982). Osteoclast activity is reduced in all mutations. In addition to the morphological
and functional aberrations present in osteoclasts in osteopetrotic animals, osteoblast
abnormaliies in three rat mutations have recently been reported (Shaloub et al.
1991 a,b) as shown in Table 2. Messenger RNA for hi$tone 4 is reduced in QR rats from
4 weeks after birth and in 11 rats at 2 weeks. Elevations in fibronectin, osteopon!in,
and alkaline phosphatase mRNA are observed in all mutations at some point between the
2nd and 6th postnatal week. Other osteoblast abnormalities include reduced osteoblasts
per unit area of bone in 11 rats, and structural and functional deficiencies in osteoblasts
from QS rabbits (Seifert et al. 1988b; Marks et al. 1987; Popoff and Marks 1990).
Bone formation--assessed by uptake of 3H-proline-is increased in the four mouse
mutations (gl, Qk, QR, Qk), but decreased in both the ia rat and QS rabbit (Marks 1989).
In addition, biochemical evidence suggests that aberrations in bone matrix may
contribute to osteopetrosis, since osteocalcin is reduced in calvarial bone of 11 and W2
rats (Lian and Marks 1990). The abnormal numbers and/or function of osteoblasts in 
rats and rabbits, together with the alterations in osteoblastic gene expression among
the rat mutations, suggest that derangements in osteoblasts may contribute and/or
compound abnormal osteoclast function in osteopetrotic animals. This is particularly
true considering that the reported derangements in gene expression are associated with
functional properties of the osteoblast, especially those believed to be involved in
osteoclast recruitment and/or development (Marks et al. 1989). Indeed, the concept
that osteoblasts playa central role in the regulation of osteoclast recruitment and
activation has grown in recent years (Marks and Popoff 1988; Rodan and Martin 1981).
Additional morphological and physiologic evidence for alterations in the skeletal
microenvironment has recently been reported. An amorphous material between the
calcified cartilage and newly-formed bone is present in growing longbones of Qk mice
(Seifert and Marks 1985). This material cannot be resorbed by either mutant or
normal osteoclasts (Van Slyke and Marks 1987), suggesting that the matrix may be
deficient in factors necessary for the recruitment or activation of osteoclasts. Impaired
production of colony-stimulating factor-1 (CSF-1 or M-CSF) by osteopetrotic bone,
bone cells, and fibroblasts of the Qg mouse has been demonstrated (Wiktor-Jedrzejczak
et al. 1990; Felix et al. 1990b; Yoshida et al. 1990).
In addition to the skeletal manifestations of osteopetrosis, numerous
extraskeletal distinctions exist. Osteopetrosis in animals is often accmpanied by
aberrations in mineral homeostasis, and many mutants are hypocalcemic and
hypophosphatemic (see Table 1). Three of the four mouse mutations (mi, , gl and the
2a rabbit have reduced serum levels of phosphate and calcium. Serum levels of 1 25-
dihydroxyvitamin D3 (1,2S(OH)2D) are elevated at some point in life for all of the
seven mutations examined to date, including mi, Qg, mice, ja, 11, Qg rats, and the 2a
rabbit (Zerwekh et al. 1987; Seifert et al. 1993). Serum levels of 1,25(OH)2D are
elevated in 11 rats at 1 week after birth, peak to almost 4 times the value for normal
siblings at 3 weeks of age, and decline to normal levels by the 5th postnatal week.
Serum levels of 1 2S(OH)2D in Qg rats remain up to 4 times those seen for normal
litermates 4-6 weeks after birth. Furthermore, infusions of high doses 
1 ,2S(OH)2D do not induce a calcemic response in 2a rabbits. These data suggest that
osteopetrotic individuals possess a skeletal resistance to 1,2S(OH)2D (Marx and
Barsony 1988). Additional evidence for skeletal resistance to 1,2S(OH)2D has come
from renal studies. Nesbitt and others (1988) have reported elevated levels of renal
25-hydroxyvitamin D-1-alpha-hydroxylase in .Q mice. This enzyme, which produces
the active metabolite of vitamin D, is suppressed with a high calcium diet, suggesting
that increased synthesis is the major cause of high levels of circulating 1,25(OH)2D in
these mutants (Nesbitt et al. 1988). These data, together with elevated serum levels of
2S(OH)2D in osteopetrotic animals suggest that skeletal resistance to 1,2S(OH)2D is
characteristic of congenital osteopetrosis in mammals (Seifert et al. 1993). Clearly,
the relationship between the skeleton and endocrine systems is complex, and deserves
further study.
Immunological complications of osteopetrosis have been reported. Early studies
in the gg rat indicated that the skeletal manifestations of the disease were caused by
thymus dysfunction. These reports described premature thymus atrophy, reduced
mitogenic responses of splenic and thymic lymphocytes, and cure of the disease by
transplantation with normal thymic tissues (Milhaud and Labat 1978, 1979; Milhaud et
al. 1975, 1977). Similarly, decreased mitogen- induced lymphocyte proliferation in
isolated spleen cells from mi and gg mice has been reported (Minkin et al. 1982; Olsen
et al. 1978). These data have led some investigators to conclude that osteopetrosis is a
thymic disorder with skeletal complications (Labat 1991). However, this hypothesis is
challenged by numerous findings. First, athymic mice are not osteopetrotic (McCauley
et al. 1989). Second, thymic transplants cure neither mi and Qj mice nor Qj rats
(Schneider and Marks 1983; Wiktor-Jedrzejczak et al. 1981; Evans et al. 1985).
Third, qualitative and quantitative studies of the cellular composition of thymus and the
T-cell zones of both spleen and lymph nodes demonstrate no differences between the mi
or 1a mutants and their normal littermates (Schneider 1978; Schneider and Marks
1983). Fourth, Popoff et al. (1990) have shown increased proliferation of QJ
thymocytes compared to normal thymocytes, when cultured in the presence of
interleukin 1. Nevertheless, immune dysfunction secondary to the skeletal
abnormalities is likely.
Some osteopetrotic mutations are cured by stem cell replacement (see Table 1),
and include the Qj and 1a rats and the mi and gl mice (Walker 1973, 1975a,b; Milhaud
et al. 1975; Marks 1976). As mentioned above, these findings were the result of the
pioneering work of Walker, who first cured osteopetrosis in a mouse by parabiosis with
a normal littermate. However, stem cell therapy does not cure osteopetrosis in QJ or 
mice, 11 rats, or sa rabbits (Marks et al. 1984; Seifert and Marks 1987; Marks
1977b; Popoff and Marks 1991). This indicates that the defect in these mutations is not
in the stem cells themselves but in other factors in luding the skeletal
microenvironment.
Experimental investigations of osteopetrotic mutations have contributed to our
understanding of bone cell biology, especially osteoclast development and function
(Marks 1989). These contributions include advances in understanding calcium and
phosphate homeostasis, the regulation of bone resorption, and the origin and function 
osteoclasts. In addition, the transplantation experiments of Walker and colleagues
provided the first successful clinical treatment of human malignant osteopetrosis
(Coccia et al. 1980; Sorell et al. 1981). These animal models are likely to provide
additional insights concerning bone cell biology, including the role of CSF-1 and other
factors in the regulation of generalized and site-specific osteoclastogenesis, end organ
resistance to vitamin D, control of bone modeling and remodeling by local factors and
cells, and the clinical management of the osteopetroses.
The human osteopetroses exhibit both autosomal recessive and dominant forms of
inheritance. The autosomal recessive forms of osteopetrosis are usually malignan1 and
fotlow a progressively deteriorating course within the first decade of life (Nussey
1938). Clinical complications of reduced bone resorption include obstruction of cranial
formina resulting in increased cranial pressure, mental retardation, optic atrophy,
blindness, and deafness (Cournot et al. 1992). Infantie osteopetrosis is often
accmpanied with low levels of serum calcium and phosphorous (Reeves et al. 1981),
increased parathyroid gland activity (Glorieux et al. 1981), and extramedullary
hemopoiesis (Freedman and Saunders 1981; Cook and Moore 1992). The autosomal
dominant forms of the disease are relatively benign and follow a progressive course with
aging (Bollerslev et al. 1993). Clinical attempts to manage infants with osteopetrosis
remain experimental and have resulted in mixed success (Sorell et al. 1981; Key et al.
1984; van Lie Peters et al. 1993; Coccia et al. 1980; Coccia 1993), thus ilustrating
the heterogeneity among human osteopetroses.
Recently, a transient form of infantile osteopetrosis was described (Monaghan et
al. 1991) in which an infant presented clinical signs of severe malignant osteopetrosis
at birth that diminished during the first year of life. This mild form of osteopetrosis
demonstrates the need to distinguish at birth, those infants in whom the disease wil
become progressively lethal, from those who wil gradually improve.
N
E
 
R
E
R
PT
I
B
O
N
E
O
Y
S
A
N
T
FO
RM
"
D
EF
lE
TH
A
L?
o
p/
op
Y
es
1/
10
th
I/D
CS
F-
1/
LE
m
i/m
i
1/
20
th
Y
es
SC
/L
E
o
c/
oc
Y
es
gl
/g
l
Y
es
Y
es
Y
es
N
E
 
R
E
R
PT
I
B
O
N
E
B
M
T
R
J\I
BI
BI
T
A
N
T
FO
RM
"
D
EF
E
LE
TH
A
L
o
slo
s
lID
O
CU
LE
Y
es
N
E
 
R
E
R
PT
I
B
O
N
E
B
M
T
R
A
T
A
N
T
FO
RM
D
EF
E
LE
TH
A
L?
ia
/ia
7/
10
th
11
0
Y
es
o
p/
op
Y
es
D
IN
Y
es
Y
es
II
 
t
 
I
1/
20
th
 
D
IN
LE
(C
SF
-1
?)
N
o?
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
m
. 
m
.
Y
es
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
M
ic
e
o
p
/o
p 
= 
o
st
eo
pe
tro
tic
m
i/
mi
 =
 m
ic
ro
ph
th
al
m
ic
o
c/
oc
 =
 os
te
os
cl
er
ot
ic
g
l/
gl
 =
 g
re
y-
le
th
al
R
at
s
m
ib
/m
ib
 =
ia
/i
a 
=
o
p
/o
p 
=
t
 
1f
t 
I 
R
ab
bi
t
o
s/o
s
(os
teo
scl
ero
tic
)
O
th
er
s
B
M
T 
=
e
x
l 
=
s
c
 
=
L
E
 
=
bo
ne
 m
ar
ro
w 
tra
ns
pl
an
t
o
st
eo
cl
as
t
st
em
 c
el
l
lo
ca
l e
nv
iro
nm
en
t
O
th
er
s
R
B
 =
 ru
ffl
ed
 b
or
de
r
D
cl
 =
 os
te
oc
la
st
25
 =
 vi
ta
mi
n 
D
Ca
 =
 ca
lc
iu
m
P
i 
= 
ph
os
ph
at
e
CS
F-
1 
= 
co
lo
ny
-s
tim
ul
at
in
g 
fa
ct
or
-
m
ic
ro
ph
th
al
m
ia
 b
la
nc
in
ci
so
r a
bs
en
t
o
st
eo
pe
tro
tic
to
ot
hl
es
s
(Q
IY
O
A 
If
M
A
lf
~
~
~
A
G
E
C
 
1
ia
/
2 
wk
in
ci
so
r a
bs
en
t
4 
wk
ha
rd
 to
6 
wk
ex
tr
ac
t
Q.
 
o
st
eo
pe
tro
tic
2 
wk
4 
wk
(50
%)
6 
wk
6 
wk
to
ot
hl
es
s
2 
wk
4 
wk
(73
%)
A
P 
= 
A
lk
al
in
e 
Ph
os
ph
at
as
e
O
P 
= 
O
ste
op
on
tin
 . .
D
C 
=
 O
lp
in
.
 
:',
:'
C1
 =
 T
yp
e
1 
Co
'i
la
ge
h
F 
= 
Fi
br
on
ec
tin
 
"
 
-
H
4 
,; 
H
is
to
ne
 4
I
 
=
 
In
cr
ea
se
D
ec
re
as
e
N
 =
 N
or
m
al
=
 
I
n
c
r
e
a
s
e
 
T
r
e
n
d
I
l 
= 
De
cr
ea
se
 T
re
nd
Part E:
Tooth Eruption--An Opportunity to Study Localized Osteoclast Development and Function
Tooth eruption is defined as the dynamic process whereby a tooth is translocated
from its developmental site in alveolar bone to its functional position in the oral cavity
(Massier and Schour 1941). For this process to occur, bone above the erupting tooth
must be removed while new bone forms below it. These events represent a localized,
bilaterally symmetrical, and precisely timed biological growth process (Cahil et al.
1988; Marks et al. 1988). The precise timing of the cellular, biochemical and
molecular events (discussed below) which cause tooth eruption, and the necessity of
bone resorption for eruption, provide a unique opportunity for the study of local
osteoclast development and function.
Theories of Eruption
Many attempts to explain the process of tooth eruption have centered on the belief
that mechanical forces, rather than biological processes accunt for the movement of
teeth during eruption (Cahil et al. 1988). Despite recent advances in understanding the
biology of tooth eruption, mechanical force explanations remain popular, perhaps a
consequence of orthodontic succss in causing erupted teeth to move by influencing bone
resorption and formation at opposite sides of the tooth via applied orthodontic apparati.
Mechanically-based theories are based on forces generated by pulp, root elongation,
alveolar bone growth, periodontal ligament, and vasculature.
Pulp-based theories state that the propulsive forces necessary to move teeth
originate in the dental pulp. Presumably, forces are produced by the generation of
higher pressure below the tooth and lower pressure above by extrusion of pulpal tissues
during dentin growth, interstitial pulp growth, or hydraulic pressure provided by the
pulp vasculature (Sicher 1942; Bryer 1957; Eccles 1961). The vascular theory of
eruption was proposed by Constant (1900). The concept is similar to the pulp theory in
that hydraulic pressure within or beneath the tooth provides the force necessary for
eruption. These theories were supported by the observation that the average tissue
pressure was higher in the pulp of erupting dog teeth than in tissues above those teeth
(Van Hassel and McMinn 1972). Despite their careful measurements, Van Hassel and
McMinn failed to compare these findings with pressure measured in and around
non erupting teeth, which may also possess higher pulp pressure. In addition, teeth
erupt when pulp is surgically removed (Herzberg and Schour 1941). Furthermore,
metal (pulpless) tooth replicas erupt in beagle dogs (Marks and Cahil 1984).
Alveolar bone growth-based theories stem from the work of Brash (1928), who
determined that the mandible grows in height during prefunctional eruption and
concluded that appositional bone growth beneath the erupting teeth raises the teeth to
their functional site. Others have shown that significant amounts of bone form below
erupting teeth (Cahil 1970; Cahil and Marks 1980). While bone apposition below
erupting teeth may partially explain the process of eruption, these authors are cautious
and point out that other factors are likely to be involved (see below).
Support for the theory that the periodontal ligament (PDL) produces the
mechanism for tooth eruption comes from studies on the continuously erupting rat
incisor (Berkovitz and Thomas 1969). Forces of between 5 and 7 grams were found
necessary to impede incisor eruption in the rat. Additional evidence stems from root
resection experiments. in which removal of the proliferative growth zone of the incisor
impeded eruption (Ness 1957). Moxham and Berkovitz (1974) continued these studies
in transection experiments--known as root resection methods--in which the distal
incisor segment continued to erupt after surgical separation from its proximal or
growing end. Since the distal segment was connected to alveolar bone by the PDL alone,
these experiments clearly indicated a role for the PDL in tooth eruption. These clever
experiments eliminated theories based on forces generated by the pulp, root growth, and
alveolar bone growth. Some investigator have suggested that contractile forces
generated by fibroblasts and/or collagen fibrils within the PDL accunt for these
observations (Ten Cate 1985; Berkovitz et al. 1982).
Clinical observations. have discounted the mechanical theories of eruption. For
example, root growth theories are compromised by the observations that teeth rendered
rootless by irradiation, congenital renal disease, or surgical interventions erupt in
children (Carl and Wood 1980; Brin et al. 1985; Barfoed et al. 1984).
The development of the tooth offers some insights concerning the biological
mechanism(s) of eruption. Teeth develop within bony crypts and are derived from the
collaborative interaction of epithelial and mesenchymal cells of the first brachial arch
(Marks et al. 1994; Slavkin 1990; Thesleff et al. 1991). As teeth develop, the
surrounding mesenchyme condenses to form bone of the mandible and maxila. This
formation of alveolar bone depends upon the timely development of the dentition, since
failure of tooth formation impedes formation of alveolar bone (Landsberger 1924;
Brash 1928). The bony crypts of developing teeth are connected to the gingiva by an
epithelial strand known as the gubernaculum, the remnant of the original epithelial
invagination from which the teeth developed (Mallassez 1885). In many mammals, the
gubernaculum narrows to form a stalk- like structure which passes through a
gubernacular foramen in the jaw. In other mammals the gubernaculum remains broad,
and the bony crypts of developing teeth are connected to the oral epithelium by a trough
or groove (Park 1973). In any case, the developing tooth is surrounded by alveolar
bone. Therefore, in order to erupt, the bone between the tooth and the oral cavity must
be removed.
A new concept of tooth eruption
These observations led to another theory of tooth eruption, which asserts that
localized bone resorption above the tooth p oduces an eruption pathway from which the
tooth emerges (Cahil and Marks 1980). Several lines of evidence support t is concept.
First, th radiographic and histologic hallmark of bone resorption during tooth eruption
is the timely formation of an eruption pathway (Marks et al. 1993). Second, teeth do
not erupt when bone resorption is absent or reduced. This is perhaps best ilustrated in
the spectrum of aberrant tooth eruption observed among the mammalian osteopetroses, a
metabolic bone disease caused by compromised osteoclastic bone resorption (see above).
Teeth do not erupt in the most severe forms of the disease (e.g.. 11, toothless rat), while
absence of erupted incisors and delays and/or absence of erupted molars is observed in
mutations with less severe reductions in bone resorption (mi, microphthalmia blanc,
la, incisors-absent rats) (Seifert et al. 1993). Earlier erupting teeth are most affected
in these mild forms. Third, tooth eruption is restored in osteopetrotic animals with
treatments that cure or improve the disease, such as stem cell replacement and
administration of CSF-1, respectively (Iizuka et al. 1992). Daily injections of this
hemopoieitic growth factor cause an increase in osteoclast number and dramatically
improve the skeletal manifestatio.ns of the disease in 11 rats. However, timing is critical
in these cases since delays in treatment compromise eruption of particular teeth. Both
incisors and molars erupt in individuals treated from birth with CSF-1, but delaying
treatment by only one day inhibits incisor eruption (lizuka et al. 1992). Fourth, tooth
eruption is blocked by surgical removal of the dental follcle, which prevents bone
resorption and formation of an eruption pathway (Marks and Cahil 1987; Cahil and
Marks 1980). Fifth, local delivery of bafilomycin A1, an antagonist of osteoclastic
proton pumps, results in a temporary inhibition of tooth eruption by blocking bone
resorption (Sundquist and Marks 1994). These data also supprt the recent hypothesis
that the dental follcle is needed for the bone resorption of tooth eruption.
Scanning electron microscpy of mineralized surfaces of the bony crypts
surrounding erupting teeth demonstrates that the crypt consists of three different
topographical regions: an upper area characteristic of bone resorption, a lower region
characteristic of forming bone, and an intermediate or transitional zone typical of
resting bone undergoing neither resorption nor formation (Marks et al. 1994). Light
and electron microscopy of these surfaces reveals that they are covered with the
appropriate cellular correlates which include numerous active osteoclasts and
osteoblasts on upper and lower crypt surfaces, respectively (Marks et al. 1983; Marks
and Cahil 1986).
Surgical experiments and clinical observations provided the first evidence that
formation of an eruption pathway requires only the dental follcle, the loose connective
tissue investment of the tooth. Cahill (1969, 1974) demonstrated that an eruption
pathway is produced by osteoclastic bone resorption even when tooth movement--and its
resultant pressure on bone--is blocked by transmandibular wires. Indeed, eruption
pathway formation is independent of the tooth, since metal replicas of dog premolars
erupt on schedule, provided they are surgically placed within the corresponding dental
follcle (Marks and Cahil 1984). Surgical ablation of the follcle impedes eruption in
dogs and clinical procedures which result in damage to the follcle block eruption in
children (Cahil and Marks 1980; Barfoed et al. 1984). Additional surgical
interventions by Marks and Cahil (1987) demonstrated that the coronal portion of the
follcle is required for bone resorption and formation of an eruption pathway above the
tooth , while the basal follcle is needed for bone formation below the tooth. These
observations imply that the dental follcle coordinates events at opposite ends of the
tooth, namely osteoclastic bone resorption on adjacent coronal crypt surfaces and
osteoblastic bone formation on adjacent basal crypt surfaces.
The mechanisms by which the fol cle regulates physiologic processes on
opposite ends of the tooth are currently being examined. Tooth eruption is preceded by a
cellular infiltration of mononuclear cells into the dental follcle in rats and dogs (Wise
and Fan 1989; Marks and Grolman 1987). It is generally believed that these cells are
progenitors to the osteoclasts responsible for the bone resorption of tooth eruption,
since they have ultrastructural and histochemical features of preosteoclasts and their
arrival in the follcle precedes or coincides with the appearance of osteoclasts on
adjacent alveolar bone surfaces (Marks et al. 1983; Marks and Grolman 1987; Wise and
Fan 1989).
Biochemical analyses of the dental follcle of canine permanent premolars have
provided additional evidence for the role of the dental follcle in tooth eruption. The dog
premolar dental follcle is a highly hydrated structure that reaches its greatest mass at
the onset of prefunctional eruption. During eruption , collagen and proteoglycan content
increase 250% and 45%, respectively (Gorski et al. 1988a,b). These authors
identiied more than 20 proteins in the follcle prior to eruption, including a
sialoprotein of 95,000 relative molecular weight (DF-9S). It is interesting to note
that DF-9S content is reduced at the onset of eruption, when three new, small molecu1ar
weight sialoproteins appear. Since the relative abundance of the three new sialoproteins
present at the onset of eruption coincides with the total content of DF-9S prior to
eruption, the authors concluded that fragmentation of DF-9S is a marker for the onset of
eruption. Additional studies have shown that the dental follcle contains collagenolytic
activity (Woessner and Cahil 1974) and the amount of metalloproteinases (collagenase
and strome lysin) is reduced during eruption (Gorski and Marks 1992), suggesting a
role for these enzymes in tooth eruption. Recently, Gorski and others (1994)
demonstrated that DF-9S is localized to the reduced enamel epithelium, providing
biochemical evidence that this derivative of the oral epithelium is involved in eruption.
Numerous proteases have been identified in'. the enamel organ during tooth development
(Nanci et al. 1989, Smith et al. 1989; Den Besten et al. 1989), and their activation at
the completion of crown formation may contribute to the eruption process by
fragmenting DF-9S and initiating the release of metalloproteinases from the follcle.
The molecular regulation of tooth eruption remains a mystery. Cohen (1962)
demonstrated that injections of epidermal growth factor (EGF) cause precocious
eruption of incisors in rodents. Recently, EGF and EGF-receptor were localized to cells
of the dental follcle and enamel organ early in erupting rat molars (Wise et al. 1992).
In addition, cells of the dental follcle produce mRNA for CSF-1 and secrete the protein
in culture (Wise et al. 1994). These data, the observation that EGF upregulates the
production of CSF-1 message and protein (Abboud 1992), and the aforementioned data
concerning the effects of CSF-1 on osteoclastogenesis suggest that both of these growth
factors are involved in the molecular cascade which produces the bone resorption of
tooth eruption (Figure 3). The precise timing of these cellular and molecular events,
together with the necessity of bone resorption in tooth eruption , provide a unique
opportunity for studying osteoclast ontogeny, tooth eruption , and bone resorption in
general.
Part F:
Future Directions
As in most fields of biological research, bone cell biologists are confronted with
the problem of how to study the complex regulation of skeletal metabolism.
Skeletal metabolism consists of the production and mineralization of a complex matrix
by one group of cells and removal of the mineralized matrix by another. These processes
are all timed and coordinated so that, in skeletal development. matrix formation and
mineralization exceed resorption to produce a functional skeleton; later these processes
are cordinated and balanced to maintain skeletal mass. These successive periods require
a precise coordination of the development and function of several different cell
populations, and may involve different mechanisms for each. In a sincere scientific
effort to limit the known and unknown variables operating in , bone cell biologists
have used an ever increasing variety of cultured bone cell and tissue preparations to
study skeletal development and regulation (Marks and Popoff 1988). While in 
approaches have provided reliable observations in some instances, they have been almost
universally deficient in demonstrating the mechanisms for precise, local regulation of
. skeletal metabolism. This is in part due to the redundancy of such controls, lessOns
which are emerging from the initially disappointing but surprising results from
specific gene knockouts (Erickson 1993). On another level in observations suffer
from the varying inabilty of culture conditions to duplicate those in
Specifically, in the recent past, studies of macrophages as osteoclast surrogates
(Kahn et al. 1978) and cloned osteosarcoma cells as osteoblast surrogates (Majeska and
Rodan 1982) have been disappointing at best and erroneous at worst (Hattersley and
Chambers 1989; Grigoriadis et al. 1985). Similarly, studies of the effects of the
growth factor, colony-stimulating factor-1 (CSF-1), on cultured osteoclasts have been
contradictory (Tanaka et al. 1993; Shinar et .sl. 1990). In addition, the use of bone
organ cultures in the initial report of the skeletal effects of the prostaglandins produced
limited, erroneous information about their true effect in (Marks and Miler
1993). Because organ cultures of bone invariably resorb, the initial report described
resorption as the major effect (Klein and Raisz 1970), and it has taken more than two
decades to reverse this view, and establish enhanced bone formation (Ueda et al. 1980;
Mori et al. 1990; Miler and Marks 1993) as the true effect in Finally, no
current methods for the isolation and culture of specific bone cells can produce pure
populations, and contaminants are seldom characterized with precision (Chatterjee et al.
1992). At best, these methods permit evaluation of either bone formation or resorption
in presumed isolation, a phenomenon rarely encountered in
The relative simplicity of all in methods to study bone cell biology wil at
best result in oversimplification of the developmental and functional capacity of the
skeleton in We have shown this to be the case for selected aspects of bone cell
biology, but numerous other examples are available.
One alternative is to undertake skeletal research in It is important that
those in bone research be wiling to move increasingly in this direction not only to
understand the true complexities of skeletal versatilty, but also to avoid repetition and
perpetuation of erroneous or irrelevant conclusions which waste resources.
Toward this end, we have described two situations, osteopetrosis and tooth
eruption, in which reproducible aberrations or local activations of bone resorption can
be examined in . This dissertation used these examples to explore aspects of
osteoclast development and function.
Part G:
Manuscripts
Some of these topics have been described in the three publications below which I
have co-authored.
1. Experimental studies of osteopetrosis in laboratory animals
2. The role of bone resorption in tooth eruption
3. Bone surface morphology refJects local skeletal metabolism
Reprinted from CUNICAL ORTHOPAEDICS, September. 199
Volume 294
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Experimental Studies of Osteopetrosis
in Laboratory Animals
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Osteopetrosis is a metabolic bone disease charac-
terized by a systemic increase in skeletal mass. It
results from a defect in the production or function
of osteoclasts and is inherited in nine genetically
distinct osteopetrotic animal mutations and man.
Studies of these mutations have revealed that os-
teopetrosis is a complex, heterogeneous disorder
in its expression, etiolog, and response to treat-
ment by bone marrow transplantation or by hor-
mone/growth factor therapy. These animal muta-
tions have been valuable tools for probing the
pathogenesis and treatment of osteopetrosis, and
information obtained from these studies has ben
used clinically for the treatment of humans with
osteopetrosis. In addition, studies of these muta-
tions have contributed significantly to understand-
ing normal bone cell biology, including the origin
of the osteoclast and the significance of colony-
stimulating factor-I in osteolast development.
The resistance of some of these mutations to cure
by stem cell transplantation and hormone therapy,
coupled with similar observations and experiences
in the human condition, indicates that these animal
mutations wil continue to serve important roles in
the development of alternative therapies to treat
resistant forms of the disease. These studies are
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bound to improve the understanding of normal
bone biology by providing additional insights into
the regulation of osteoclasts by osteoblasts and
their products or by other elements of the skeletal
microenvironment.
Osteopetrosis in mammals is an inherited
disorder of bone metabolism resulting from
reduced osteoclast function and is character-
ized by a generalized, net accumulation of
skeletal mass. Recent reviews of osteopetro-
sis have emphasized the skeletal parameters
of the diseas, and its heterogeneous expres-
sion has been explained on the basis of inter-
cepted osteoclast function sometime within
their complex life history.27,28 This review
summarizes these parameters and concen-
trates on the implications of new information
about cytokines and matrix factors in the
pathogenesis and therapy of osteopetrosis.
This information reinforces the remarkable
heterogeneity among the mammalian osteo-
petroses with respect to pathogenetic mecha-
nisms of expression of this disease. Recent
studies show that deficiencies in osteoclast
number and/or function can be caused by ge-
netic defects in other cells in bone, including,
but not necessarily limited to, osteoblasts.
Thus, successful treatment of some of these
mutations may require methodology more
complex than presently imagined and, as a
result, wil provide new insights into bone bi-
ology.
The most commonly studied animal mu-
tations and their distinguishing characteris-
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tics are listed in Figure 1. Each mutation is
inherited as an autosomal recessive trait. The
four mutations in the mouse are on different
chromosomes. Two of these mutations are
lethal, causing the affected animals to die of
unknown cause three to five weeks after
birth. The four mutations in the rat are not
alleles 46.47 and one mutation
, the op rat, is
lethal. The microphthalmic (mib) rat muta-
tion has the mildest skeleta manifestations of
the animal mutations. The single mutation
in the rabbit is lethal, causing the affected an-
imals to die within five weeks of birth. Thus,
nine genetically distinct osteopetrotic muta-
tions occur in common laboratory animals
and have lifespans that vary from a few weeks
to normal longevity when given proper care
and nutrition. The cellular and biochemical
bases for the phenotypic heterogev.eity in os-
teopetrosis are explored below.
SKELETAL MANIFESTATIONS
TISSUE SIMILARITIES PRODUCED BY
DIVERSE ABERRTIONS IN THE SKELETAL
MICROENVRONMENT
At the tissue level, the skeletal manifesta-
tions of the osteopetroses are remarkably sim-
ilar. Bone shape is abnormal. The ends of
long bones are typically broad and cylindrical
and lack the external modeling characteristic
of normal bones. Internally, marrow cavity
formation is either delayed or, as more often
the case, absent. This produces the pathogno-
monic radiogrphic appence of homoge-
neously dense bone. At birth, individual
FIG. 1. Comparison of data regard-
ing osteoclast biology and response to
cure by bone marrow transplantation
of animal and human osteopetroses.
Increases or decreases relative to un-
affected animals indicated by arrows,
presence or absence by + or - , and
recessive or dominant inheritance by 
R or D. ?, unknown. Opposite param-
eters reported together indicate both
have been observed.
mutations cannot be distinguished from each
other radiogrphically. Later, however, mu-
tations whose skeletons become progressively
less dense with age (i. e.. ia. mib) can be distin-
guished from those whose skeletons change
little in density with age (i.e., mi. t/). External
modeling of long bones and the formation of
marrow spaces require bone resorption, and
thus, the tissue manifestations of osteopetro-
sis are the direct result of reduced bone re-
sorption. Bone resorption has been measured
in four mutations, and the results are shown
in Figure 2. Resorption rates range from un-
detectable in tf rats to 70% of that in normal
littermates of ia stock. 18 Values for mp2 and
DC mice lie in between. Reduced bone re-
sorption is also responsible for a delay or fail-
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FIG. 2. Summary of meaurements of bone re-
sorption in four osteopetrotic mutations.
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ure of tooth eruption that occurs in all osteo-
petrotic mutants.
.53 
In contrat to the tissue level similarties
noted above, there are differences in skeletal
cells and matrix among the mutations. Os-
teoclast numbers per unit area of the skeleton
are reduced in most mutations but increasd
in ia rats and in tibial bone from oc mice. 17 In
addition, the active site for bone resorption in
osteoclasts, the ruffed border 31 is absent or
poorly developed in most mutants.26 An ex-
ception is the op mouse where extensive ruf-
fled borders are seen on the few osteoclasts
present in the skeleton. Regardless of the
numbers and ultrastructure of osteoclasts,
net osteoclast function is reduced in all muta-
tions. Abnormalities in osteoblasts have been
reported but have not been studied exten-
sively. Reductions in osteoblasts per unit area
ofthe skeleton in tl rats 74 and ultrastructural
and functional evidence of degrdative
changes in osteoblasts from os rabbitsJO.
have been reported. Bone formation , evalu-
ated by 3 proline uptake is increased in
the four osteopetrotic mutations in the
mouse,3S,36 but decreased in all other muta-
tions in which it has been examined. Thus
it appears that in the mouse mutations, ele-
vated bone formation complements reduced
resorption to accentuate skeletal sclerosis.
The reductions in osteoblast numbers and/or
functional capacity in tl rats and os rabbits
may be related to the reduction in bone re-
sorption. The role of osteoblasts in regulating
osteoclast function is increasingly appre-
ciated. s9 Thus, the failure of osteoblas to
produce local mediators of resorption could
produce the reduced resorption seen in some
osteopetrotic mutants.
Morphologic, physiologic, biochemica,
and molecular evidence of aberrtions in the
skeletal microenvironment in osteopetrosis
has appeared recently, providing additional
support for a primar osteoblast defect in
some osteopetrotic mutations. The persis-
tence of an amorphous material between ca-
cified calage and bone in metaphyse tra-
beculae from oc mice72 provides morpho-
Studies of Osteopetrosis in Animals
logic evidence of a matrix abnormality in this
mutation. This amorphous material overlies
the lamina limitans of cacified cailage, and
neither the material nor the lamina limitans
can be resorbed by either mutant or normal
osteoclasts. 2,80
Physiologic evidence for an abnormality in
the skeleta microenvironment in osteopetro-
sis is the impaired production of colony-
stimulating factor- l (CSF- l, or macrophage
colony-stimulating factor, M-CSF) by mu-
tant bone,89 bone cells,7 and fibroblasts in 
mice. 89.91 Further characterization of the
CSF- l defect has shown that a bas pair
insertion in the coding region for the gene
results in synthesis of a truncated molecule
without biologic acti vity. This, the first molec-
ular brekthrough in osteopetrosis, suggest
that the op mouse phenotyp, having few
macrophages88 and osteoclasts, with the
latter possssing well-developed ruffed
borders,24 is caused by the absence of CSF-
This condition is not lethal, and the postnatal
skeletal sclerosis in op mice improves with
age. These data suggest that CSF-
needed for macrophage and osteoclast devel-
opment, but not function. Treatment of
young op mice with CSF- I (see below) re-
stores bone resorption and cures the skeleta
sclerosis. Recently, it has been shown that
osteopetrosis and tooth eruption in tl rats is
improved but not cured by treatment with
CSF- 37 These different effects of CSF-
treatment in op mice and tl rats suggest that
use of this growth factor might stimulate
bone resorption in other mutations.
Biochemical evidence of matrix aberr-
tions in osteopetrosis consist of the observa-
tion that osteocalcin is reduced in calvarial
bone from tl and op rats. IS Gene expression
in ia. tl. and op rats during development
shows distinct differences among these muta-
tions with respect to bone cell proliferation
(histone H4) and extracellular matrix (colla-
gen Typ I, alkaline phosphatase, osteopon-
tin, and osteocalcin) mRNA levels compared
with normal littermates. These data rase
questions about osteoblast competence in
Seifert et aI.
some osteopetrotic mutations (i. e., op and 
rats) and suggest that aberrtions in matrix
synthesis or composition may contrib te to
the reduced bone resorption in thesJrhuta-
tions.
The reviews above show that the common
tissue phenotyp in osteopetrosis, skeleta
sclerosis with deformities in bone shape, is
accompanied by a host of differences in bone
cell function and matrix components.
CURE OF THE SKELETAL PHENOTYPE
THE VARIABLE SUCCES OF STEM CELL
TRANSPLANT AND HORMONE/GROWT
F ACfOR THERAPY
The first cellular breakthrough in osteope-
trosis was the demonstration by Walker8
that parabiotic union of a mi mouse and its
normallittermate cured the skeletal sclerosis
in the mutant. Further work by this imagina-
tive pioneer8 showed that temporary para-
biotic union for two weeks resulted in a cure
two months later and that the same effect
could be produced by a single transplant of
normal hemopoietic tissue (bone. marrow
or spleen in the mouse) into mi or gl mu-
tants. S-7 This was soon confirmed by
. others and also was shown to cure skeletal
sclerosis in the 
42 
and mutations in the
rat. The cellular bases of these results have
ben pursued by fluorescence-activated cell
sorting to show that the cure is effected by
hemopoietic stem cells of the grnulocyte-
monocyte lineage. This pioneering work
was directly responsible for the firs success-
ful clinical treatments of children with osteo-
petrosis. lI,
However, not all mutations are cured by
stem cell transplantation. This treatment
, does not produce a cure in 
op3 or mice,
. i" tl rats
21 or 
os rabbits,54 and has not been suc-
cessful in severa childcen. This implies that
'!1dn these mutations
, the defect lies in cells
'other than transplantable stem cells or in the
10c microenvironment. One example is the
. CSF- l deficiency in the op mouse.
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The fact that bone resorption is reduced in
osteopetrosis prompted the use ofpharaco-
logic doses of known promoters of resorption
in an attempt to overcome a suspected resis-
tance. This treatment is not new. Bamicot2
noted that gl mice thrived on amounts of
parthyroid extract that otherwse killed their
normallittermates by prolonged hypercalce-
mia. Resistance to the hyprcalcemic effects
of parathyroid hormone (PTH) has also been
noted in mi, OC, 35 and op29 mice, and and
tPI rats. Prolonged treatment with pharmaco-
logic doses of PTH fails to cure osteopetrosis
in gl mice ia rats, 18 and os rabbits. 83
The use of pharmacologic doses of 1 25-
dihydroxyvitamin D (I ,25(OHhD) to cure
osteopetrotic mutants has been equally frus-
trating. 56 Serum levels of 1 25(OH)2D are
elevated in all mutations examined 92 and has
led to the suggestion that osteoclasts are resis-
tant to the effects of this hormone in these
animals. Administration of high doses of
1 ,25(OH)2D in the os rabbit failed to increase
bone resorption 56 despite increases in osteo-
clast number and acid hydrolase content.
Similarly, such treatment has met with vari-
able clinical success in children with osteope-
trosis. 14 
The recent cure of osteopetrosis in the 
mouse by injections of CSF- I represents the
specific delivery of a substance known to be
deficient in . this m utation. 7,89,9 I Whether the
use of this or other cytokines wil be success-
ful in children will depend in large meaure
on the cellular and biochemical parameters
of their disee. Children or other mutations
with low numbers of monocyes, macro-
phages, and osteoclasts wil be good candi-
dates. The rationale for the use of CSF- I wil
be significantly improved if fibroblasts or
other cells from these individuals produce
low or undetectable levels of this growth fac-
tor. Therapeutic options for the treatment of
osteopetrosis have been ' enhanced by this
demonstration of the effectiveness ofCSF-
However, the challenges of developing crite-
ria for specific treatments remain.
Pathogenetic and therapeutic characteris-
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tics of various osteopetrotic mutations are
summarzed in Figure 3. Among the animal
mutations, there are great differences in num-
bers of osteoclasts, presence of a rum
border, and response to cure by transplants
stem cells. Many of these parameters are un-
known for the human osteopetroses, and
when known, they are variable. It is likely
that the various interceptions of osteoclast
function present in the animal mutations are
also seen in the human conditions. However
the absence of an animal mutation with car-
bonic anhydrase II deficiency should pre-
clude undue reliance on parallels between the
two groups. Furthermore, criteria to distin-
guish between mutations cured and those not
cured by stem cell transplantation and devel-
opment of rational options for those not re-
sponding to such transplants, such as a combi-
nation of multiple treatments, remain impor-
tant challenges to basic scientists and
clinicians.
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OSTEOPETROTIC MUTATIONS
FIG. 3. Serum concentrations of 1,25-dihydrox-
yvitamin D) in seven osteopetrotic mutations in
three species. For each stock, paired mean values
are shown for normallittermates (open bars, left)
and for mutants (shaded bars, right). (Reprinted
with permission from Marks, S. c., Jr. : Osteoclast
biology: Lessns from mammalian mutations.
Am. J. Med. Genet. 34:43, 1989.
EXTRASKELET AL MANIFESTATIONS
A major extrakeleta manifestation in os-
teopetrotic animals is significantly elevated
serum 1 25-dihydroxyvitamin D. Figure 3
shows that serum 1 25(OHhD is markedly
elevated in the seven mutations examined to
date compared with their normallittermates.
Also note the variation in serum levels of
normal animals among the various stocks,
particularly the op rat. Age-related determina-
tions of serum 1,25(OH)2D levels have only
been done in a few mutations. Serum levels
in tl rats are already elevated one week after
birth, peak almost four times the level in nor-
mallittermates at three weeks of age, and re-
turn toward normal levels by five weeks. 
Serum levels in op rats remain four times
those in normal littermates four and six
weeks after birth, whereas those in ia rats
peak about three weeks after birth. IS These
data in the presence of reduced bone resorp
tion suggest a skeletal resistance to 1,
(OHhD. Whether other tissues are resistant
to 1 25(OH)2D remains to be shown. How-
ever, studies of vitamin D-dependent intes-
tinal calcium binding protein (calbindin-
in oc mice and tl rats show precocious devel-
opment parallel to the elevations in serum
25(OH)2 There are few studies of
renal function in osteopetrotic animals, but
data of Nesbitt and colleagues show that
renal 25-hydroxyvitamin D- l a-hydroxylas
is elevated in oc mice and that this enzyme is
suppressible with a high calcium diet, sug-
gesting increased synthesis as a major cause
of high-circulating 1,25(OH)2D. These data
together suggest that skeletal resistance to
25(OH)2D and abnormal production of
this vitamin D metabolite are characteristics
of congenital osteopetrosis in animals. The
relationship of the skeletal and endocrine
manifestations of the disease clearly deserve
more study.
Studies of immune function in osteopetro-
sis have produced conflcting results. Early
studies in the op rat desribed premature thy-
mic atrophy, reduced mitogenic responses of
Seifert et al.
splenic and thymic lymphocytes, normaliza-
tion of these parameters after bone marrow
transplantation from normallitterma,es, and
cure of skeletal sclerosis after transplantation
of normal thymic tissue.40. 43 Reduced mi-
togen-induced lymphocyte proliferation has
also been reported in spleen cell isolates from
mi and op mice 51 and op rats. These data
have led to the hypothesis that osteopetrosis
is the skeletal result of a thymic disorder.40.
However, thymic transplants fail to cure os-
teopetrosis in mi mice and op rats, 50 and
when the compensatory splenic hemopoiesis
of osteopetrotic mutants is taken into ac-
count by comparing the mitogenic responses
of mononuclear cell isolates (lymphocytes)
rather than whole spleen cell suspensions, no
differences in mitogenesis are seen in op and
mi mice64.90 and op rats. Additional evidence
for normal thymic function in osteopetrosis
is the demonstration of a normal delayed-hy-
persensitivity response in ia rats,60 the ab-
sence of qualitative and quantitative differ-
ences between mutants and normal litter-
mates of mi and ia stock in the cellular
composition of the thymus and thymus-de-
pendent (T-cell) zones in lymph nodes and
spleen 60.64 the absence of cytopenia in T-cell
subsets from thymus and peripheral lym-
phoid organs of op rats, and the iJ1creased pro-
liferation of op compared to normal thymo-
cytes cultured in the presence of interleukin-
I and a co-mitogen. 52 These data together
with the observation that athymic rats are not
osteopetrotic, 39 have been interpreted to
mean that the thymus is not directly involved
in bone resorption and that any thymic ab-
normalities are likely to be secondary to the
skeletal or nutritional condition.
Aberrations in T-cell independent im-
mune function in osteopetrosis are supported
by the following: reduced macrophage oxida-
tive metabolism and iodination in ia rats;
decreased fusion abiHty ofmi macrophages;
impaired macrophage migration and chemo-
taxis in ia rats and mi mice;44 reduced natu-
ral kiler (NK) cell activity coexisting with de-
creased (mi mouse), normal (tl andop rats),
Clinical Onhopaedics
and Related ResearCh
or increasd (ia rat) numbers of 
cells;52. 68.78 and an interleukin-2 (IL-2) de-
ficiency in ia rats.66 In ia rats and mi mice,
there are parallels between NK/macrophage
and osteoclast numbers and function perhaps
reflecting a common prog nitor or common
developmental influences. This relationship
is supported by the abilty of IL-2 infusions
to restore NK cell function66 and elevate
bone resorption63 in ia rats. Although skeletal
and immune dysfunctions coexist in osteope-
trotic animals, their relationships remain un-
clear. Whether they are causative (i.e.. CSF-
in op mice or perhaps IL-2 in ia rats) or coin-
cidental wil require additional work.
THE CARE AND NURTURE OF
OSTEOPETROTIC MUTANTS
Any investigator using osteopetrotic ani-
mals must maintain a breeding colony for
each mutation to be studied and must con-
sider the fragile condition of most mutants 
the results of any study are to be reliable.
Maintaining a breeding colony for osteope-
trotic mutations is greatly facilitated by pro-
viding an optimal environment. Periodic
changes of clean cages, bedding, and water,
circulation of clean, warm air, and protection
of individual cages or groups of animals by
air filtration or laminar flow rack systems are
good investments for maintaining a healthy
colony and for producing healthy off-
spring.27,8 Meticulous record keeping is re-
quired for monitoring breeding performance,
output of mutant offspring, and dates of
birth. Additionally, a test breeding program
is necessry for most mutations (rats, rabbit)
to identify heterozygote carrers that wil
serve to replace retired breeders. Reduced
bone resorption interferes with tooth erup-
tion in mutants,23.27 making the daily provi-
sion of a soft diet to these animals after wean-
ing a requirement for maintaining their
health. In addition , compromises in immune
function of osteopetrotic mutants can be eas-
ily produced by the stress of malnutrition or
the failure to limit exposure of mutants to
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other strans or species of rodents. 27,
48,64 Body
weights of all mutants will eventualy lag be-
hind those of normal littermates, and this
may be sen in some mutations befor wean-
ing.29,33 After ' weaning, mutants shg\lld be
provided with a wet, ground mash ) to ensure
adequate nutrition. In addition, before mu-
tants are included in the study, body weights
should be checked for severa days, and ani-
mals with decreasing body weight should be
excluded. Mutants in poor health typicaly
lose weight for two or more days before they
die. These precautions safeguard against in-
. cluding malnourished or dying mutants in ex-
perimenta studies.
THE CONTRIBUTIONS OF
CONGENITAL OSTEOPETROSIS TO
BONE CELL BIOLOGY
Studies of osteopetrotic mutations have
made significant contributions to an under-
standing of the regulatory biology of bone
cells, particularly the osteoclast. These in-
clude the origin of the osteoclast, the role of
carbonic anhydrase II in bone resorption
and the significance of CSF- l in osteoclast
development. In addition, the resistance of
several mutations to cure by stem cell trans-
plantation and hormone therapy indicates
that studies of these mutations are likely to
provide additional insights into bone cell biol-
ogy in the areas of regulation of osteoclasts by
osteoblasts and their products, selective skele-
tal resistance to vitamin D, and control 
bone modeling. These opportunities, re-
cently reviewed,28 await exploration using os-
teopetrotic mutations.
PATHOGENETIC PATHWAYS AND
THE CLINICAL SIGNIFICANCE OF
CONGENITAL OSTEOPETROSIS
IN ANIMALS
A summar of pathogenetic possibilties
for osteopetrosis in animals is shown in Fig-
ure 4. This figure incorprates the data dis-
cuss above but is likely incomplete beuse
the mechanisms of osteoclast inactivation are
not known in several mutations. Osteoclasts
(Fig. 4) are derived from mononuclear pre-
cursors that are themselves the products of
proliferation of stem cells in hemopoietic tis-
sues. These precursors migrte to the skele-
ton, where they develop the ability to make
acid hydrolases and fuse with each other or
with preexisting osteoclasts. Some of these
steps in osteoclast ontogeny are regulated by
CSF- l and 1 25(OH)2D. Osteoclasts, in turn
need to be activated to resorb bone, a process
that includes the production and locaized re-
lease of acid hydrolases, the acidification of
the extracellular space at the ruffed border
and cell membrane turnover (exocytosis and
endocytosis). Bone resorption is inhibited
by calcitonin and activated by PTH, 1
(OH)2 , and other hormones and factors
through osteoblasts and other cells in the lo-
ca microenvironment. ) Some mutations
(Fig. 3) have few osteoclasts, suggestingabnor-
malities in osteoclast development. In other
mutations, the absence of ruffed borders indi-
cates aberrtions in osteoclast activation. In
mutations cured by bone marrow transplan-
tation (Fig. 3), stem cell incompetence is be-
lieved to be involved, whereas in those not
cured by this procedure, the primary defect
may involve an abnormal skeleta microen-
PATHENETIC PATHWAYS IN OSTEOPETROIS
FIG. 4. Potential pathogenetic
pathways in osteopetrosis. PTH, para-
thyroid hormone; 1,25(OH)2D, 1,25-
dihydroxyvitamin D ; CT, calcitonin;
CSF, macrophage colony-stimu-
lating factor (CSF-I).
pro1tferatton
.tgrattonPTH precursor - stte s.1ectton2S(011)2D .L fuston
ost.o ast actd hydro1as.s
acttvator .. OSTEOCLAT
.. 
BOE RESOPTION
1f actd hydro1as.scarbtc anhydrase IItnhtbttor .xocytostsCT .ndoytostsother ce115
M-F
1 . 2SCOI1)2D
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vironment that neither support endogenous
osteoclast functon nor the development of
trnsplanted normal osteoclas precursors
(Figs. 3 and 4).
The clinica significance and ration e for
studying osteopetrosis in laboratory animals
include their relevance to understanding nor-
mal bone cell biology and human osteopetro-
sis. The formerJs summarized in the preced-
ing section and will have wide clinical appli-
cation in preventing bone loss and in the
therapeutic management of metabolic bone
diseases. The latter includes establishing crite-
ria for mutations amenable to treatment by
bone marrow transplantation and developing
rational therapies for mutations not curable
by transplantation. Fibrosis of marow
spaces is a feature common to animals and
children not curable by bone marrow trans-
plantation. 26.32 These stromal differences
may reflect changes in cells or growth factors
in the local environment, and if measurable,
a bone biopsy could provide suffcient mate-
rial to indicate if transplantation will be suc-
cessful. The rapid postnatal reduction in skel-
etal sclerosis and the normal lifespan of mib
rats (Cielinski, unpublished data) implies
that not all infants with osteopetrosis will
need treatment. Further characterition of
this rat mutation should reveal the pathoge-
netic mechanisms of this transient typ of os-
teopetrosis.
Animal mutations not curable by stem cell
transplantation (Fig. 3) could be used to de-
velop alternative therapies. These might in-
clude transplantation and 1 25(OH)2D and/
or cyokines/growth factors, with different
sequences or timing for each mutation. The
comparison of various features of these mu-
tations, including their responses to multi-
procedure therapy, could lead to a host of al-
ternative therapies.
These data show the complicated pathoge-
netic pathways of osteopetrosis in laboratory
animals and how this diversity can be ex-
ploited for the benefit of those who inherit
osteopetrosis, those who endure a varety of
other skeleta disorders, and those who sek
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to unlock the mysteries of normal skeleta bi-
ology.
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SUMMARY
Teeth develop within crypts in alveolar bone and this bone is resorbed by
osteoclasts during tooth eruption. This activity is dependent upon the adjacent part of
the dental follcle which accumulates early in eruption a population of mononuclear cells
which have ultrastructural and cytochemical features of osteoclast precursors. Evidence
that bone resorption plays a key role in tooth eruption includes a bone surface
topography and cellular composition reflecting resorption, a delayed or absent eruption
in conditions of reduced resorption and the local production of matrix metalloproteinases
during eruption. Furthermore, eruption can be accelerated and retarded by substances
which respectively increase or inhibit osteoclastic activity. Understanding the spatial
and temporal contributions of alveolar bone resorption to tooth eruption wil have
clinical application in the pharmacological regulation of tooth eruption , tooth movement
and the stabilzation of retained deciduous teeth and of dental implants.
Key words - tooth eruption, bone resorption, osteoclast, monocyte, dental follcle,
colony-stimulating factor- , bafilomycin, osteopetrosis.
Teeth Develop Within Bone
The embryology of the mammalian dentition demonstrates that teeth develop from
the collaborative interaction of epithelial and mesenchymal cells in the first branchial
arch (Ruch, 1990; Slavkin, 1990; Thesleff et aI., 1991). During tooth morphogenesis
the surrounding mesenchyme condenses to form the bone of alveolar processes of the
mandible and maxila. It has been appreciated for almost a century that development of
alveolar bone ina jaw segment depends on tooth formation in that sarne area
(Landsberger, 1924; Brash, 1928). Failure of tooth development precludes formation
of adjacent alveolar bone. The dependence of teeth on alveolar bone support ilustrates
the interdependence of the dentition and its osseous support.
The bony crypts of developing teeth are connected to the oral epithelium by an
epithelial strand, the gubernaculum, which is the persistent connection of the enamel
organ to the oral ectoderm from which it arose (Mallassez, 1885). In some mammals
this connection narrows to a cord- like structure and passes through a gubernacular
foramen in the jaw (Fig. 1) while in others this connection remains broad and a trough
or groove, rather than a foramen, connects the bony crypt of the developing tooth and the
oral cavity (Park, 1973).
Thus, the contemporaneous development of a tooth and its adjacent alveolar bone
results in the tooth's being surrounded by a bony crypt. For a tooth to erupt, the bone
between the tooth and the oral cavity must be removed. This is the indispensable role of
bone resorption during tooth eruption.
Evidence that Tooth Eruption ReQuires Bone Resorption
1. In the direction of tooth movement the topography of bone surfaces and the cellular
investment of these surfaces show resorption and its cellular correlate, osteoclasts. 
scanning electron microscopy the anorganic crypt surfaces around erupting teeth have
three distinct phenotypes (Fig. 2); a scalloped surface in the direction of movement, an
intervening smooth surface and a trabeculated area with a granulated surface on the
opposite surface of the crypt(Marks, 1987). These are, respectively, the
pathognomonic hallmarks of resorbing, resting and forming bone surfaces (Boyde and
Hobdell, 1969). Furthermore, the scalloped surfaces of such a crypt are essentially a
carpet of osteoclasts which have ultrastructural and cytochemical features
of active cells (Marks, Cahil and Wise, 1983; Marks and Cahil, 1986; Marks and
Grolman, 1987). The radiographic and histological hallmark of bone resorption during
tooth eruption is formation of a distinct eruption pathway (Cahil, 1969; Cahil and
Marks, 1980; 1982).
2. Bone resorption and tooth eruption depend upon the dental follcle. Surgical removal
the dental follcle, a distinct connective tissue investment of the tooth, prevents tooth
eruption . (Cahil and Marks, 1980) and removal of that part of the follcle in the
direction of eruption prevents tooth eruption by intercepting bone resorption and
precluding the timely development of an eruption pathway (Marks and Cahil, 1987).
3. Teeth do not erupt when bone resorption is reduced or absent. The best ilustration of
this principle is the status of tooth eruption in congenital mammalian osteopetrosis, an
inherited metabolic bone disease caused by variable reductions in bone resorption
(Seifert et aI., 1993). In this disease tooth eruption is either absent or delayed
depending upon the extent to which bone resorption is reduced. In mutations with little
or no resorption, such as toothless (1) in the rat, no teeth erupt. In other mutations
with less severe reductions in bone resorption such as incisors-absent (.i or
microphthalmia blanc (mi in the rat incisors don t erupt or are delayed but some first
molars and all second or third molars erupt (Cielinski and Marks, 1992; Schour et aI.,
1949). In all cases the status of bone resorption and the probabilty of eruption of a
tooth can be ascertained by analysis of the surfaces of its crypt during the period of
normal eruption (Fig. 3).
Reoulation of the Bone Resorption of Tooth Eruption
The dental follcle (see above) is required for tooth eruption and appears to
cordinate the resorption and formation of alveolar bone that occur on opposite sides of a
tooth during its eruption (Cahil and Marks, 1980; Marks and Cahil, 1987). These
activities could be produced by either the dental follcle or the reduced enamel
epithelium because both of these structures were removed in these surgical
experiments. However, the recent demonstration that teeth with only the enamel
epithelium fail to erupt suggests that regulation of tooth eruption is a propert of the
dental follcle (Larson et al., 1993).
The infiltration of mononuclear cells into the dental follcle coincidental to
alveolar bone resorption and formation of the eruption pathway has been noted above.
Recent biochemical analyses of the dental follcle have identified numerous proteins
(:Gorski et aI., -1988). Some of these proteins change during eruption suggesting that
they may playa role in the process. Prominent among them are the matrix
metalloproteinases collagenase and stromelysin which can be found in the follcle prior
to eruption but whose concentrations decrease dramatically as eruption proceeds (Gorski
and Marks, 1992). Analysis of follcular extracts has also provided evidence for
developmentally regulated proteolytic activity during tooth eruption (Gorski and Marks,
1992). The potential roles of these enzymes in cell migration, cell communication,
matrix degradation and/or growth factor activation are currently being examined.
The bone resorption of tooth eruption can be accelerated by substances which
promote the differentiation and/or activation of osteoclasts. A prime example of this is
the premature eruption of incisors and molars in rats treated with colony-stimulating
factor-1 (CSF-1) (Cielinski, Jolie and Marks, 1993 and in the Proceedings of this
conference). This growth factor produces its effect by increasing the number and
accelerating the appearance of monocytes in the dental follcle and of osteoclasts on crypt
surfaces of the mandibular first molar. Wise and Un (1994) have recently
demonstrated that follcles from these teeth transcribe and translate CSF-1 mRNA and
that interleukin 1
- and CSF-1 itself increase transcription of CSF-1 mRNA. These data
taken together indicate that the dental follcle can be the source of CSF-1 and that
activation of CSF-1 gene expression may be a marker of tooth eruption. The local
bilaterally symmetrical regulation of CSF-1 gene expression in alveolar bone during
tooth eruption and how systemic administration of this growth factor causes its spatial
and temporal effects in the jaws deserve further study.
In similar fashion, temporary inhibition of bone resorption can delay tooth
eruption. Bone resorption by osteoclasts requires the participation of a unique proton
pump on the ruffled border of these cells (Blair et aI., 1989; VAAnAnen et al., 1990;
Sundquist et aI., 1990). Bafilomycin A1 is a potent, specific inhibitor of .vacuolar H+
A TPases (Bowman, Siebers and Altendorf, 1988) and blocks resorption by irreversibly
binding to one of its subunits (Rautiala, Koskinen and VAAnAnen, 1993). The action of
bafiomycin is reversible upon its withdrawal because osteoclasts synthesize new,
functional proton pumps (Lakkakorpi and VAAnAnen, personal communication). Local
delivery of bafilomycin A to the dental follcle of erupting mandibular premolars in dogs
suspends resorption during the period of infusion and temporarily prevents the
formation of an eruption pathway (Sundquist and Marks, 1994 and Fig. 4).
Other proteins are known to influence tooth eruption but their mechanisms are
unknown. Injections of epidermal growth factor (EGF) cause premature eruption of
incisors and eyelid opening in mice (Cohen, 1962) but has no effect on molar eruption
(Un, Fan and Wise, 1992; Cielinski and Marks, 1992). Proteins of 167kDa and
200kDa isolated from the rat dental follcle retard eruption of incisors and molars in
rats when injected subcutaneously in the perinatal period (Un et aI., 1992). Whether
the action of these and other compounds capable of modulating tooth eruption work by
influencing bone resorption or other mechanisms remains to be established.
plinical Applications of the BioloOY of Tooth Eruption
Tooth eruption is a complicated process involving not only alveolar bone
resorption but also alveolar bone formation and formation and renewal of the periodontal
ligament and the epithelial attachment between tooth and gingiva. While knowledge of
each component and its regulation is rudimentary at present, the clinical applications of
current and future information wil extend to most oral health disciplines. Knowledge of
the local initiation and directionality of tooth eruption wil lead to rational , predictable
control of ectopic eruption and tooth movement. Permanent local inhibition of bone
resorption wil insure the retention of deciduous teeth without a permanent successor
wil limit the growth of jaw cysts and may stabilze the progressive loss of bone around
teeth and their replacements in the periodontal diseases. More significantly, the
predictable formation of alveolar bone that occurs during tooth eruption (Fig. 2f,g) or
in response to the local delivery of growth factors such as prostaglandin E1 (Marks and
Miller, 1993) can produce accelerated repair of facial fractures and integration of
transplants or implants and provide predictable periodontal regeneration. Finally, the
molecular mechanisms determining position and renewal of the junctional epithelium
wil provide ways to position and stabilze a healthy esthetic epithelial attachment on
teeth and dental implants regardless of the position of the alveolar crest.
These examples ilustrate the variety of clinical applications of current and
future studies of the biology of tooth eruption.
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P a l a t a l  v i e w  o f  t h e  s k u l l  o f  a  5 -
y e a r - o l d  c h i l d  s h o w i n g  t h e  g u b e r n a c u l a r
f o r a m i n a  ( a r r o w s )  o f  t h e  p e r m a n e n t  
i n c i s o r s .  T h e  
f o r a m i n a  o f  t h e  m a x i l a r y
c e n t r a l  i n c i s o r s  a r e  l a r g e r  t h a n  t h o s e  o f  t h e  l a t e r a l  i n c i s o r s  b e c a u s e  t h e y  a r e
b e i n g  e n l a r g e d  a s  p a r t  o f  t h e  e r u p t i o n  p a t h w a y  o f  t h e  p e r m a n e n t  c e n t r a l
i n c i s o r s ,  w h i c h  c a n  b e  s e e n  i n  t h e i r  c r y p t s .  R u l e r  a t  
b o t t o m  i n d i c a t e s  m m .
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d u r i n g  e r u p t i o n  o f  t h e  
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w e e k - o l d  d o g .  T h e  m e d i a l  
s u r f a c e  o f  t h e  c r y p t  ( F i g .
'  2 A )  l i e s  a b o v e  t h e
m a n d i b u l a r  c a n a l  ( M C )  a n d  c a n  b e  d i v i d e d  i n t o  t h r e e  d i f f e r e n t  r e g i o n s
i n d i c a t e d  b y  n u m b e r .  T h e  s u p e r i o r  p a r t  o f  t h e  c r y p t  
( l a b e l l e d  1  i n  F i g .
2 A , C  a n d  D )  i s  s c a l l o p e d  a n d  i s  t h e  r e s u l t  o f  r e s o r p t i o n  b y  o s t e o c l a s t s .  T h e
m i d d l e  a r e a  ( l a b e l l e d  2  i n  F i g .  2 A ,
D  a n d  E )  i s  s m o o t h ,  
r e f l e c t i n g  a n  i n a c t i v e
b o n e  s u r f a c e .  T h e  i n f e r i o r  p a r t  o f  t h e  c r y p t  
( l a b e l l e d  3  i n  F i g .  2 A ,
E )  i s
t r a b e c u l a t e d  a n d  c o n s i s t s  o f  n e w l y  f o r m e d  b o n e  w i t h  s u r f a c e  d e p r e s s i o n s  o f
o s t e o c y t e s  ( a r r o w h e a d s  i n  F i g .  2 F  a n d  0  i n  F i g .  2 G ) .  
.  B a r s  =  2 0 0  
m  i n  A
t h r u  F  a n d  1 0  
m  i n  G .
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a  1 4 -
d a y - o l d
n o r m a l  r a t  ( a )  a n d  i t s  
o s t e o p e t r o t i c  ( t o o t h l e s s ,  1 l )  l i t t e r m a t e  ( b ) .  
I n  n o r m a l
r a t s  a t  t h i s  a g e  c r y p t  
s u r f a c e s  a r e  s c a l l o p e d  ( a r r o w s  i n  a )  
r e f l e c t i n g  t h e
f o r m a t i o n  o f  a n  e r u p t i o n  p a t h w a y  b y  o s t e o c l a s t s  a s  t h i s  t o o t h  e r u p t s .  
o s t e o p e t r o t i c  r a t s  ( b )  f i r s t  m o l a r s  d o  n o t  e r u p t  a n d  b o n e  
f o r m a t i o n ,  n o t  b o n e
r e s o r p t i o n ,  i s  s e e n  o n  c r y p t  
s u r f a c e s .  B a r  =  2 0 0  
J . m .
,;:
F I G U R E  4
R a d i o g r a p h s  o f  t h e  
m a n d i b u l a r  t h i r d  ( 3 )  a n d  f o u r t h  ( 4 )  p e r m a n e n t
p r e m o l a r s  a n d  f i r s t  m o l a r  ( M )  i n  t w o  
2 0 - w e e k - o l d  d o g s .  
T h e  o n e  o n  t h e  l e f t
( F i g .  4 a )  s h o w s  t h e  u s u a l  
p r o g r e s s i o n  o f  e r u p t i o n  o f  t h e  p r e m o l a r s  w i t h
f o r m a t i o n  o f  a n  e r u p t i o n  p a t h w a y  ( a r r o w h e a d )  a n d  r o o t  g r o w t h .  
T h e  d o g  o n
t h e  r i g h t  r e c e i v e d  b a f i l o m y c i n  A 1 '  a  
p o t e n t  i n h i b i t o r  o f  b o n e  r e s o r p t i o n ,
d e l i v e r e d  t o  t h e  c r y p t  o f  t h e  f o u r t h  
p r e m o l a r  f o r  t h e  p r e v i o u s  t w o  w e e k s  b y  a
c a n n u l a t e d  o s m o t i c  m i n i p u m p  w h o s e  m e t a l  t i p  a n d  r e t a i n i n g  s c r e w s  a r e
c l e a r l y  v i s i b l e .  N o t i c e  t h a t  i n  
t h i s  d o g  t h e  
e r u p t i o n  p a t h w a y  ( a r r o w h e a d )
s t i l  c o n t a i n s  b o n e ,  t o o t h  m o v e m e n t  h a s  n o t  p r o g r e s s e d  a n d  r o o t  
g r o w t h  o n
t h i s  t o o t h  h a s  
i n v a d e d  t h e  m a n d i b u l a r  c a n a l  ( a s t e r i s k ) .  
B a r  =  1 0  m m .
.", "
3. Bone Surface Morphology Reflects Local Skeletal Metabolism
Accepted for publication in: Microscopy Research and Technique , JE Johnson, Editor-
in-Chief, entitled "Microscopy of Bone , A. Nanci and M. McKee, Guest Eds. (in press)
Sandy C. Marks, Jr.,
Matthew J. Cielinski
Kai T. Sundquist 1
Department of Cell Biology
University of Massachusetts Medical School
Worcester, MA 01655 USA
Running title: Bone Surface Morphology Reflects Metabolism
for correspondence:
present address:
Dr. Sandy C. Marks, Jr.
Department of Cell Biology
University of Massachusetts
Medical Center
55 Lake Avenue North
Worcester MA 01655
tel - 508-856-3848
Department of Oral Surgery
University of Oulu
Aapistie 3
90220 Oulu, Finland
Key words: bone formation, bone resorption, scanning electron
microscopy, tooth eruption, osteopetrosis
ABCT
The metabolic activity of bone cells is faithfully reflected in the surface
toporaphy of mineralized bone surfaces and this can be easily detected by scanning
electron microscopy (SEM). Forming bone surfaces exhibit knobby projections which
represent foci of mineralization, resorbing surfaces are scalloped and resting surfaces
undergoing neither activity are smooth as shown by Boyde and Hobdell 25 years ago.
These phenomena are ilustrated in by tooth eruption, a local activity in alveolar
bone where resorption and formation are polarized around an erupting tooth, and
osteopetrosis, a metabolic bone disease characterized by a congenital reduction or
absence of bone resorption. The abilty to analyze bone metabolism over large areas of
the skeleton by SEM offers a convenient and powerful microscopic technique to assess
regional and global bone cell activity in an era where the investigative focus is
increasingly molecular.
INTODUCTION
Twenty-five years ago Boyde and Hobdell (1969) reported that mineralized bone
surfaces exhibited three distinct topographics by scanning electron microscopy (SEM)
and that these corresponded to different overlying cellular activities. Bone formation by
osteoblasts consists of the production and mineralization of a complex extracellular
matrix and forming bone surfaces seen by SEM exhibit knobby projections which
represent foci of mineralization. Bone resorption by osteoclasts results in a confined,
localized removal of mineral and matrix and resorbing bone surfaces seen by SEM are
scalloped. In a growing skeleton most bone surfaces are undergoing formation or
resorption and they wil appear either knobby or scalloped by SEM. As the skeleton
matures the extent of these activities decrease and a third, smooth bone surface
phenotype becomes most prominent. Thus, a smooth bone surface indicates a region
undergoing neither formation nor resorption and is covered by squamous bone living
cells or flattened osteoblasts.
These seminal observations by Boyde and Hobdell (1969) have been confirmed
and used by others to evaluate bone metabolism in a variety of situations in and in
. The fidelity of bone surfaqe topography to overlying metabolism and the ease of
tissue preparation and analysis by SEM make this a convenient microscopic method for
analysis of regional or systemic activities in the skeleton. The applications of this
method wil undoubtedly expand with the increasing molecularization of biology and the
need to analyze the skeletal effects in transgenic animals and after gene deletions or
knocouts. We review tissue preparation procedures for bone and present examples of
the application of SEM to study local skeletal metabolism during tooth eruption and the
generalized skeletal metabolic derangements in the congenital bone disease osteopetrosis.
Jissue Preparation for Analysis of Mineralized Surfaces by SEM
While much can be gained by analyzing the cellular investment of bone by SEM,
analysis of metabolic activity as described by Boyde and Hobdell (1969) necessitates
removal of all organic material because organic material covers all forming and
quiescent bone surfaces making them indistinguishable without this step (Chow and
qhambers, 1992). Bone specimens are fixed in 10% neutral-buffered formalin or 3%
gluteraldehyde in 0. 1 M cacodylate buffer. Fixation protocls are not as rigorous as those
for cell preservation because there is little inherent deterioration of mineralized
surfaces. Caution should be used with phosphate-based buffers, however, because they
tend to promote precipitation of crystals on mineralized surfaces. Fixed specimens are
rendered anorganic by treatment with commercial bleach (5% NaOCI) for 2 to 12
hours, depending on the density of the organic coating. Specimens are subsequently
washed extensively in distiled water to remove cell and organic matrix debris,
dehydrated in a graded series of alcohols, air-dried, mounted and sputter-coated prior to
examination in a scanning electron microscope.
Tooth Eruption - an example of discretely localized changes in bone metabolism
Tooth eruption is the process by which teeth that develop within alveolar bony
crypts in each jaw move into their functional positions (see Gorski and Marks, 1992;
Marks, 1987 for reviews). This process is illustrated radiographically in Figure 
which shows the eruption of the third and fourth permanent mandibular premolars in
dogs. Notice that as these teeth move upward, the overlying bone and roots of the
deciduous precursors are resorbed and that below the erupting teeth roots elongate and
bone is formed, most prominently between the roots of each tooth. Tooth eruption is
accmpanied, indeed accmplished, by bone resorption and bone formation on opposite
,,,
sides of the erupting tooth. This is ilustrated in Figures 2 and 3 which are of anorganic
preparations of mineralized crypt surfaces from a dog premolar midway through
eruption. At low magnification (Fig. 2) one can see three different topographies
(numbered in Fig. 2) on the surface of each crypt during eruption. The superior surface
of the crypt (1 in Fig. 2 and 3A,B) is scalloped, indicative of resorption. A thin strip in
the middle (2 in Fig. 2 and 3C,D) is smooth and is quiescent, undergoing neither
resorption nor formation. The inferior part of the crypt is trabeculated and has a
knobby surface (3 in Fig. 2 and 3E,F) indicative of bone formation. The cells in these
regions of the crypt have been shown to have the appropriate ultrastructural and
histochemical features for bone resorption, maturation and formation, respectively
(Marks et aI., 1983; Marks and Cahil, 1986; Marks and Grolman, 1987; Wise et aI.,
1985). Thus, bone surfaces during tooth eruption are elegant local examples of the
principles demonstrated by Boyde and Hobdell (1969). The demonstration that eruption
itself is dependent upon the regulation of cell migration and differentiation by the dental
follcle (Cahil and Marks, 1980; Marks and Cahil, 1984; 1987) has led to recent
attempts to characterize the molecul regulation of eruption (Marks et aI., 1994; Wise
et aI., 1994).
Tooth eruption has been shown to be accelerated by systemic administration of
the growth factor, colony-stimulating factor-1 (CSF-1), to neonatal rats (Cielinski et
aI., 1994) and to be retarded by local delivery of bafiomycin A, to crypts of dog
premolars (Sundquist and Marks, 1994). Bafiomycin A1 is a specific inhibitor of the
vacuolar H:t ATPase in osteoclasts (Bowman et aI., 1988) and blocks resorption by
binding to one of its subunits (Rantiala et aI., 1993). The retardation of eruption by
bafilomycin is accmplished by a temporary inhibition of bone resorption. This can be
seen radiographically in Figure 4 where, on the experimental side, an eruption pathway
has not formed by resorption and tooth root growth has invaded the mandibular canal in
the absence of eruption. The suspension of bone resorption is also evident on deciduous
tooth root (Fig. SA,B) and bone (Fig. SC,D) surfaces in the direction of eruption. In
control crypts both tooth root (Fig. SA) and bone (Fig. SC) surfaces show clearly the
scalloped surfaces of resorption. In the bafiomycin-treated crypt (Fig. 5B and D) the
scalloped !?urfaces of previous resorption can be distinguished but they have been made
much less distinctive by two weeks of arrested resorption.
Osteopetrosis. an example of a oeneralized reduction in bone resorption
Congenital osteopetrosis in mammals is an inherited metabolic bone disease
characterized by reduced bone resorption due to interceptions of osteoclast development
or function (Marks 1984; 1987; Osier and Marks, 1992; Seifert et aI., 1993). The
disease is diagnosed radiographically and, as expected, skeletal effects are easily detected
by SEM. Figure 6 is such an example. It demonstrates that the sites where bone
resorption occurs in the normal skeleton (Fig. 6A,D) are replaced in mutants with
resting or forming bone surfaces (Fig. 6B,E), distorting bone contours both externally
and internally. Furthermore, if resorption is restored (Marks et aI., 1992), as with
CSF-1 in the toothless mutation, resorption pits appear in these sites as scalloped
surfaces (Fig. 6C,F).
As shown above, tooth eruption is a bone resorption-dependent process and tooth
eruption is delayed or absent in all osteopetrotic mutations. This can be detected by SEM
of crypt surfaces as ilustrated in Figure 7. Osteopetrotic mutants have crypt surfaces
with features of bone formation (Fig. 7A) only. In affected animals of the toothless (11
mutation, CSF-1 injections restore bone resorption (Marks et aI., 1992) and if begun
at birth result in eruption of incisors and molars (Iizuka et aI., 1992). Treatment of
these mutants from birth with CSF-1 results in scalloped molar crypt surfaces in the
direction of eruption (Fig. 7B) which are indistinguishable from those seen in normal
littermates (not shown).
ponclusions
Scnning electron microscopy of mineralized surfaces can reveal the state of bone
metabolism at that site as shown initially by Boyde and Hobdell (1969) 25 years ago.
The use of this method of sample preparation and analysis since that time has provided
significant insights on a variety of biological processes. Two ilustrated here, tooth
eruption and osteopetrosis, show that both local and systemic skeletal conditions and
their regulation can be accurately analyzed at least qualiatively by SEM of mineralized
surfaces.
This morphologic method can have wide application as the increasing
molecularization of biology produces a plethora of transgenic and gene deletion strains in
which the skeletal consequences can be rapidly and accurately assessed.
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R a d i o g r a p h s  o f  e r u p t i n g  t h i r d  ( 3 )  a n d  f o u r t h  ( 4 )  p e r m a n e n t  
p r e m o l a r s  i n  a
y o u n g  d o g  a t  1 6 ,  1 8  a n d  2 3  w e e k s  ( F i g s .  1 A ,
B  a n d  C ,  r e s p e c t i v e l y ) .  
E r u p t i o n
o f  t h e s e  t e e t h  b e g i n s  a t  1 5  w e e k s  w h e n  t h e  f i r s t  b a s a l  a n d  
i n t e r r a d i c u l a r  b o n e
( a r r o w s )  i s  e v i d e n t  r a d i o g r a p h i c a l l y  
b e t w e e n  t h e  c r o w n  a n d  t h e  
m a n d i b u l a r
.  c a n a l  ( m e  -  F i g .  
1 A ) .  A s  e r u p t i o n  p r o c e e d s  ( F i g .  
1  B )  
r o o t s  l e n g t h e n  a n d
a l v e o l a r  b o n e  r e s o r p t i o n  r e m o v e s  t h e  r o o t s  o f  t h e  o v e r l y i n g  d e c i d u o u s  t o o t h
( o p e n  a r r o w )  a n d  c r e a t e s  a  
r a d i o l u c e n t  e r u p t i o n  p a t h w a y  ( a r r o w s )  m o s t
v i s i b l e  a b o v e  t h e  m a i n  c u s p  o f  t h e s e  t e e t h .  
I m m e d i a t e l y  a f t e r  e r u p t i o n  i s
c o m p l e t e  ( F i g .  
1  C )  
b a s a l  a n d  s u p p o r t i n g  b o n e  i s  c o n s o l i d a t e d  a r o u n d  t h e  r o o t s
( a r r o w s ) .  X  2 .
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S c a n n i n g  e l e c t r o n  m i c r o g r a p h  o f  a n  a n o r g a n i c  p r e p a r a t i o n  ( s e e  t e x t )  o f  t h e
m e d i a l  c r y p t  s u r f a c e  o f  a n  e r u p t i n g  m a n d i b u l a r  
f o u r t h  p e r m a n e n t  p r e m o l a r
i n  a  1 9 - w e e k - o l d  d o g .  
T h r e e  d i s t i n c t  r e g i o n s  a r e  i d e n t i f i e d  b y  s u r f a c e
t o p o l o g y  a n d  r e v e a l  t h e  m e t a b o l i c  .
s t a t e  o f  t h e  b o n e  a t  t h e  t i m e  o f  p r e p a r a t i o n :
a  s c a l l o p e d  s u p e r i o r  s u r f a c e  ( 1 )  
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. ,
D e t a i l e d  S E M  a n a l y s i s  o f  t h e  c r y p t  s u r f a c e s  i d e n t i f i e d  i n  F i g u r e  2 .
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r e s o r p t i o n  o f  b o n e  b y  o s t e o c l a s t s ,
w h i c h  f o r m  a n  e r u p t i o n  p a t h w a y  f o r  t h e  
m a n d ! b u l a r  p e r m a n e n t  f o u r t h  p r e m o l a r .
I n d i v i d u a l  r e s o r p t i o n  l a c u n a e  ( R )  a r e  e v i d e n t  a t  h i g h e r  
m a g n i f i c a t i o n  ( 3 B ) .
T h e  s u p e r i o r  r e s o r b i n g  r e g i o n  ( 1 )  g i v e s  w a y  t o  a  
s m o o t h  m i d d l e  s u r f a c e  ( 2 )
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,  0  i n  3 F )  o n  t h e  t r a b e c u l a t e d  s u r f a c e  w h i c h  i s
c o v e r e d  w i t h  k n o b b y  p r o j e c t i o n s  ( o p e n  a r r o w s ,  3 F )  c a u s e d  b y  n e w  m a t r i x
m i n e r a l i z a t i o n .  V  =  v a s c u l a r  c a n a l
C  a n d  D  =  X  8 2 ;  B  =  X  2 4 5 ;  E  =  X  4 9 0 ;  F  =  X  1 6 3 0
. .  ,

E l :
R a d i o g r a p h s  o f  e r u p t i n g  t h i r d  ( 3 )  a n d  f o u r t h  
( 4 )  m a n d i b u l a r  p e r m a n e n t
p r e m o l a r s  i n  a n  u n t r e a t e d  d o g  a t  2 0  w e e k s  ( F i g .  4 A )  a n d  a n  a g e - m a t c h e d  d o g
i n  w h i c h  t h e  f o u r t h  p r e m o l a r  w a s  t r e a t e d  
w i t h  1 0 -
7  b a f i l o m y c i n  A 1  f o r  t h e
l a s t  t w o  w e e k s  ( F i g .  4 B )  b y  a  c a n n u l a t e d  o s m o t i c  
m l n i p u m p .  I n  t h e  c o n t r o l
d o g  ( F i g .  4 A )  a l v e o l a r  b o n e  s u p e r i o r  t o  t h e  c u s p  o f  t h e  f o u r t h  
p r e m o l a r  ( 4 )
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h a s  f o r m e d  b e t w e e n  t h e  r o o t s  o f  t h e  p e r m a n e n t  p r e m o l a r  
( a r r o w h e a d ) .  L o c a l
d e l i v e r y  o f  b a f i l o m y c i n  A 1  
( F i g .  4 B )  d e l a y s  t o o t h  
e r u p t i o n  b y  i n h i b i t i n g
r e s o r p t i o n  o f  a l v e o l a r  b o n e  s u p e r i o r  t o  t h e  p e r m a n e n t  
p r e m o l a r
( a r r o w h e a d ) .  A r r o w  i n  b o t h  f i g u r e s  
s h o w s  n e w  b o n e  f o r m a t i o n  b e l o w  t h e
e r u p t i n g  f o u r t h  p r e m o l a r .  
R o o t  g r o w t h  i n  i m p e d e d  p r e m o l a r  ( F i g .  4 B )  h a s
i n v a d e d  t h e  m a n d i b u l a r  c a n a l  
( a s t e r i s k ) .  M =
f i r s t  m o l a r ,  X  2 .
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: :!, ,
S c a n n i n g  e l e c t r o n  m i c r o g r a p h s  o f  r e s o r b i n g  d e c i d u o u s  p r e m o l a r  ( F i g .  S A ,
.  a n d  a d j a c e n t  b o n e  ( F i g .  5 C ,
D )  s u r f a c e s  d u r i n g  t o o t h  e r u p t i o n  i n  a n  u n t r e a t e d
d o g  ( F i g .  S A ,
C )  a n d  a n  a g e - m a t c h e d  d o g  i n  w h i c h  t h e  f o u r t h  p e r m a n e n t
p r e m o l a r  w a s  t r e a t e d  f o r  t w o  w e e k s  w i t h  1 0 -
7  b a f i l o m y c i n  A 1 '  I n  t h e
c o n t r o l  d o g  n u m e r o u s  r e s o r p t i o n  l a c u n a e  ( R )  a r e  p r e s e n t  o n  t h e  s u r f a c e s  o f
b o t h  t o o t h  ( F i g .  S A )  a n d  b o n e  ( F i g .  S C ) .  R e s o r p t i o n  l a c u n a e  ( R )  a r e  a l s o
p r e s e n t  o n  t h e s e  s u r f a c e s  i n  t h e  b a f i l o m y c i n -
t r e a t e d  d o g  ( F i g .  5 B
D )  b u t
t h e i r  d e p t h  a n d  n u m b e r  a r e  b l u n t e d  b y  i n h i b i t i o n  o f  o s t e o c l a s t i c  b o n e
r e s o r p t i o n .  A r r o w s  =  d e n t i n  t u b u l e s .  
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CHAPTER II
SPECIFIC AIMS
SPECIFIC AIM TO EXINE THE SKELEAL AND DENTAL EFFECTS OF THE
OSTEOCLAST GROWTH FACTOR, COLONY-STIMULATING FACTOR-1 (CSF-1 OR M-CSF)
ON THE COMPROMISED OSTEOCLAST DEVELOPMENT AND FUNCTION IN TOOTHLESS
(OSTEOPETROTIC) RATS.
SPECIFIC AIM 2 TO CHARACTERIZE THE SKELEAL AND DENAL EFFECTS OF
OSTEOPETROSIS IN A NEW OSTEOPETROTIC MUTATION IN THE RAT, MICROPHTHALMIA
BLANC (M, IN RELATION TO OSTEOCLAT DEVELOPMENT AND FUNCTION.
CHAPTER II
The following procedures and techniques were used to obtain the data for this
dissertation. They are described below in alphabetical order.
Animals: care -and breeding
The .m animals used in this study were the offspring of ml.m males and
+/ml females derived from breeding stock donated by Dr. Rene Moutier, Centre de
Selection et d' Elevage d'Animaux de Laboratorie, CNRS, Orleans, France. In June 1990,
Dr. Moutier sent 6 +/? animals (3 of each sex) from which the colony at the University
of Massachusetts Medical School was derived. The animals were housed, maintained, and
used in accrdance with the NIH Guide for the Care and Use of Laboratory Animals. 1985
and the guidelines of the University of Massachusetts Animal Advisory Committee. The
colony was managed by Matthew Cielinski , who was responsible for breeding to
perpetuate the colony, determining sex and phenotype of newborn animals, and other
related duties. Breeding cages were arranged with one male ml.m and 2-3 females
(+/rn. Offspring of mated mimi males and +/mi females were either of normal
phenotype (+/rn or mutant homozygotes (mimi); therefore the normal animals
used in this dissertation were heterozygous for the wildtype and mi characteristics.
This differs from studies concerning other animal mutations, in which tested breeders
(+/Qg, for example) typically have progeny consisting of three genotypes (+/Qg, +/+
normals, and ggQg mutants). In these cases, normal animals are of either genotype, are
indistinguishable from one another except by breeding, and are denoted +/? Normal
females were typically bred up to 1 year, but occasionally produced viable litters up to
5 years, and mi females were determined to be sterile. Mutant males were sexually
viable up to 1 year, but typically useful up to 6 months. Therefore, spent males were
kiled when litter production ceased and fresh mutant males provided to established
breeding cages when necessary. Mutant rats were identified at birth by lack of retina
pigment. All animals were weighed prior to use and their boy weight recorded at
regular intervals.
The 11 rats used to derive data for this thesis were offspring of tested breeders
(+/10 perpetuated from stock originally donated by Dr. Carl Hansen of the Veterinary
Resources Branch, Division of Research Services, NJ.H., Bethesda, MD, USA. All rats
were bred, maintained, and used accrding to recommendations in the Guide for Care and
Use of Laboratol) Animals , prepared by the ILAR, NRC (DHEW Publication No. NIH 86-
23-1985) and guidelines of the Animal Care Advisory Committee of the University of
Massachusetts Medical School. Carole MacKay was responsible for maintaining the
colony, determining phenotype of offspring, and related tasks, and Matthew Cielinski
assisted when necessary. Primary breeding cages contained 2-4 young untested females
(+/?) and test-proven males (+/10 were rotated between these cages to prove or test-
out females, as normal animals are indistinguishable except by breeding. Secondary
breeding cages contained 2 test-proven females (+/10, which were either bred to test- 
proven males (+/10 to produce progeny for experimental use, or used to test males of
unknown genotype to perpetuate the colony. Homozygous toothless (1V11) rats were
identified in litters at birth under hypothermic anesthesia (Schneider et al. 1979). 
heterozygous (+/11) and. homozygous (+/+) normal rats are indistinguishable except by
breeding, the normal rats used in this dissertation were of either genotype.
Rats born to timed-pregnant CD rats (Charles River)were used for studies
concerning the effects of EGF, CSF-1, and combinations of both growth factors on the
eruption of incisors and molars.
' ,: !
Animals: treatment
Purified human recombinant CSF-1 was generously provided by chiron
Corpration (Ladner et al. 1987; Halenbeck et al. 1989). Unless otherwise noted, one
: I
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milion units of CSF-1 were injected subcutaneously daily into 11 rats, beginning at
birth or varying times thereafter. For _dose-respone experiments, CSF-1 doses ranging
from 102 to 107 units were given as above. Untreated or sham (phosphate-buffered
saline)- injected normal and mutant littermates served as controls.
To monitor the effects of EGF on tooth eruption, EGF (Upstate Biotechnology Inc.,
receptor grade, purified from submaxilary gland of male mice) was injected daily,
beginning at birth, into the dorsal neck of normal rats (0.1 J.g/1.0g body weight,
subcutaneously). At least 6 controVsham-treated rats (phosphate-buffered saline)
and 6 EGF-treated rats were kiled at each age examined.
Bone formation
To study the formation rate of alveolar bone and dentin, at least 4 animals of each
genotype (+/mib, mib/mib) at 1, 7, 14 , 21, and 28 days were given 5.0 J.Ci 3H-
proline (New England Nuclear) per gram body weight and kiled 6 hours later (Walker
1966, Marks 1969). Serial sections were cut from paraffin-embedded mandibles,
dipped in lIord-L4 emulsion, and alternate slides were placed in dry chambers for 1 or
2 week exposures, respectively. Exposed slides were developed in D-19 (Kodak) for 4
minutes, rinsed in tap water for 1 minute, fixed in 30% sodium thiolsulfate for 5
minutes, and rinsed in tap water. Some sections were then counterstained with
hematoxylin and eosin.
To quantitate bone formation at least 5 mutant and 5 normallittermates of 
stock were injected intraparietally with 5.0 J.Ci 3H-proline (New England Nuclear) per
gram body weight at birth and weekly intervals during the first postnatal month
(Walker 1966, Marks 1969). Rats were kiled 6 hrs later, and the calvariae were
removed, cleaned of excess soft tissue, air dried, weighed, minced into a fine powder
with scissors, and subjected to digestion with 1 M HCI at C overnight. Samples were
then neutralized with an equivalent volume of 1 M NaOH, mixed with 10mL scintilation
fluid, and placed in a scintilation counter and values normalized to counts per minute
per gram calvarial bone. Rate of bone formation at each age was expressed as values of
mutants divided by values of normal littermates.
Bone histochemistry
Tibiae and femora were rapidly removed, bisected longitudinally, and fixed for 2
hr in 2.5% glutaraldehyde in 0. 1 M cacodylate buffer with 7% sucrose, demineralized in
10% EDT A, dehydrated in a graded series of ethanol, and embedded in resin for
histochemical analyses of tartrate-resistant acid phosphatase (TRAP) and tartrate-
resistant acid ATPase (TrATPase) as previously reported (Cole and Walters 1987,
Undunger et al. 1990). Controls included incubation without substrate or with 10 mM
sodium orthovanadate, both of which were negative in all cases. In addition, sections of
bone from normal rats of another stock known to be positive for TRAP and TrATPase
were included in reactions as positive controls.
Mandibles were rapidly removed, cleaned of soft tissue, and processed described
abve.
Histomorphometry
For histomorphometric analyses, anaesthetized rats were kiled at 1-2, 3, 5, 7,
10, 14, and 18 days after birth. Mandibles were then rapidly removed, transected
anterior and posterior to the gubernacular trough of the first molar and immersion-
fixed in 2.5% gluteraldehyde in 0.1 M cacodylate buffer with 7% sucrose for 2.5 hours
at 4 C and demineralized in 10% EDTA. These blocks were then dehydrated in a graded
series of ethanol, transected through the center of the first molar and embedded in resin
for histochemical analyses of tartrate-resistant acid phosphatase (TRAP) as reported
previously (Cole and Walters 1987).
The number of TRAP+ (TRAP+) mononuclear cells in the dental follcle and
TRAP+ osteoclasts on adjacent alveolar bone surfaces were enumerated at 1 OOX in
transverse sections of the first molar using the softare package Osteomeasure
(Osteometrics, Inc., Atlanta, GA). A representative section and corresponding
Osteomeasure field are shown in CHAPTER IV, Part C. Cell density was expressed as
number per unit length of dental follcle (mononuclear cells) or alveolar bone surface
(osteoclasts). The statistical significance of differences between groups at various ages
was determined using a two-tailed student-test.
Northern analyses of osteoclast-specific messages
Total cellular RNA was isolated from long bones (tibiae and femora) by a
modification of the Chirgwin procedure (Chirgwin et al. 1979) as described previously
(Shalhoub et al. 1991). Briefly, long bones were isolated from at least 4 normal and
mi littermates, soft tissue removed, snap-frozen in liquid N2, and stored at -
until use. Bone samples were crushed into powder using a pre-cooled (liquid N2)
Bessman tissue pulverizer (Fisher). Total RNA was extracted (SM guanidine
thiocyanate with 2% sarcosyl and 72 mM B-mercaptoethanoland) and recovered as a
translucent pellet after centrifugation through a cesium chloride (5.7 M). This RNA
pellet was resuspended (10mM Tris, pH 7.4 and 5 mM EDTA),precipitated with 2.
volumes ethanol, partially dried under vacuum, and resuspended and precipitated a
second time in TE buffer and 2.5 volumes ethanol, respectively. RNA was resuspended in
ultrapure water (Sigma), quantitated by absorbance at 260 nm, and stored at -
The quality of RNA was monitored with respect to representation of ribosomal RNA (28S
and 18S) as an internal standard, and the intactness monitored by electrophoretic
fractionation (1 % agarose gels, 6.6% formaldehyde, ethidium bromide staining).
Between 10 and 15 J. of each RNA sample was then transferred by capilary action to
Genescreen Plus hybridization transfer membranes (Dupont, NEN Research Products).
Transferred RNA was cross-linked to the membrane by UV light exposure for 1.
min and stored- at 4 oC in sealed plastic bags.
Probes were labeled with (a-32P)dCTP by the random primer method (Freiberg
I:'
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and Vogelstein 1983) to a specific activity of at least 1 x 109 dpm/J1g DNA.
Prehybridization and hybridization of membranes were performed in 50% formamide,
SX SSC, 10X Denhardt's solution (100X Denhardt's solution is 2% Ficoll , 2%
polyvinylpyrolidone), SO mM sodium phosphate (pH 6.5), 1 % SDS, SO J1g/ml single
stranded salmon sperm DNA (Sigma) for 24 hours at 42 C. Blots were washed 3 x 20
mins with 2X SSC, 0.1% SDS at SooC, 2 x 20 mins with 1X sse, 0. 1% SDS at SOoC,
and once with 0. 1X SSC, 0.1% SDS at 65 C. The blots were then exposed to X-OMAT AR
x-ray film (Eastman Kodak) using a Cronex Lightning Plus intensifying screen at
C. The resultant autoradiograms were quantitated by scanning laser densitometry
(LKB 2400 GelScan XL) within the linear range of signals. All data obtained in this way
was normalized with respect to :18S ribosomal RNA and expressed in densitometric
units. Statistical significance was defined as differences with a probabilty less than
5% (two-tailed student- test).
Radiooraphy
High-resolution radiographs were used for the following: 1. to identify newborn
l1' s and their normal littermates at birth under hypothermic anesthesia (Schneider et
al. 1979); 2. to evaluate treatment of 11 rats in anesthetized animals (6:1 Ketamine-
Zylagine at 4.0 ml/g intramuscularly); 3. to document and compare changes in the
i' !
amount of skeletal sclerosis and marrow cavity size in the hindlimbs and axial skeleton
of mi rats and their normal littermates.
Scanning electron microscopy
Scanning electron microscopy of anorganic bone surfaces was used to evaluate
local skeletal metabolism as previously described (Boyde and HobdeU 1969, Marks et al.
1994). To examine the bony crypt of first molars during eruption, the lingual cortical
r:,
plate and underlying first molar were removed, fixed in 10% neutral-buffered formalin
(NBF), and the exposed crypt was subjected to organic digestion by immersion in 2%
sodium hypochloride. For evaluation of local bone metabolism in long bones in normal
and mutant rats of mi stock, tibiae were rapidly removed, cleaned of excess soft tissue,
and fixed overnight in 10% NBF. Fixed specimens were rendered anorganic by
immersion in 2% sodium hypochloride. Anorganic crypt surfaces or tibiae were then
washed in ddH20, dehydrated in a graded ethanol series, blotted onto paper towels, and
mounted on aluminum stubs using silver paint as adhesive for sputtercoating and
observation in an ETEC scanning electron microscope.
Tooth eruption
Tooth eruption was defined as the age at which the given tooth first pierced
through the oral epithelium. For incisors, eruption was monitored by daily inspection
beginning seven days after birth. Molar eruption was determined by palpation of
anesthetized animals on alternate days (7:1 Ketamine-Zylagine at 0.4 ml/Kg,
intramuscularly) beginning fourteen days after birth. Because EGF injections promote
precocious incisor eruption (Cohen 1962), daily inspection for eruption began at 5 days
in treated animals.
Ultrastructural observations
At birth and 7 weeks a minimum of 4 normal and 4 miiittermates were kiled
by decapitation and their tibiae and femora rapidly removed, cleaned of soft tissue,
transected longitudinally to faciltate penetration of fixative, and fixed in 4%
gluteraldehyde in 0.1 M sodium cacoylate buffer, pH 7.2 for 1.5 hrs at 4 C. Fixed
specimens were rinsed in 0.1 M sodium cacoylate buffer, demineralized in 10% EDT A
in 10 mM Tris buffer, postfixed in 1 % osmium tetroxide, dehydrated in a graded ethanol
series and embedded in epon. Semi-thin sections (1 J1) were stained with toluidine
blue to study cytological details before cutting thin sections for transmission electron
microscopy. These were collected on 200-mesh grids and stained with 8% uranyl
1:,1
acetate and 2% lead citrate.
Statistical Analyses
All quantitative data were expressed as means and standard deviations of
observations from at least 3 determinations. The statistical significance of differences
between groups (mutant verus normal, treated versus untreated, etc.) was determined
using a two-tailed student's (-test
CHAPTER IV
RESLTS
SPECIFIC AIM 1
Part A:
':,
The Effects of CSF-1 on Osteolast Development and Function
in Rats of Toothless (1, osteopetrotic) Stock
 !
,11
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Rationale
Toothless (11 is an osteopetrotic mutation in the rat characterized by few
osteoclasts, undetectable bone resorption, and resistance to cure by stem cell
replacement. Treatment of mutant 11 rats with daily systemic doses of 1 x1 06 units of
CSF-1 from birth results in a dramatic skeletal improvement, as evidenced by the
formation of marrow spaces and increased numbers of osteoclasts; however
metaphyseal sclerosis persists. The purpse of this study was to determine the range of
doses of CSF-1 which are beneficial, and ascertain the cause of the persistent
metaphyseal sclerosis following such treatments.
Summary of Results and Conclusions
Within a range of 103 to 2 X 106 units, CSF-1 caused marrow cavities to form
in the long bones of toothless rats and osteoclast numbers increase. However, osteoclast
numbers remained below those seen in normal siblings and their function, as determined
by histochemical staining for TRAP and TrATPase, was reduced compared to normal
littermates. Despite increases in cell number and function , osteoclasts were absent
from the subepiphyseal areas of long bones of treated mutant rats. Withdrawal of CSF-
caused the return of skeletal sclerosis. These results indicate that regular treatments of
mutants with . exogenous CSF-1 are needed to maintain the beneficial effects of this
growth factor. The persistent sclerosis which is present after CSF-1 treatments is
related to the failure to restore osteoclasts to the subepiphyseal regions of long bones,
indicating that the cause of osteopetrosis in 11 rats is not merely a lack of circulating
CSF-
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ABCT
Toothless, (1) one of four osteopetrotic mutations in the rat, is characterized by
few osteoclasts, undetectable bone resorption and failure to be corrected by bone marrow
transplantation. We recently reported that CSF-1 treatment improves these skeletal
problems but that metaphyseal sclerosis persists. In the present study we demonstrate
II'
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that optimal reduction of the skeletal sclerosis in 11 rats following CSF-1 treatment has
lower and upper dosage thresholds and that skeletal sclerosis returns after CSF-
withdrawal. Osteoclasts increase significantly in 11 rats after CSF-1 treatment but
compared to untreated normal littermates histochemical staining for characteristic
enzymes and osteoclast number are reduced and no osteoclasts appear in the
subepiphyseal areas of long bones. These data are interpreted to mean that there are
dosage limits to the beneficial skeletal effects of CSF-1, that persistent sclerosis is
related to the failure to restore subepiphyseal osteoclasts, that osteoclast or progenitor
populations may be deficient or differ in their responses to CSF-1, and that the defect in
11 rats is not merely lack of a circulating, biologically active form of CSF-
KEY WORDS: Colony-Stimulating Factor-1 (CSF-1), Macrophage Colony-Stimulating
Factor (M-CSF), Osteopetrosis, Osteoclast, Tartrate-Resistant Acid Phosphatase
(TRAP), Rat
INTRODUCTION
Osteopetrosis in mammals is a heterogeneous group of inherited metabolic bone
disorders characterized by a generalized skeletal sclerosis, the result of reduced bone
resorption (Osier and Marks 1992). The toothless (1111 mutation in the rat exhibits
the usual skeletal and dental manifestations, failure of both marrow cavity development
and tooth eruption, and is characterized by severe reductions in osteoclasts, monocytes
and macrophages (Cotton and Gaines 1974; Marks 1977; Seifert et al. 1988; Marks et
al. 1992). Osteoclasts in 1J1L rats stain weakly for the characteristic enzymes
tartrate-resistant acid phosphatase and tartrate-resistant acid ATPase (Ek-Rylander et
al. 1989) and bone resorption is undetectable in (Raisz et al. 1981).
The osteopetrosis (QgQJ) mutation in the mouse has numerous similarities with
the toothless mutation in the rat including reductions in osteoclasts, macrophages and
monocytes and failure to be cured by bone marrow transplantation (Marks and Lane
1976; Marks 1982; Wiktor-Jedrzejczak et al. 1982). The QJQJ mouse mutation has
been shown to be associated with a total absence of colony-stimulating factor-1 (CSF-
also known as M-CSF), to be located within the coding region of the CSF-1 gene (Yoshida
et al. 1990; Wiktor-Jedrzejczak et al. 1990; Felix et al. 1990a) and to be cured by
treatment with CSF-1 (Felix et al. 1990b; Kodama et al. 1991 a; Wiktor-Jedrzejczak et
al. 1991).
Recently we have shown that CSF-1 treatment of 1V1l rats has beneficial effects
on the skeletal, dental and macrophage defects in this mutation but that significant
skeletal sclerosis persists (Marks et al. 1992; lizuka et al. 1992). In the present
study we describe the dose response to CSF-1, the effects of withdrawal of treatment and
the effects of CSF- 1 treatment on osteoclast number, location and enzyme content in 
.t11
rats. These data suggest a differential sensitivity of osteoclast populations . or
progenitors to CSF-1 and a broader base than mere CSF-1 deficiency for the skeletal
derangements in 1111 rats.
MATERIALS AND METHODS
Source and Treatment of Animals
Rats were obtained from our breeding colonies at the University of Massachusetts
Medical School. Mutants (1111 were identiied radiographically at birth (Schneider et
al. 1979) by the failure of development of marrow cavities in long bones. Normal
homozygotes (+/+) and heterozygotes (11+) are distinguishable only by breeding, and
normal littermates included both these genotypes. Animals were maintained and used in
accordance with recommendations in the Guide for the Care and Use of Laboratory
Animals prepared by the Institute on Laboratory Animal Resources, National Research
Council (DHHS Pub!. NIH 86-23, 1985). Rats were treated with highly purified
recombinant human CSF-1 (M-CSF; Ladner et al. 1987; Halenbeck et al. 1989) by
subcutaneous injection at daily doses ranging from 102 to 107 units (Ralph et al. 
1986), beginning at birth for up to eight weeks. Untreated or sham (phosphate buffered
saline) injected normal and mutant littermates served as controls.
Evaluation of Treatment
Phosphate buffered saline (PBS)- injected (sham) and CSF-1 injected rats were
observed daily for weight gain. Subsequently, anesthetized (6:1 Ketamine-Zylagine at
0 ml/Kg intramuscularly) animals were kiled and evaluated using radiologic and
histopathologic methods. High resolution radiographs were made .of the hind limbs and
axial skeleton (Schneider et al. 1979). Tibiae and femora were rapidly removed,
bisected longitudinally and fixed for 2 hr in 2.5% glutaraldehyde in 0.1 M cacodylate
buffer with 7% sucrose, demineralized in 10% EDTA, dehydrated in a graded series of
ethanol, and embedded in resin for histochemical analyses of tartrate-resistant acid
phosphatase (TRAP) and tartrate-resistant acid ATPase (TrA TPase) as previously
reported (Cole and Walters, 1987; Undunger et aI., 1990). Controls included
incubation without substrate or with 10 mM sodium orthovanadate, both of which were
negative. SeCtions were evaluated by microscopic morphometry as previously described
(Marks et al. 1984). Osteoclast profiles, identified as TRAP or TrATPase positive cells
in sections without a counterstain, were counted in at least eight non-adjacent sections
of tibial and femoral metaphysis from 26 animals using the software package
Osteomeasure (Osteometrics, Inc., Atlanta, GA). The statistical significance of
quantitative differences between groups of animals was determined. using a two-tailed
Student' s t-test.
RESULTS
The skeletal effects of CSF- 1 treatment of neonatal toothless (11111) rats could be
detected radiographically within four days and a prominent marrow cavity was present
in one week (Fig. 1). However, as has been reported earlier, sclerotic metaphyseal bone
persisted in long bones of treated mutants (Fig. 1 B). This metaphyseal sclerosis
remained in animals treated for six weeks (Fig. 2A,B) and was especially prominent at
costochondral junctions (Fig. 3A,B). CSF-1 treatment for up to eight weeks did not
reduce the persistent skeletal sclerosis in mutants.
The beneficial skeletal effects of CSF-1 treatment required repeated injections of
the growth factor. With cessation of treatment metaphyseal sclerosis slowly returned
(compare Fig. 2B and C). Again, this can be most easily appreciated at the costochondral
junctions (Fig. 3B and C).
Treatment of neonatal mutants with various doses of CSF-1 showed that
beneficial skeletal effects have upper and lower limits (Fig. 4). Daily doses of 102 and
1 07 units did not produce radiographic evidence of marrow cavity formation within one
week (Fig. 4d, h). Between these doses (Fig. 4b, c, e, f, g) marrow cavity development
could be detected radiographically.
To determine the cause of persistent metaphyseal sclerosis in CSF- treated 
rats we compared the metaphyseal distribution of osteoclasts in these animals and 
untreated normal and mutant littermates. We took advantage of the selective
histochemical staining of osteoclasts by TRAP and TrATPase to examine their
distribution in the proximal tibia and distal femur in sections without counterstains
(Fig. 5). In untreated normal rats osteoclasts are seen in three regions of the
metaphysis (Fig. SA); immediately below the epiphyseal plate (the capilary invasion
front), on the marrow cavity ends of metaphyseal trabeculae and in the periosteum
between these two locations. In untreated mutants (Fig. SB) osteoclasts were routinely
absent in all of these locations. In CSF- treated 11 rats (Fig. SC). osteoclasts were
present on marrow cavity ends of trabeculae and in the adjacent periosteum.
Osteoclasts could be detected in CSF- treated mutants within three days after
treatment was begun. Examination of TRAP-stained osteoclasts at higher magnification
showed more intense staining of osteoclasts in normal rats (Fig. 6A) than in treated
mutant littermates (Fig. 6B). The distribution and staining intensity of osteoclasts for
TRAP and TrATPase. in treated mutants were similar at all doses. However, osteoclasts
were absent in subepiphyseal regions of all CSF-1-treated mutants regardless of dose,
and periosteal osteoclasts were located more toward the center of the tibia than in
normal littermates. Because the number of osteoclasts varied, we counted osteoclast
profiles per unit area of tibial metaphysis at several doses. These data are shown in
Table 1.
CSF-1 treatment of newborn mutants for one week produced a significant
increase in osteoclast numbers in the proximal tibial metaphysis in a dose-related
manner but even at the highest dose osteoclast density was not restored to normal levels
(Table 1). Because osteoclasts in treated mutants do not have the same distribution as in
untreated normal littermates (Fig. SA,C), we counted osteoclasts in areas where they
were found in -each group. By not including the osteoclast-free subepiphyseal region in
the area analyzed in treated mutants our counts actually overestimated the
osteoclastogenic response/unit area of the mutant tibia to different doses of CSF-
DISCUSSION
These data show that daily CSF-1 treatment of neonatal toothless rats is followed
by the appearance of osteoclasts and bone resorption in the center of long bones within a
week, that treatment must be continued to maintain these beneficial skeletal effects and
that daily doses between 103 and 2 x 106 units can produce these effects. However, 
treated mutants osteoclasts were reduced in number and staining for TRAP and TrATPase,
osteoclasts were absent in subepiphyseal and adjacent periosteal sites and metaphyseal
length and sclerosis were greater than in normal littermates at all doses even after
treatment for up to eight weeks.
The failure to restore subepiphyseal osteoclasts in 11 rats after CSF-1 treatment
could result from: 1. a sub-optimal local CSF-1 production reflecting different regional
sensitivities of osteoclast or progenitor populations to this cytokine via local regulation,
or 2. aberrations in vascular patterns or endothelial cell signaling for mononuclear
precursors of osteoclasts which are known to exit vascular pathways and enter the
skeleton to form osteoclasts at this site, the capilary invasion front (Kimmel and Jee
1980), or 3. the failure of rh CSF-1 to exhibit the full spectrum of activities in the rat
as the native molecule in this species. In the CSF-1 deficient osteopetrotic (QJQI)
mouse, there is substantial evidence that macrophage subpopulations are affected
differently by the deficiency of this growth factor (Cecchini et al. 1992; Naito et al.
1991; Pollard et al. 1992; Wiktor-Jedrzejczak et al. 1992). Macrophages in the bone
marrow and uterus of ggQR mice are greatly reduced whereas those il1 the epidermis are
unaffected by CSF-1 deficiency. Macrophages in liver and spleen are present in reduced
numbers. Furthermore, changes in these populations with age in QWQJ mice suggest a
differential dependency of local macrophage populations on CSF- for both
differentiation and maintenance. The failure of CSF-1 to restore subepiphyseal
osteoclasts in 1V1l rats suggests that there may be similar regional differences among
osteoclasts or precursors in different skeletal sites. Osteoclasts in subepiphyseal sites
have been shown to arise from fusion of thymidine-labeled mononuclear precursors
which exit venous sinuses in this region (Kimmel and Jee 1980). Nothing is known
about the local control for these events. However, CSF-1 is known to playa role in
osteoclastogenesis (Hattersley et al. 1991; Kodama et al. 1991 b; Corboz et al. 1992),
osteoblasts are present at this site, are known to produce CSF-1 (Horowitz ii. 1989)
and osteoblasts are reduced in number and function in 1V1l rats (Seifert and Pedigo
1992). Therefore, either aberrations in venous sinusoidal patterns or inadequate
signals from local cells (endothelial or osteoblast) or species differences could prevent
the appearance of osteoclasts . at this site in 1V1l rats treated with rh CSF-1. These
possibilties deserve further study.
It is interesting that osteopetrotic mutations cured by bone marrow
transplantation show the first radiographic signs of cure in subepiphyseal sites and
marrow cavity formation proceeds centripetally (Walker 1975). In CSF- 1 treated
1111 rats the first signs are seen centrally and marrow cavity formation proceeds
centrifugally. The key to both these differences and the failure of CSF-1 treatment to
produce a normal skeleton may be the absence of subepiphyseal osteoclasts in treated
1111 rats.
Both the .QQg mutation in the mouse and the 1111 mutation in the rat exhibit
severely reduced numbers of monocytes, macrophages and osteoclasts, are resistant to
cure by bone marrow transplantation and show improvement in the cellular and skeletal
, '
aberrations foliowing injections of CSF-1. However, the following observations indicate
that these mutations are produced by different mechanisms: 1. untreated.
,W mice but not
1 '
11 rats exhibit a gradual resolution of skeletal, hematopoietic and some macrophage
deficiencies beginning at six weeks after birth (Marks and Lane, 1976; Marks 1977;
Begg et al 1992; Wiktor-Jedrzejczak et al 1992) CSF- 1 treatment results in
greater improvement in the cellular and skeletal defects in 
.QQg mice than in 1111 rats
(Felix et al 1990 ab ; Kodama et al 1991 a ; Marks et al 1992; Wiktor -Jedrzejczak et
al 1991; data in present study). This suggests that analyses of skeletal and hematopoietic
cells in each mutation will continue to reveal different aspects of the biological effects of
CSF-
Taken together with previous demonstrations of aberrations in osteoblast gene
expression (Shalhoub et al. 1991) in untreated 1V11 rats, reduced TRAP and TrA TPase
staining in osteoclasts of CSF-1 treated 11 rats (lizuka et al. 1992), and the existence of
CSF-1 in both secreted and cell- surface-bound forms (Baccarini and Stanley, 1990
Ralph and Sampson-Johannes, 1990) data presented in the present study indicate that
the defect in this mutation is not merely lack of the secreted form of CSF-1 but may be
another local cell population or its product.
Table 1. Number of osteoclast profiles in eight-day-old rats of
toothless stock treated from birth with CSF-
Daily dose of Osteoclasts/mm Osteoclasts
CSF- (units) # Animals (:I SEM) (0/0 of control)
78. 0 :I 6 100
t I 6 :I 0.
t I 11. 0 :I 3
t I 5 x 1 13. 0 :I 3
t I 50. 0 :I 4
* At least eight nonadjacent sections of the proximal tibia, stained
histochemically for TrA TPase, examined per animal. NLM = normal
littermate, tI = toothless mutant. 8Significantly different from
untreated mutants and normal littermates, oe 0.001.
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Part B:
The Effects of CSF-1 on Tooth Eruption in Toothless Rats
Rationale
The toothless (11 rat is a congenital osteopetrotic mutation characterized by a
generalized sk letal sclerosis from birth, few osteoclasts, and complete lack of erupted
teeth due to a severe reduction in osteoclastic bone resorption. Treatment of mutants i Ih
from birth with systemic administration of CSF-1 improves the skeletal manifestations
of the disease and promotes eruption of some teeth. The purpose of this study was to
investigate the effects of treating mutants with CSF-1 on the following: 1. the eruption
of all teeth; 2. the timing of treatments; 3. the morphology of developing teeth; and
4. the cytochemistry of osteoclasts around erupting molars.
Summary of results and conclusions
Untreated 11 rats had no erupted teeth and the roots of incisors and molars were
severely distorted by compression against bone. The incisor apex did not extend past the
first molar and continued growth of its apical end produced odontoma-like abnormalities
due to fusion of dentin and enamel matrices with bony matrix. Treatment of mutants
with CSF-1 from birth caused the eruption of all teeth, but this was delayed compared to
normal littermates. Delays in treatment compromised eruption in a time-dependent
manner, with earlier erupting teeth more severely affected than later ones.
Morphological analysis of erupting molars and incisors in treated 11 rats revealed
normal root and crown development. Histological staining for TRAP and TrA TPase was
reduced or negligible in osteoclasts of untreated 11 rats, heavy in normal siblings, and
intermediate in treated 11 rats. These data support the concept that bone resorption is a
necessary and rate- limiting component of tooth eruption and that complete failure of
eruption in untreated mutant rats is a consequence of reduced resorption caused by the
disease. Increased ,bone resorption--provided by CSF-1 injections--restores tooth
eruption by increasing bone resorption, provided that treatment begins early after
birth.
Publication
This study has been published and a reprint follows. Please refer to it for
specific details.
THE EFFECTS OF COLONY-STIMULATING FACTOR-1 ON TOOTH
ERUPTION IN THE TOOTHLESS (OSTEOPETROTIC) RAT ILLUSTRATE THE
CRITICAL PERIODS FOR BONE RESORPTION DURING TOOTH ERUPTION
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ABCT
The toothless (11 rat is an osteopetrotic mutation characterized by a generalized
skeletal sclerosis, reduced bone resorption, few osteoclasts and a total absence of erupted
teeth. This mutation is not cured by bone marrow transplants from normal littermates.
We have previously shown that the skeletal defects in 11 rats are greatly improved
followingtreafment with colony-stimulating factor-1 (CSF-1). In this study, we
investigated the effects of CSF-1 treatment on the development and eruption of the
dentition of 11 rats using radiography, histology and histochemistry. Untreated 11 rats
had no erupted teeth by 56 days after birth and the roots of incisors and molars were
severely distorted by compression against bone. The apex of the mandibular incisor did
not extend past the first molar and continued growth of its apical end produced odontoma-
like masses consisting of distorted dentin and enamel matrices. In addition, few
osteoclasts were seen on alveolar bone surfaces surrounding the teeth. Mutants treated
with CSF-1 were characterized by delayed eruption of all molars and sometimes
incisors. The incidence of incisor eruption was related inversely to the age at which
CSF-1 treatment began. Molars of treated 11 rats had well developed roots similar to
those in normal rats. Treated mutants had numerous osteoclasts in alveolar bone and
well developed hemopoietic marrow spaces in the mandible. Histochemical staining for
both tartrate-resistant acid phosphatase and tartrate-resistant acid ATPase was reduced
or negligible in osteoclasts of untreated 11 rats, heavy in normal osteoclasts and of
intermediate intensity in CSF- treated mutants. These data demonstrate that the
complete failure of tooth eruption in 11 rats is directly related to the reduced bone
resorption characteristic of the disease an that an early (neonatal) increase in bone
resorption, provided by injections of CSF-1, restores tooth eruption in 11 rats.
KEY WORDS: colon)'-stimulation factor- 1, osteopetrosis, tooth eruption
INTRODUCTION
Osteopetrosis is a metabolic bone disease in mammals characterized by a
generalized skeletal sclerosis caused by reduced bone resorption. The toothless 11 rat,
originally described by Cotton and Gaines (1974) as an osteopetrotic mutation
completely lacking erupted teeth, possesses few osteoclasts that, when present, are
small cells with little cytoplasmic vacuoles that stain weakly for tartrate-resistant acid
phosphatases (Marks 1977; Seifert et al. 1988). The 11 rat is unable to elevate serum
calcium levels in response to exogenous parathyroid extract (Marks 1977) and cultured
11 bone does not release previously incorporated calcium-4S in the presence of potent
stimulators of bone resorption (Raisz et al. 1981). Thus, bone resorption in this
mutation is extremely low or negligible. The pathogenesis of the disease is believed to be
due to reduced bone resorption resulting from the severe reduction in the number of
osteoclasts (Marks 1977; Seifert et al. 1988). Despite reduced medullary hemopoiesis,
mutants are not anemic and typically survive one year if maintained on a powdered diet
(Cotton and Gaines 1974; Marks 1977).
Toothless rats are also among the osteopetrotic mutations not cured by
transplantation of bone marrow or spleen cells from normal littermates (Marks 1977;
Seifert et al. 1988). Recently it was shown that 11 bone particles implanted
subcutaneously into normal littermates do not differ from normal bone in respect to the
recruitment of giant cells and subsequent bone removal (Anderson et al. 1986). 
addition, using the metatarsal culture system (Burger et al. 1982), it has been
demonstrated that 11 metatarsals co-cultured with normal liver or spleen cells failed 
develop normal osteoclasts or to show evidence of bone resorption (Osier et al. 1987).
These data suggest that the resistance of 11 rats to cure by bone marrow transplantation
is due to neither the production of unresorbable bone nor to a bone matrix deficient in
its abilty to recruit giant cells, but that the mutant skeletal environment is unable to
supprt the development and differentiation of normal osteoclasts. This conclusion is
supported by the recent demonstration of aberrations in bone matrix in 11 rats (Lian and
Marks, 1990; Shalhoub et al. 1991).
Osteopetrotic (QRQR) mice, which also have few osteoclasts, monocytes and
peritoneal macrophages (Marks & Lane 1976; Marks 1982; Wiktor-Jedrezejczak et al.
1982) and cannot be cured by transplants from normal spleen or bone marrow cells
(Marks et al. 1984), have been shown to have a defect in the production of colony-
stimulating factor-1 (macrophage colony-stimulating factor, hereafter denoted CSF-
(Yoshida et al. 1990; Wiktor-Jedrzejczak et al. 1990; Felix et al. 1990).
Furthermore, injections of CSF-1 not only elicited osteoclastic bone resorption in op/op
mice (Felix et al. 1990b; Wiktor-Jedrzejczak et al. 1991), but also produced partial
eruption of molars (Kodama et at 1991).
We have recently shown that CSF-1 treatment of 11 rats corrects some skeletal,
macrophage and dental defects in this mutation (Marks et al. 1992). The present study
describes in detail the effects of such treatment on the dentition of 11 rats.
MATERIALS AND METHODS
Animals
Animals used in this study were offspring of tested breeders (11+) derived form
stock originally donated by Dr. Carl Hansen of the Veterinary Resources Branch,
Division of Research Services, N. I.H., Bethesda, MD. All animals were bred, maintained
and used accrding to recommendations in the Guide for the Card and Use of Laboratory
Animals, prepared by the ILAR, NRC (DHEW Publication No. NIH 86-23-1985) and
guidelines of the Animal Care Advisory Committee of the University of Massachusetts
Medical School. Homozygous toothless (1110 rats (hereafter referred to as 11 rats)
were identified in litters at birth by radiography using hypothermic anesthesia
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(Schneider, 1979). Since heterozygous (+/10 and homozygous (+/+) normal rats are
indistinguishable except by breeding, normal rats (+/?) used in this study were of
either genotype.
CSF-1 Administration
Purified human recombinant CSF-1 was generously provided by Cetus
Corpration (Ladner et al. 1987; Halenbeck et al. 1989). One milion units of CSF-
was subcutaneously injected daily into 25 11 rats, beginning at birth or varying times
thereafter. After treatment, animals were anesthetized (7:1 Ketamine-Zylagine at 0.
ml/kg intramuscularly) and kiled at 1, 2, 3, 4, 6 and 8 weeks after birth. Untreated
normal (13) and mutant (4) littermates served as controls.
Evaluation of tooth eruption
Eruption of incisors was determined by visual inspection daily. To observe the
eruption of the molars, animals were lightly anesthetized and inspected on alternate
days. Mandibles and maxilae were rapidly removed, radiographed and cut in the sagittal
plane for histology. Half of each specimen was then fixed in 10% neutral buffered
formalin, radiographed, demineralized in 10% EDTA, dehydrated via a graded series of
ethanol, and embedded in paraffin. Serial sections were stained with hematoxylin and
eosin. The other half of each specimen was fixed for 2 hours in 2.5% glutaraldehyde in
1 M cacodylate buffer with 7% sucrose, demineralized in 10% EDTA, dehydrated in a
graded series of ethanol, and embedded in resin for histochemical analyses of tartrate-
resistant acid phosphatase (TrAP) and tartrate-resistant acid ATPase as previously
reported (Cole and Waters 1987; Undunger et al. 1990).
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RESLTS
The effects of CSF-1 injections on tooth eruption in 11 rats are shown in Figure 
and summarized in Table 1. The incisors in normal rats of this stock erupt at 9 to 10
days after birth and the first, second and third molars erupt at 17 to 18, 20 to 22, and
36 to 40 days after birth, respectively. In contrast, neither incisors nor molars
erupted by 56- days in untreated 11 rats. However, in 11 rats treated with CSF- , all
molars erupted, albeit delayed when compared to normallittermates. In addition, one or
more incisors erupted in about half of the treated 11 rats, again delayed compared to
normal littermates. The eruption of incisors in CSF- treated mutants was markedly
affected by the onset of treatment (Table 2). CSF-1 treatment begun at birth caused
eruption of all incisors. Delaying CSF-1 treatment by a day or more greatly
compromised incisor eruption and delayed molar eruption (Table 1).
Radiography confirmed these observations (Fig. 2). In untreated 11 rats
unerupted molars exhibited poor root development. Furthermore, the posterior
extension of the apex of mandibular incisors in these animals was abnormal, failng to
extend past the first molars. In contrast, CSF-1 treated 11 rats displayed normal root
formation for molars, but the incisor apices did not extend posterior to the first molars.
Microscopic examination of the dentition in normal rats revealed the usual
growth of roots and the alveolar crest (Fig. 3a, 4a, Sa, 6a). In untreated 11 rats,
developing roots of molars were severely distorted by compression against irregular
bone trabeculae (Fig. 3b, 4b, Sb, 6b) and alveolar bone covered the occlusal surfaces of
developing tooth crowns (2b). Few osteoclasts were observed on alveolar bone surfaces
surrounding the developing teeth. Furthermore, proliferation of d ntal issues in the
absence of socket enlargement produced distortions or surface contour and areas of
ankylosis of tooth to bone (Fig. 4b). Posterior extension of the mandibular incisor
appeared to be prevented by failure of bone resorption near the apical end (Fig. 5b).
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Continued growth of the apical end of these incisors produced odntoma- like masses
consisting of distorted dentin and enamel matrices (Fig. 6b).
In 11 rats treated with CSF-1, molars had well developed roots (Figs. 3c, 4c)
similar to those found in normal rats. The presence of numerous osteoclasts on alveolar
bone trabeculae, enlarged hemopoietic marrow spaces in the mandible and formation of
an eruption pathway were features seen in normal rats and only in mutants treated with
CSF-1. Although molars emerged into the oral cavity and possessed well developed roots
and periodontal ligaments in CSF- treated mutants, tooth surface irregularities were
observed in the cervical portion of some first molars. Numerous osteoclasts were
present on alveolar bone surrounding the apical end of the incisors and there was no
ankylosis of tooth to bone (Fig. Sc, 6c).
Histochemical studies of tartrate-resistant acid phosphatase (TrAP) and
tartrate-resistant ATPase (TrATPase) expression in osteoclasts on alveolar bone
surfaces surrounding the erupting molars are shown in Figs. 7 and 8. respectively. In
normal rats, numerous osteoclasts stained intensely for TrAP and TrATPase (Fig. 7a,
8a). In untreated 11 rats the few osteoclasts present stained weakly for TrAP and were
unreactive for TrATPase (Fig. 7b, 8b). In 11 rats treated with CSF- , numerous
osteoclasts stained positively for both enzymes (Fig. 7c, Be), but the intensity was less
than that seen in normal littermates.
DISUSON
These data show that daily injections of CSF-1 have a beneficial effect on tooth
eruption in the toothless (11 mutation in the rat and that the age at which these
injections are begun is a major determinant of whether particular teeth wil erupt. The
effects on tooth eruption are clearly supported by our radiographic, histologic, and
cytochemical studies. All molars and incisors erupted in 11 rats treated from birth with
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CSF-1. While molars in untreated 11 rats were poorly developed, the molars in treated
11 rats were not encased in alveolar bone and had fully developed roots without ankylosis.
In addition, two enzymes linked to osteoclast function (Minkin 1982; Ek-Rylander et al.
1989), namely tartrate-resistant acid phosphatase (TrAP) and tartrate-resistant acid
ATPase (TrATPase), were greatly elevated in treated mutants. This evidence 
osteoclast function coincides with tooth eruption in treated mutants and ilustrates the
dependence of tooth eruption on bone resorption (Marks 1976; 1981).
We observed that CSF-1 treatment had to begin at birth in order to have a
predictable effect on eruption of the incisors. Delaying treatment for only one day
greatly compromised incisor eruption (Table 2). These data are understandable when
viewed within the emerging concepts of tooth eruption as a localized process within
alveolar bone in which formation of an eruption pathway is produced by bone resorption
(Cahil and Marks 1982; Marks 1986). Formation of this eruption pathway is
controlled locally, is linked to the dental follcle and results in a window for tooth
eruption which occurs at a characteristic time for each tooth (Cahil and Marks 1980;
Marks 1987; Cahil et al. 1988; Marks et al. 1988; Gorski et al. 1988). Because
incisors are the first teeth to erupt in rodents, formation of the eruption pathway for
them must ocur earlier than molars. Our studies suggest that signals for the
development of osteoclasts must be provided at or very soon after birth for incisor
eruption to ocur. Otherwise, with delayed development of the eruption pathway,
ankylosis occurs and eruption becomes impossible. A corollary is that later erupting
teeth have later critical periods for formation of the eruption pathway. This is shown in
Table 1 and the work of Kodama et al. (1991) who demonstrated that supplying CSF- 1 to
QI mice at 11 days after birth severely retards eruption of the first molar so that the
second molar erupts before it. This suggests that the critical period for formation of the
eruption pathway for the first molar by CSF-1 injections occurs before 10 days.
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The present study confirms our earlier report (Marks et al. 1992) that CSF-
treatment increases the osteoclast population in 11 rats. In addition, we show that this
treatment has beneficial effects on the abilty of these cells to synthesize two enzymes
linked to bone resorption. However, these histochemical studies show that restoration of
the enzymatic capacity of 11 osteoclasts by CSF-1 treatment is not complete (Fig. 7 and
8a, c), as has -been shown earlier with respect to osteoclast number (Marks et al.
1992). The basis for these discrepancies deserves further study.
Taken together these data show that daily injection of 11 rats with CSF-1 restores
bone resorption and that the timing of these injections is critical for the eruption of
different teeth.
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TAB 1: CHRONOLOGY OF TOOTH ERUPTION (DAYS) IN RATS OF TOOTHLESS STOCK
Incisor
NLM 9 - 17- 20- 36-
111L ntx
1111 M-CSF
start 0 or 1 day 14- 20- 22-
3 day
11 day 31 -
- = No tooth eruption by 8 weeks
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TABLE 2: EFFECT ON INCISOR ERUPTION OF DELAYING CSF-1INJECTIONS IN 11 RATS
Frequency of eruption of incisors
Geno Number of animals 0/4 1/4 2/4 3/4 4/4
NLM 100
1V1l untreated 100
1V1l treated 0 day 100
1 day 100
2 days
3 da 100
Age of first injection of CSF- (106 units/day)
. . 
Incisors erupt between 9-10 days after birth in normal rats of this stock.
Numbers under fractions represent the percentage of animals in which 0, 1, 2,
3 or all 4 incisors, maxilary and mandibular, were erupted by 17 days after
birth.
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Part C:
The Effects of CSF.1 on the Cellular Mediators
of Bone Resorption During Tooth Eruption
Rationale
CSF-1 -promotes tooth eruption in toothless (11 rats, presumably by stimulating
the bone resorption necessary for the formation of an eruption pathway during tooth
eruption. Other studies have shown that CSF-1 promotes the development of osteoclasts
from mononuclear precursors. Since the mononuclear cells appearing in the dental
follcle early in eruption in dogs and rats have histochemical and ultrastructural
features of preosteoclasts and their appearance coincides with the influx of osteoclasts on
adjacent alveolar bone, we examined the cellular effects of CSF-1 administration on the
eruption of mandibular first molars in mutant and normal rats of 11 stock with emphasis
on the populations of osteoclasts and mononuclear cells around erupting teeth.
Summary Qf results and conclusions:
CSF-1 injections accelerated the eruption of first molars in normal rats and
caused their eruption in toothless rats but this was delayed (2-4 days) compared to
normal siblings. Eruption was accmpanied by an influx of TRAP+ mononuclear cells in
the dental follcle and TRAP+ osteoclasts on adjacent bone surfaces. CSF-1 treatment
increased the number of these cell types in normal rats, but did not affect the timing of
their appearance. In mutant rats, CSF-1 increased the numbers of these cell types, but
the timing of their appearance was delayed compared to normal littermates. These data
demonstrate that CSF-1 accelerates eruption in normal rats by increasing the number of
osteoclasts and their precursors around erupting teeth. The delayed eruption of molars
in treated 11 rats is identical to the length of the delayed appearance of these cell types
during eruption. In addition, the presence of a few osteoclasts around erupting first
113
molars in untreated 11 rats, when they are very rarely seen throughout the remainder of
the skeleton, indicates the strong influence of local factors in osteoclast recruitment and
development during tooth eruption. These findings show that CSF-1 plays a role in the
molecular events governing eruption and suggest that local administration of CSF- 1 may
be useful clinically in the movement and eruption of teeth.
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SUMMARY
The congenital disease osteopetrosis is characterized by a systemic sclerosis due
to absent or reduced bone resorption. The dental abnormalities caused by this disease,
which range from lack of erupted teeth in severe mutations to delays in the eruption of
incisors and/or molars in the milder mutations, provide unique opportunities for
investigating the development and eruption of teeth.
Recently we have shown that systemic administration of colony-stimulating
factor-1 (CSF-1 or M-CSF) to the osteopetrotic mutation toothless (1 in the rat
promotes tooth eruption, presumably by stimulating the bone resorption necessary for
the formation of an eruption pathway.
. Other studies have shown that CSF-1 fosters the
development of osteoclasts from their mononuclear precursors. Since the mononuclear
cells which appear in the dental follcle early in eruption in dogs and rats possess
histochemical and ultrastructural features of preosteoclasts and precede the influx of
osteoclasts on adjacent alveolar bone, we decided to examine the effects of CSF-
administration on the eruption of first molars in mutant and normal rats of the toothless
stock with emphasis on the populations of osteoclasts and their precursors around the
erupting tooth.
CSF-1 injections accelerated the eruption of first molars in normal rats and
promoted eruption in toothless rats that was delayed (2-4 days) compared to normal
littermates. These events were preceded by an influx of tartrate-resistant acid
phosphatase-positive (TrAP+) mononuclear cells in the dental follcle early in eruption
and TrAP+ osteoclasts on adjacent bone surfaces consistent with previous studies.
Treatment with CSF-1 increased the number of these cell types in normal rats but did
not affect the timing of their appearance. In mutant rats CSF-1 increased the numbers
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of these cell types and the timing of their apearance was delayed in comparison with
normal littermates. We believe that CSF-1 acclerates eruption in normal rats by
increasing the n mber of TrAP+ osteoclasts and their precursors and promotes delayed
eruption in CSF-1-treated toothless rats due to delays in the appearance of TrAP+
osteoclasts and their precursors. These findings indicate that CSF-1 plays a role in the
molecular events regulating tooth eruption and suggest that locl administration of CSF-
1 may be useful in the movement and eruption of teeth clinically.
Key Words: Tooth eruption, colony-stimulating factor, bone resorption, osteoclast,
dental follcle, monocyte, rat
Abbreviations: colony-stimulating factor-1 (CSF-1 or M-CSF); toothless (tI);
tartrate-resistant acid phosphatase (TrAP)
117
INTODLCTION
Teeth develop within bony crypts and, in order to assume their functional role in
the oral cavity, must be translocated through alveolar bone by the process k own as
tooth eruption (Marks, 1987 and these proceedings). Although the mechanism(s)
governing this process remain a matter of debate, it is becrning increasingly apparent
that the dental follcle plays a central role in mediating tooth eruption. This was shown
by Marks and Cahil (1980, 1982) who, using surgical techniques, dernonstrated that
tooth eruption is inhibited in the absence of the follcle and that the tooth itself plays a
passive role in eruption. Additional histochemical and ultrastructural investigations of
erupting teeth and surrounding tissues have revealed that a cellular infiltrate of
mononuclear cells bearing features characteristic of preosteoclasts is present in the
dental follcle of rats (Wise and Fan, 1989) and dogs (Marks, Cahil and Wise, 1983)
early in eruption. These cells precede the appearance of osteoclasts on bone surfaces
adjacent to the coronal portion of the dental follcle, suggesting that they are precursors
to the osteoclasts responsible for producing the eruption pathway through bone.
That bone resorption is necessary for normal tooth eruption is exemplified by
the various rat and mouse strains with congenital osteopetrosis, a disease characterized
by a general skeletal sclerosis that is caused by a lack of or severely reduced bone
resorption (Seifert et al., 1993). Among these animal mutations a spectrum of tooth
eruption exists, ranging from lack of erupted teeth altogether to delays in incisor and/or
molar eruption. One such mutant, toothless (1) in the rat lacks erupted teeth, despite
normal tooth formation and crown development (Cotton and Gaines, 1974). The teeth in
11 mutant rats remain embedded within their bony crypts due to ankylosis of dentine and
enamel rnatrices to alveolar bone (lizuka et aI., 1992).
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Recently we have shown that daily injections of colony-stimulating factor-
(CSF-1) alleviates most of the skeletal manifestations of osteopetrosis in 11 rats (Marks
et aI., 1992). In addition, CSF-1 treatment of 11 rats from birth promotes eruption of
incisors and molars, albeit delayed compared to normal littermates (lizuka et aI.,
1992). To examine the mechanism(s) responsible for stimulating tooth eruption in
toothless rats and the possible role of CSF-1 in normal tooth eruption, we performed
histomorphometric analyses of erupting mandibular first molars and their normal
littermates with emphasis on populations of tartrate-resistant acid phosphatase-
positive (TrAP+) mononuclear cells in the dental follcle and TrAP+ osteoclasts on
adjacent alveolar bone surfaces.
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MATERIALS AND METHODS
Animals
The animals used in this study were derived from tested breeders (+/11 from
our inbred stock maintained to perpetuate the osteopetrotic mutation, toothless (U in
the rat. All animals were housed, maintained, bred and used in accrdance with the
recmmendations in the Guide for the Care and Use of Laratory Animals, prepared by
the ILAR, NRC (DHEW Publication No. NIH 86-23-1985) and guidelines of the Animal
Care Advisory Committee of the University of Massachusetts Medical School. Homozygous
toothless (1V1I rats were identified at birth by radiography under hypothermic
anesthesia (Schneider, Chenoud and Marks, 1979) and are hitherto denoted as 11 rats.
The normal littermates used in this study were either homozygous (+/+) or
heterozygous (+/11, since the two genotypes are indistinguishable except by breeding
(Cotton and Gaines, 1974).
Treatment
Normal and mutant animals were treated from birth by daily subcutaneous
injections of 106 units of purified human recombinant CSF-1, generously donated by
Chiron Corpration (Ladner et aI., 1987, Halenbeck et aI., 1989). After the first seven
postnatal days animals were treated as above, but on alternate days. The effects of CSF-
injections given every other day or daily do not differ with respect to tooth eruption
(unpublished data). Eruption of first molars was determined by daily inspection of
anesthetized animals (6:1 Ketamine/Zylagine at 4 ml/kg body weight, intramuscularly)
beginning on the 12th postnatal day. For histomorphometric analyses, anesthetized rats
were kiled at 1-2, 3, 5, 7, 10, 14 and 18 days after birth. Mandibles were then
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rapidly removed, transected anterior and posterior to the gubernacular trough of. the
first molar and immersion-fixed in 2.5% gluteraldehyde in 0.1 M cacodylate buffer with
k sucrose for 2.5 hours at 4 C and demineralized in 10% EDT A. These blocs were
then dehydrated in a graded ethanol series, transected through the center of the first
molar and embedded in resin for histochemical analyses of tartrate-resistant acid
phosphatase (TrAP) as reported previously (Cole and Walters, 1987).
The number of TrAP-positive (TrAP+) mononuclear cells in the dental follcle
and TrAP+ osteoclasts on adjacent alveolar bone surfaces were enumerated at 100X in
transverse sections of the first molar using the softare package Osteomeasure
(Osteometrics, Inc., Atlanta, GA). A representative section and corresponding
Osteomeasure field are shown in Figure 1. Cell density was expressed as number per
unit length of dental follcle (mononuclear cells) or alveolar bone surface (osteoclasts).
The statistical significance of differences between groups at various ages was determined
using a two-tailed student-test.
In some 10-day-old rats mandibles were removed for scanning electron
microscopy (SEM) of the bony crypt during eruption (Boyde and Hobdell, 1969).
Briefly, the lingual cortical plate and the underlying first molar were removed and the
exposed crypt was subjected to o.rganic digestion by immersion in 2% sodium
hypohloride and prepared for SEM as described previously (Marks and Cahil, 1986).
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RESLTS
The effecs of CSF-1 injections on tooth eruption are shown in Table 1. 
previously reported, treatment of toothless rats from birth promotes eruption of the
first molar (lizuka et al. 1992), but it is delayed compared to untreated normal
littermates. Treatment of normal littermates with CSF-1 from birth accelerated
eruption of first molars by 3-4 days.
Histomorphometric analyses of the dental follcle and the adjacent alveolar bone
surfaces revealed that TrAP+ mononuclear cells and osteoclasts could be found in all 4
groups, but their time of appearance or numbers differed. These data are shown in
Figures 2 (normal animals :t CSF-1) and 3 (1 rats :t CSF-1).
TrAP+ mononuclear cells (Fig. 2a) are present in the dental follcles of first
molars in normal rats at 1-2 days after birth and reach their hjghest population density
at 3 days postnatally. After fallng to low levels at 5 days, TrAP+ mononuclear cells are
present in greater numbers at 7 days, declining thereafter. Treatment with CSF-
caused a similar mononuclear cell profile, but the number of TrAP+ mononuclear cells
per length dental follcle was generally greater compared to untreated normal
littermates. A similar pattern was seen for TrAP+ osteoclasts on alveolar bone surfaces
(Fig. 2b). In untreated normal littermates, osteoclasts were. present early in eruption
around first molars, attained their highest population density at 3 days and declined
thereafter. Treatment of normal animals with CSF-1 caused a dramatic increase in
populations of TrAP+ osteoclasts on bone surfaces. As with mononuclear cell density,
the greatest number of TrAP+ osteoclasts on alveolar bone surfaces was attained at 3
days after birth and was followed by a secondary peak at 7 days, declining thereafter.
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These cell populations around first molars of untreated and CSF-1-treated 11 rats
are shown in Figure 3. CSF-1 treatment of 11 rats (Fig 3a) caused a dramatic influx of
TrAP+ mononuclear cells into the dental follcle. While untreated 11 rats possess few
TrAP+ mononuclear cells during the period examined, treatment with CSF-1 caused the
appearanc of TrAP+ mononuclear cells between the third and fifth postnatal day.
Mononuclear cells reach their highest levels at 7 days. decline at 10 days; attain a
secndary elevation at 14 days and decease thereafter. CSF-1 treatment also increases
the number of TrAP+ osteoclasts on alveolar bone surfaces around erupting first molars
(Fig. 3b). Untreated 11 rats possess few osteoclasts during the period examined, but
CSF-1 treatment of toothless rats results in a substantial increase in osteoclast
numbers, which peaks at 5 days after birth and then steadily decline.
Scanning electron microscopy of 10-day-old crypts from mutant and normal
rats CSF-1 revealed differences in crypt size and shape and resorptive activity as
assayed by surface topology (Fig. 4). In normal rats, the first molar occupied a large
crypt that, when examined at higher magnification, contained large areas with surface
characteristics of active bone resorption (Fig. 4 a,b). However, in untreated toothless
rats the first molars rested within smaller crypts (Fig. 4c) which lack the remodeling
seen in normal littermates and had surface topologies characteristic of forming bone
(Fig. 4d). Treatment of 11 rats with CSF-1 produced a larger mandibular first molar
crypt (Fig. 4e) that possessed regions of active bone resorption, similar to the surface
contours seen in normal littermates (Fig. 4b).
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DISUSON
These data show that CSF-1 treatment from birth causes early eruption of first
molars in normal rats and promotes tooth eruption in toothless littermates. These
observations are consistent with previous work which has shown that CSF-1 fosters
osteoclast development by acclerating the differentiation of osteoclast precursors
(Tanaka et aI., 1993, Udagawa et aI., 1990).
Analyses of the populations of both TrAP+ mononuclear cells within the dental
follcle and TrAP+ osteoclasts on adjacent bone surfaces shows that the accelerated
eruption in normal littermates is preceded by significant increases in these cell types
early in the eruptive process. Similarly, CSF-1 treatment of mutant (11) rats causes an
early influx of TrAP+ mononuclear cells in the dental follcle of first molars and greater
numbers of TrAP+ osteoclasts per unit length of the adjacent alveolar bone surface.
However, in treated 11 rats the time of the appearance of these cell types is delayed in
comparison with normal littermates and first molar eruption is delayed an identical
period. TrAP+ mononuclear cells are present at 1-2 days in normal littermates, but do
not appear in the dental follcle of treated toothless rats until 3-5 days. Osteoclasts are
present in follcles of normal littefmates as early as 1 day and appear on bone surfaces
around erupting first molars of 11 rats between the 3rd and 5th postnatal days. 
addition, while peak population density for both TrAP+ mononuclear cells and osteoclasts
is reached at day 3 for normal rats, the corresponding peaks for 11litterrnates are not
attained until 7 days for mononuclear cells and 5 days for osteoclasts. The numbers of
mononuclear cells in 11 rats never reach the levels seen in normal littermates. The
delays in the appearance of these cell types together with reduced numbers of TrAP+
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mononuclear cells are likely to account for the delayed eruption of first molars in t1 rats
treated with CSF-
Our data agree with previous studies describing the influx of TrAP+ mononuclear
cells early in the eruptive process in the beagle dogs (Marks and Grolman, 1987) and in
rats (Wise and Fan, 1989) and imply that the bone resorption necessary for the
formation of the eruption pathway is mediated by the supply to the surrounding bony
crypt of TrAP+ mononuclear precursors in the dental follicle. That bone resorption is
necessary for the eruption of teeth is evident in the various animals with congenital
osteopetrosis, a disease characterized by severely reduced or absent bone resorption
(Seifert et aI., 1993). All of these animal mutations possess dental abnormalities
ranging from complete lack of erupted teeth to delayed eruption of incisors and/or
molars. In certain mutations treatments which restore bone resorption in the neonatal
period, such as stem cell replacement (Marks, 1981) or CSF-1 injections (lizuka et
aI., 1992), also permit tooth eruption. However, the timing of the restoration of bone
resorption has different implications for different teeth (lizuka et al.,
' 1992).
The powerful influence of local factors in the recruitment of osteoclasts and their
precursors is supported not only by the influx of these cell populations around erupting
teeth during the eruptive process in dogs and rats (Figs. 2, 3; Marks et al., 1983; Wise
and Fan, 1989; Marks and Grolman, 1987) but also by the timing of their 
appearance
around first molars in untreated t1 rats (Fig. 3), in which very few osteoclasts can be
found in the remainder of the skeleton. Since CSF-1 is produce by cells of the dental
follcle (Wise these proceedings, Wise and Un
, 1994) it is likely to be involved in the
molecular signaling which governs the eruptive process. Furthermore, two proteins
produced by cells in the dental follcle and stellate reticulum have been shown to delay
tooth eruption in postnatal rats (Un, Fan and Wise, 1992).
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Taken together these data show that systemic administration of CSF-1, a factor
that causes a locl increase in TrAP+ mononuclear cells, osteoclasts and bone resorption
around erupting teeth, can accelerate eruption of a tooth after this process has begun.
This suggests that bone resorption is a rate-limiting step of the early phase of eruption
and that its increase accelerates this process. Whether local aplications of CSF-1 can
produce the same effect, whether eruption can be initiated by CSF-1 much earlier than
it would normally ocur, and whether CSF-1 can accelerate orthodontic tooth movement
are three potential clinical applications of this work which need to be examined.
TABLE 1
The Effects of CSF-1 on Eruption of First Molars in Rats of 11 Stock
Groups: NLM NLM t lit I tlitl
untx +CSF,. untx +CSF-
Age of Eruption: 17-18 . 13- never 20-(days)
H i s t o l o g i c a l  s e c t i o n s  ( F i g .  
1  a  
a n d  1  b )  o f  t r a n s v e r s e  s e c t i o n s  o f  t h e  
m a n d i b u l a r  f i r s t
m o l a r  o f  a  7 -
d a y - o l d  r a t  a n d  t h e  
h i s t o m o r p h o m e t r i c  r e p r e s e n t a t i o n  ( F i g .  1 c )  o f  
p a r t  o f  t h e
s e c t i o n  s h o w n  i n  F i g .  
1  b ,  
u s i n g  t h e  
O s t e o m e a s u r e
s o f t a r e  p a c k a g e .  
O s t e o c l a s t s  ( l a r g e  a r r o w s ,
b l a c k  c i r c l e s  i n  b  a n d  c )  o n  
a l v e o l a r  b o n e  ( A B ,  d a r k  l i n e )  a n d  T r A P +  m o n o n u c l e a r  c e l l s  
( s m a l l
a r r o w s ,  w h i t e  c i r c l e s )  i n  t h e  d e n t a l  f o l l c l e  
( D F ,  w h i t e  l i n e )  w e r e  e n u m e r a t e d  a n d  
e x p r e s s e d
a s  n u m b e r  o f  c e l l s l m m  b o n e  o r  f o l l c l e  s u r f a c e ,  r e s p e c t i v e l y .  D  =  d e n t i n e ,  E  =  e n a m e l
,  P  =
p u l p ,  o p e n  a r r o w  =  g u b e r n a c u l u m
,  l a r g e  a r r o w  =  
d i r e c t i o n  o f  e r u p t i o n .  1 A  =  7 0 X ,  
1  B  =  
1 6 0 X ,
1 C  =  1 0 S X .
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P o p u l a t i o n s  o f  T r A P +  m o n o n u c l e a r  ( a )  a n d  o s t e o c l a s t s  ( b )  a r o u n d  e r u p t i n g  f i r s t
m o l a r s  i n  n o r m a l  r a t s  o f  
1 1  s t o c k .
M o n o n u c l e a r  c e l l s  w e r e  p r e s e n t  e a r l y  i n  t h e  e r u p t i v e  p r o c e s s  a n d  
r e a c h e d
p e a k  v a l u e s  a t  7  d a y s  i n  b o t h  C S F -
1  t r e a t e d  n o r m a l  r a t s  ( c l o s e d  c i r c l e s )  a n d  c o n t r o l s  ( o p e n
s q u a r e s ) .  C S F -
1  t r e a t m e n t  c a u s e d  a  g e n e r a l  i n c r e a s e  i n  t h e  n u m b e r s  o f  T r A P +  
m o n o n u c l e a r
c e l l s  w i t h i n  t h e  d e n t a l  f o l l c l e  e a r l y  i n  
e r u p t i o n .
O s t e o c l a s t s  w e r e  p r e s e n t  e a r l y  i n  e r u p t i o n  a n d  p e a k e d  a t  3  d a y s  i n  n o r m a l
r a t s  t r e a t e d  w i t h  C S F -
1  ( c l o s e d  c i r c l e s )  a n d  c o n t r o l s  ( o p e n  s q u a r e s ) .  C S F -
1  c a u s e d  a
s i g n i f i c a n t  i n c r e a s e  i n  t h e  n u m b e r s  o f  T r A P +  o s t e o c l a s t s  o n  a l v e o l a r  b o n e  s u r f a c e s  a d j a c e n t  t o
t h e  e r u p t i n g  f i r s t  
m o l a r  i n  r a t s .
E l :
P o p u l a t i o n s  o f  T r A P +  m o n o n u c l e a r  c e l l s  ( a )  a n d  o s t e o c l a s t s  ( b )  a r o u n d  
e r u p t i n g
f i r s t  m o l a r s  i n  
1 1 1 1  r a t s .
F e w  m o n o n u c l e a r  c e l l s  w e r e  o b s e r v e d  i n  t h e  d e n t a l  f o l l c l e  i n  u n t r e a t e d  
1 1 1 1
r a t s  ( o p e n  s q u a r e s ) .  C S F -
1  t r e a t m e n t  o f  
1 1 1 1  r a t s  
( c l o s e d  c i r c l e s )  s t i m u l a t e d  t h e  a p p e a r a n c e
o f  T r A P +  m o n o n u c l e a r  c e l l s  i n  t h e  d e n t a l  f o l l c l e  b e t w e e n  3  a n d  5  d a y s .  
P e a k  v a l u e s  w e r e
r e a c h e d  a t  7  d a y s ,  d e l a y e d  4  d a y s  c o m p a r e d  t o  n o r m a l s  ( F i g .  2 a ) .
F e w  o s t e o c l a s t s  w e r e  o b s e r v e d  o n  a l v e o l a r  b o n e  s u r f a c e s  i n  c o n t r o l  
1 1 1 1
r a t s  ( o p e n  s q u a r e s ) .  C S F -
1  i n d u c e d  o s t e o c l a s t o g e n e s i s  i n  t r e a t e d  
1 1 1 1  r a t s  
( c l o s e d  c i r c l e s )
b e t w e e n  3  a n d  5  d a y s ,  a n d  p e a k  n u m b e r s  o f  o s t e o c l a s t s  w e r e  o b s e r v e d  a t  5  d a y s ,  d e l a y e d  2  d a y s
c o m p a r e d  t o  n o r m a l  r a t s  ( F i g .  2 b ) .
Mononuclear Cells Around Erupting Osteoclasts Around EruptingMilndlbular First Molars Mandibular First Molars
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S c a n n i n g  e l e c t r o n  m i c r o g r a p h s  o f  t h e  
m i n e r a l i z e d  s u r f a c e s  o f  b o n y  c r y p t s  o f  f i r s t
m a n d i b u l a r  m o l a r s  f r o m  1  O -
d a y - o l d
'  r a t s .
I n  n o r m a l  r a t s  ( a ,
b )  t h e  f i r s t  
m o l a r  c r y p t  i s  l a r g e  w i t h  s c a l l o p e d  s u r f a c e  f e a t u r e s
c h a r a c t e r i s t i c  o f  r e s o r b i n g  b o n e .  T h e  c r y p t  o f  u n t r e a t e d  
1 V 1 1  r a t s  ( c ,
d )  w a s  s m a l l e r  a n d  h a d  a
s u r f a c e  t o p o l o g y  w i t h  k n o b b y  p r o j e c t i o n s  ( l a r g e  a r r o w s )  i n d i c a t i v e  o f  f o r m i n g  b o n e  ( d ) .  
C S F -
1  t r e a t m e n t  e n l a r g e d  t h e  c r y p t  o f  t r e a t e d  1 V l l l i t t e r m a t e s  ( e )  a n d  
s t i m u l a t e d  b o n e  
r e s o r p t i o n
o f  c r y p t  s u r f a c e s  ( f ) ,  a s  e v i d e n c e d  b y  s c a l l o p e d  s u r f a c e s  ( s m a l l  a r r o w s )  a n d  n u m e r o u s
o s t e o c l a s t  l a c u n a e  ( o p e n  a r r o w s ) .  a , e  =  1 8 X ,  b ,
f  =  1 8 0 X
NLM
t I
untx
t I
CSF-1
I J
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Part D:
The Contrasting Effects of CSF-1 and EGF on Tooth Eruption in Normal Rats
Rationale
Cohen (1962) demonstrated that systemic doses of EGF cause precious eruption
of incisors in rOdents. Although the mechanism by which EGF influences incisor
eruption remains a mystery, it is possible that EGF stimulates bone resorption through
a secnd factor. Because EGF stimulates expression of CSF-1 mRNA and release of CSF-
protein by cultured murine marrow stromal cells (Abboud 1992), it is possible that
EGF mediates eruption via CSF-1. Therefore, we explored the effects of CSF-1, EGF, and
a combination of both factors on incisor and first molar eruption, with an emphasis on
the populations of TRAP+ mononuclear cells and osteoclasts around the erupting molar.
Summary of Results and Conclusions
Systemic administration of CSF-1 accelerated molar eruption
, but not incisor
eruption, in normal rats. As with the above study, CSF-1 increased osteoclasts and their
precursors around erupting first molars. Treatment of normal rats with EGF
acclerated incisor eruption, but molar eruption was unaffected. Populations of
osteoclasts and their precursors 
.around erupting first molars were not influenced by
injections of EGF. These data indicate that incisor and molar eruption in rodents respond
to different molecular signals or events. EGF plays a major role in incisor eruption, .
while CSF-1 contributes to the molecular cascade of molar eruption.
Publication
This study wil be presented at The Vth International Conference on Tooth
Morphogenesis and Differentiation in Kerkrade, The Netherlands in May 1994, and
submitted for publication in Connective Tissue Research. The key figures follow; please
refer to them for specific details.
Table 
The Effects of CSF- and/or EGF
on Tooth Eruption in the Rat
Avera Eru tion Ran Eru tion Age
oup Incisors First Molars
Controls 10. (9- 11) 17. (17- 18)
+ EGF 42 :t 9 0 (6- 16. (16- 18)
CSF- :t 1. 0 (7-11) 14. (14-15)
+ EGF and CSF- 70 :t 1. 0 (6- 14. (14-16)
a r o u n d  e r u p t i n g  f i r s t  m o l a r s  i n  m u t a n t  
( t o p )  a n d  n o r m a l  ( b o t t o m )  r a t s  o f  
1 1  s t o c k .
P o p u l a t i o n s  o f  T r A P +  m o n o n u c l e a r  c e l l s  ( l e f t )  a n d  o s t e o c l a s t s  ( r i g h t )
L e f t  T o p :
R i g h t  T o p :
L e f t  B o t t o m :
M o n o n u c l e a r  c e l l s  w e r e  p r e s e n t  e a r l y  i n  t h e  e r u p t i v e  p r o c e s s  a n d
r e a c h e d  p e a k  v a l u e s  a t  7  d a y s  i n  b o t h  C S F -
1  t r e a t e d  n o r m a l  r a t s  a n d
c o n t r o l s .  C S F -
1  t r e a t m e n t  c a u s e d  a  g e n e r a l  i n c r e a s e  i n  t h e  n u m b e r s  o f
T r A P +  m o n o n u c l e a r  c e l l s  i n  t h e  d e n t a l  f o l l i c l e  e a r l y  i n  
e r u p t i o n .
O s t e o c l a s t s  w e r e  p r e s e n t  e a r l y  i n  e r u p t i o n  a n d  p e a k e d  a t  3  d a y s  i n  n o r m a l
r a t s  t r e a t e d  w i t h  C S F -
1  a n d  c o n t r o l s .  C S F - 1  c a u s e d  a  s i g n i f i c a n t  i n c r e a s e  i n
t h e  n u m b e r s  o f  T r A P +  o s t e o c l a s t s  o n  a l v e o l a r  b o n e  s u r f a c e s  a d j a c e n t  t o  t h e
e r u p t i n g  f i r s t  m o l a r  i n  r a t s .
F e w  m o n o n u c l e a r  c e l l s  w e r e  o b s e r v e d  i n  t h e  d e n t a l  f o l l c l e  i n  u n t r e a t e d  t l / t l
r a t s .  C S F -
1  t r e a t m e n t  o f  t V t l  r a t s  s t i m u l a t e d  t h e  
a p p e a r a n c e  o f  T r A P +
m o n o n u c l e a r  c e l l s  i n  t h e  d e n t a l  f o l l c l e  b e t w e e n  3  a n d  5  d a y s .  P e a k  v a l u e s
w e r e  r e a c h e d  a t  7  d a y s ,  d e l a y e d  4  d a y s  c o m p a r e d  t o  n o r m a l s .
R i g h t  B o t t o m :  F e w  o s t e o c l a s t s  w e r e  o b s e r v e d  o n  a l v e o l a r  b o n e  s u r f a c e s  i n  c o n t r o l  
t V t l
r a t s .  C S F - 1  i n d u c e d  o s t e o c l a s t o g e n e s i s  i n  t r e a t e d  t l / t l  r a t s  b e t w e e n  3  a n d  5
d a y s ,  a n d  p e a k  n u m b e r s  o f  o s t e o l a s t s  w e r e  o b s e r v e d  a t  5  d a y s ,  
d e l a y e d  2
d a y s  c o m p a r e d  t o  n o r m a l  r a t s .
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Osteoclasts Around Erupting Firat
Mandibular Molars In Normal Rats
NLM+O
NLM + CSF-
AGE (days)
Osteoclasts Around Erupting
Mandibular First Molars in tl Rats
tV+o
II !V + CSF-1
AGE (days)
E l :
T h e  e f f e c t s  o f  E G F - t r e a t m e n t  o f  n o r m a l  r a t s  o n  t h e  c e l l u l a r  m e d i a t o r s  o f  b o n e
r e s o r p t i o n  d u r i n g  t o o t h  e r u p t i o n .  E G F  h a d  n o  
s i g n i f i c a n t  e f f e c t s  o n  T r A P +  o s t e o c l a s t s
( b o t t o m )  d u r i n g  e r u p t i o n  i n  n o r m a l  r a t s .
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Mononuclear Cells Around Erupting
Mandibular First Molars
Control
II -+
Age (days)
Osteoclasts Around Erupting
Mandibular First Molars
Control
II -+
Age (days)
i l :
S c a n n i n g  e l e c t r o n  m i c r o g r a p h s  o f  t h e  m i n e r a l i z e d  s u r f a c e s  o f  b o n y  c r y p t s  o f
f i r s t  m a n d i b u l a r  m o l a r s  i n  1 4  d a y  o l d  r a t s  o f  
1 1  s t o c k .
I n  n o r m a l  r a t s  ( a ,  b )  t h e  f i r s t  
m o l a r  c r y p t  i s  l a r g e  w i t h  s c a l l o p e d  s u r f a c e
f e a t u r e s  a n d  n u m e r o u s  o s t e o c l a s t  l a c u n a e  ( a r r o w s )  c h a r a c t e r i s t i c  o f  b o n e  
r e s o r p t i o n .
C S F - 1  t r e a t m e n t  e n h a n c e d  b o n e  r e s o r p t i o n  a s  e v i d e n c e d  b y  n u m e r o u s  s c a l l o p e d  s u r f a c e s
w i t h  a b u n d a n t  o s t e o c l a s t  l a c u n a e  ( a r r o w s  d ) .
T h e  c r y p t  o f  u n t r e a t e d  
1 1  r a t s  ( e ,  f )  
w a s  s m a l l e r  a n d  h a d  a  s u r f a c e  t o p o l o g y  w i t h
a r e a s  o f  k n o b b y  p r o j e c t i o n s  ( b o l d  a r r o w )  
i n d i c a t i v e  o f  f o r m i n g  b o n e ,  a n d  v e r y  f e w
s c a l l o p e d  s u r f a c e  f e a t u r e s  ( o p e n  a r r o w )  c h a r a c t e r i s t i c  o f  r e d u c e d  b o n e  
r e s o r p t i o n .  C S F -
t r e a t m e n t  e n l a r g e d  t h e  c r y p t  o f  t r e a t e d  
1 1 l i t t e r m a t e s  ( g )  a s  e v i d e n c e d  b y  s c a l l o p e d  s u r f a c e s
w i t h  o s t e o c l a s t  l a c u n a e  ( a r r o w s  h ) .
2  =  s e c o n d  m o l a r ,  a ,  c ,  e ,  g  =  
1 8 x ,  b ,  d ,  f ,  h  =  
1 8 0 x .
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SPECIFIC AIM 2
Part E:
The General and Skeletal Manifestations of Osteopetrosis
in a New Mutation (microphthalmia blanc) in the Rat
Rationale
Osteopetrotic mutations interrupt the development and/or function of osteoclasts
and represent reproducible models in which to study the systemic and local factors
essential for osteoclast differentiation and function. Recently, a new osteopetrotic
mutation (microphthalmia blanc) in the rat was described (Moutier et al. 1989). These
mutants have small eyes, lack skin and fur pigmentation, and inherit a typical skeletal
sclerosis at birth, which diminishes by 8 weeks. The limited data about the skeletal
manifestations of osteopetrosis in the microphthalmia
. blanc mutation and the central
role animal mutations have played in our understanding of osteoclast development and
function have rnotivated us to characterize the osteopetrotic manifestations in the
microphthalmia blanc mutation.
Summary of Results and Conclusions
Neonatal mutant (mi rats exhibit the typical skeletal deformities and sclerosis
which are reduced significantly during the first postnatal month. Osteoclast numbers,
staining for TRAP and TrATPase, and bone resorption are reduced in mutants during the
first two postnatal weeks, but all of these elements improve by one month. Serum
concentrations of calcium and phosphorous are normal in mi rats, but 1,25-
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dihydroxyitamin D levels are higher at one week than in normal littermates. Neonatal
m. rats also exhibit extramedullary hemopoiesis in the spleen. These results indicate
that the transient perinatal skeletal sclerosis in m. rats is caused by reduced
producJion and function of osteoclasts during this period.
Publication
: -
This study has been submitted for publication in Bone, and a copy of the
manuscript with original Figures follows. Please refer to it for specific details.
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ABCT
We have examined the general and skeletal manifestations of osteopetrosis in a
new, mild osteopetrotic mutation in the rat, microphthalmia blanc (m. Newborn
mutant (m. rats exhibit the typical skeletal deformities and sclerosis at birth which
are reduced significantly during the first postnatal month but don t disappear entirely
up to 8 months later. Osteoclast numbers, staining for TRAP and TrA TPase, and bone
resorption are reduced in mutants during the first two postnatal weeks but improve by
one month. In mutants, serum concentrations of calcium and phosphorus are normal but
1 ,2S(OH)2 D levels are higher at one week than those in normal littermates.
Neonatally, mutants exhibit extramedullary hemopoiesis in the spleen. These results
are interpreted to mean that the transient perinatal skeletal sclerosis in ro rats is
caused by reduced production and function of osteoclasts in this period. The recent
description of transient, perinatal osteopetrosis in a child suggests that analyses of the
early differences between mild and severe animal mutations might distinguish those
children with osteopetrosis who need treatment from those who do not.
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INTUCON
Osteopetrosis is a rare metabolic bone disease distinguished by a generalized skeletal
sclerosis caused by reduced bone resorption (Marks 1987, Osier and Marks 1992).
While spontaneous mutations have been documented in cattle (Gopal et al. 80,
Zetterhqlm 1972), dogs (Lees and Sautter 1979), deer (Smits and Bubenik 1990), and
humans (Loria-Cortes et al. 1977), the nine distinct mutations found in common
laboratory animals (mice, rats, and rabbits) have been most studied (Marks and
McGuire 1988, Marks 1984, Seifert et al. 1993). These mutations are congenital,
inherited as autosomal recessive traits. All mutants possess a characteristic skeletal
sclerosis at birth, which persists in the severe forms of the disease, but may gradually
diminish in the milder mutations. Because these mutations interrupt the development
and/or function of osteoclasts, they represent reproducible models in which to study the
systemic and local factors essential for osteoclast differentiation and function (Marks
and Walker 1976, Marks 1992). In addition , because osteoclasts fail to develop in
certain skeletal sites in different mutations, these mutants offer models in which to
explore the emerging site-specificities of osteoclast development and function (Marks et
al. 1993).
Microphthalmia blanc (mi) is a new osteopetrotic mutation in the Norway rat
discovered by Moutier and others (1989). Affected mutants, hitherto designated 
rats, lack body and fur pigmentation, have small eyes and abnorrnal incisors, and inherit
a mild form of osteopetrosis at birth, which significantly improves by the sixth
postnatal week. The limited data concerning the skeletal manifestations of osteopetrosis
in the microphthalmia blanc mutation and the central role animal mutations have played
in our understanding of osteoclast development and function have motivated us to
characterize the osteopetrotic manifestations in the microphthalmia blanc rat.
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MATERIALS AND METODS
Animals: Breeding stoc for the mi mutation was generously donated by Dr. Rene
Moutier, Centre de Selection et d'Elevage d'Animaux de Laboratorie, CNRS, Orleans,
France. Animals used in this study were offspring of tested females (+/mi and mutant
males (mimi derived from Dr. Moutier's stock and maintained at the University of
Massachusetts accrding to the NIH Guide for the Care and Use of Laboratory Animals
(1985) and the guidelines of the University of Massachusetts Animal Advisory
Committee. Homozygous microphthalmia blanc (mib/mib) rats were visually identified
at birth by lack of pigmentation.
All animals were weighed prior to use and their body weight recorded at regular
intervals. At 1, 7, 14, 21, and 28 days after birth, a minim urn of 4 normal and 4
mutant animals were kiled at each age and the following tissues removed for analysis.
Blood was removed via cardiac puncture of anesthetized animals (7:1 Ketamine: Zylagine
at 0.4 mVKg intramuscularly); serum concentrations of calcium were measured by
atomic absorption spectroscopy (Trudeau and Freier 1967) and phosphorous was
determined by a colorimetric method (Chen et al 1956). Serum 1,25-
dihydroxyvitamin D levels were determined for 3 +/mi and mimi rats by Dr. Joe
Zerwekh using the calf thymus receptor assay as previously described (Zerwekh et al.
1987; Reinhardt and Horst, 1990). Tibiae and femora were removed bilaterally and
those on one side were used for high resolution radiography (Schneider et al. 1979) or
scanning electron microscopy, while those on the opposite side were procssed for
histochemical and histological analyses. Marrow cavity size as a percent of bone length
was measured in high resolution radiographs of tibiae from at least 5 animals at each
age. For light microscopy and histochemical analyses, long bones were rapidly removed,
cleaned of excess soft tissue, bisected longitudinally, and fixed for 2 hours in 2.
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glutaraldehyde in 0. 1 M cacodylate buffer (pH 7.2) containing 7% sucrose as previously
described (Cole and Walters 1987). Fixed specimens were then demineralized in 10%
EDTA in 0.1M Tris buffer, pH 7.0 and embedded in methyl methacrylate or epoxy resin.
Sections cut at 0.6 J1m were reacted for tartrate-resistant acid phosphatase (TRAP) or
tartrate-resistant acid ATPase (TrATPase) by methods previously described (Cole and
Walters 1987; Andersson and Marks 1989; Lindunger et aL 1990). These sections
were used for general skeletal surveys and for quantitation of osteoclasts in metaphyseal
bone (Marks et al. 1984). Osteoclasts were identifed as large, multinucleated cells on
bone surfaces and their density in tibial metaphyses was expressed as number of cells
per unit area. Histochemical reactivity of mutant osteoclasts at various ages was
evaluated and compared to that in normal littermates. Negative and positive controls for
these histochemical analyses included incubation without substrate or with 10 mM
sodium-orthovanadate, and incubation of sections from normal rats of a different stock
known to possess reactivity for TRAPlTrATPase. Negative controls demonstrated neither
TRAP nor TrATPase reactivity.
Scanning electron microscopy of the mineralized surfaces of tibiae was
performed to examine and compare the metabolic state of surface bone in mutant and
normal siblings of mi stock (Boyde and Hobdell, 1969). Briefly, tibiae were rapidly
removed, carefully cleaned of excess soft tissue, and fixed in 10% neutral buffered
formalin (NBF) for 4 hours. Remaining soft tissue and non-mineralized bone was
removed in 1.5% sodium hypochloride, and the specimens were dehydrated in a graded
ethanol series. Tibiae were then mounted on aluminum stubs with the anterior surface
exposed, sputtercoated, and observed using an ETEC scanning electron microscope 
previously described (Marks et al. 1994).
In order to screen for possible extraskeletal manifestations or complications of
osteopetrosis in mi rats, the following soft tissues were histologically examined in 0.
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to 1.0 J1m epon sections: liver, spleen, kidney, thymus, inguinal lymph nodes, and
parathyroid gland.
RESULTS
The boy weights of normal and mutant rats of mi stock are shown in Figure 
for the first four postnatal weeks. There are no significnt differences in weight
between the two groups until weaning (three weeks), when mutants weigh less than
their normal littermates. As is typical in most osteopetrotic mutations, ml rats
continue to weigh less than normal rats throughout life.
Radiographs of mutants and normal littermates from birth to four weeks at
weekly intervals are shown in Figure 2. Notice that at each age shown the skeleton of
mutants exhibits greater sclerosis than that in normal rats of this stock. At birth, in
contrast to normal littermates, there are no marrow cavities in ml rats, but these
appear during the first week. However, metaphyseal sclerosis remains prominent in
some long bones and caudal vertebrae. Sclerosis in caudal vertebrae is present even
eight months after birth (Fig. 3). Direct measurement of marrow cavity size in
radiographs confirms that significant metaphyseal sclerosis persists in mutants four
weeks after birth (Fig. 4).
Examination of anorganic preparations of tibial surfaces by scanning electron
microscopy revealed reduced resorption in ml rats (Fig. 5). This is especially evident
in the proximal tibia where the prominent flare, a product of local resorption in normal
rats (Fig. Sa), is poorly developed in mutants (Fig. Sb), producing a bulbous convexity
rather than a concavity at this site. At higher magnification (Fig. Sc-f) sites exhibiting
the characteristic scalloping seen at resorbing surfaces in normal rats (Fig. SC,e) are
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replaced in many areas in mutants by surfaces with impressions of new osteocyte
lacunae (Fig. Sd,f), characteristic of bone formation.
Histological analyses of the skeleton, as expected, showed no obvious
morphological differences between the ,osteoblast populations in mutants and normal
rats. However, quantitation of osteoclasts in these two phenotypes during the first
postnatal monttl (Fig. 6) showed significant reductions in osteoclast profiles in mutants
through the second postnatal week. Histochemical studies of staining for TRAP (Fig. 7)
and TrA TPase (not ilustrated) demonstrated that all osteoclasts in 
.m rats up to 14
days after birth stained less intensely for these enzymes than osteoclasts in normal
littermates. By 30 days after birth, the staining intensity was not different between
these two groups (Fig. 7g,h).
Analyses of the bloo levels of calcium and phosphorus showed no significant
differences between mutants and normal littermates during the first postnatal month
(Fig. 8). Analyses of circulating levels of 1,25-dihydroxyvitamin D in pooled samples
demonstrated that this hormone in 
.m rats was elevated (90 and 55 pg/ml vs. 40,
and 35 pg/ml in normal littermates) at one week after birth.
To determine the extent of the extramedullary manifestations of osteopetrosis in
the microphthalmia blanc mutation during the first month, we examined the microscopic
anatomy of selected tissues. Relative enlargement of the red pulp in the spleen of
neonatal mutants was suggestive of extramedullary hemopoiesis but there were no
hepatic foci of hemopoiesis in either phenotype. The kidney, spleen and liver of mutants
showed no cytoarchitectural abnormalities, and mutant thymus and lymph nodes
contained well-develope Band T -cell-dependent zones. Thus, with the exception of
splenic hemopoiesis, no morphological differences between mutants and normal
littermates were noted in the spleen, liver, thymus, lymph nodes, kidney and
parathyroid glands.
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DISUSON
We have describe the general skeletal manifestations of a new osteopetrotic
mutation, microphthalmia blanc (mi, in the rat. As reported by Moutier et al.
(1989) the mi mutation exhibits a mild, transient osteopetrosis in which the skeletal
sclerosis present at birth is gradually reduce by the 6th postnatal week. However, the
disease is not completely resolved in mi rats because residual rnetaphyseal sclerosis
persists in the long bones and axial skeleton up to 8 months after birth. Mineral
homeostasis is not compromised in mimi rats, even at birth, when the disease is
most acute. Our data show that serum calcium and phosphorous levels are normal from
birth to the fourth postnatal week in mutant rats. This is in contrast to other animal
mutations including three mouse mutations (mi g1 and the Qa rabbit which exhibit
hypocalcemia and hypophosphatemia and two rat mutations (.e !a) which are
hypophosphatemic at least early in life (Seifert et aI., 1993).
Elevations of serum 1,2S-dihydroxyvitamin D (1,2S(OH)2D) at some point in
life have been detected in all animals with congenital osteopetrosis (Popoff et al. 1992).
Our data show this to be the case for 1-week-old mutant (.m rats. These data supprt
the concept of interdependence of the skeleton and the vitamin D-endorine system and
suggest that elevations in serum (1 ,2S(OH)2D) are a consequence of the reduced bone
resorption caused by osteopetrosis (Popoff et aI., 1992).
Our data indicate that aberrations in osteoclast development and function early in
life account for the early and transient sclerosis in mi rats. . First, scnning electron
microscopy (SEM) of tibial bone surfaces reveals little bone resorption in 1 week old
mi rats. Second, marrow cavity space increases dramatically in mi rats between
birth and 10 days. Third, osteoclast numbers are severely reduced in mutant 
.m rats
144
at birth (48% compared to normal littermates), but increase to normal levels by four
weeks. Fourth, histochemical analysis of tartrate-resistant acid phosphatase (TRAP)
reveals little reactivity in mutant osteoclasts between birth and the first postnatal week.
However, osteoclasts contain nearly normal levels of this functional enzyme by four
weeks. These data taken together suggest that within the limitations of the methods we
used: (1) decreased osteoclast numbers combined with reduced osteoclast function early
in life bring about the severe sclerosis present at birth in mi rats, (2) the gradual
improvement of osteoclast numbers and function leads to reduced skeletal sclerosis, and
(3) residual metaphyseal sclerosis present up to 8 months after birth is caused by 
persistent reduction in osteoclast function. It is interesting that osteoclasts in two mild
osteopetrotic mutations in the rat, mi and incisors-absent (ia exhibit minimal and
excessive numbers and reactivity for TRAP, respectively (present data, Marks 1973).
This underscores the remarkable variety of cellular manifestations even in two
mutations with early, improving skeletal sclerosis.
Studies on osteopetrotic mutations have shed light on the remarkable
heterogeneity of the disease in mammals and provided insights concerning bone
metablism in general. The pathogenetic mechanisms of osteopetrosis, whether due to
deviations in osteoclast origin, st(ucture, or function serve as models for understanding
normal osteoclast biology. This is exemplified by the pioneering work of Walker, in
which he cured miml and gJgl mice via parabiotic union (Walker 1972; 1973) and
subsequently cured mice of the disease using normal spleen and marrow transplantation
(Walker 1975a; 1975b). These studies lead to the first successful clinical treatment of
human infantile osteopetrosis and fostered our current understanding of the hemopoietic
origin of osteoclasts. Recent investigations with the 11 rat and Wl mouse have ilustrated
the importance of local factors or cytokines in supporting osteoclast development,
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recruitment, function, and maintenance (Yoshida et al. 1990; Felix at aI., 1990; Marks
et al. 1992; 1993; Sundquist et al. 1994; Wiktor-Jedrzejczak et aI., 1990).
Recently, Monoghan and others (1991) reported a patient with transient
infantile osteopetrosis in which neonatal, asymptomatic, biopsy-proven osteopetrosis
resolved by 28 months. Infantile osteopetrosis is usually a malignant, autosomal
recessive disease distinguished clinically by anemia, compressive cranial neuropathies,
skeletal fractures, upper airway obstruction, and a progressively fatal course if left
untreated (Reeves et al. 1981, Cook and Moore 1992). Given the availabilty and risk
associated with several experimental treatments for patients with infantile
osteopetrosis (van Ue Peters et al. 1993, Coccia 1993), identifying those infants with
osteopetrosis destined to recover spontaneously is a principal concern. Our studies
indicate that the mi mutation in the rat is similar to the patient reported by Monoghan
et al. Additional studies of the differences between mi rats and more severe mutations
(1 and QI rats)could lead to clinical tests to distinguish neonates with a sclerotic
skeleton who need treatment from those who do not.
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F I G U R E  2
R a d i o g r a p h s  o f  r e p r e s e n t a t i v e  n o r m a l  ( l e f t  c o l u m n )  a n d  m u t a n t  r a t s  o f  
s t o c  a t  
b i r t h  ( 0  d a y s ) ,  7
,  2 1  a n d  2 8  d a y s .  A t  
b i r t h  m u t a n t  l o n g  b o n e s  h a v e
n o  m a r r o w  s p a c e s  ( a r r o w s )  b u t  t h e y  d e v e l o p  b y  t h e  f i r s t  w e e k .  A t  
a l l  a g e s
m u t a n t s  c a n  b e  d i s t i n g u i s h e d  f r o m  n o r m a l  l i t t e r m a t e s  b y  i n c r e a s e d
m e t a p h y s e a l  s c l e r o s i s  i n  l o n g  b o n e s  a n d  c a u d a l  v e r t e b r a e  ( a r r o w s )
r e p r o d u c e d  a c t u a l  s i z e .
- - -- -
nlm mib
F I G U R E  3
R a y s  o f  t h e  c a u d a l  s k e l e t o n  o f  n o r m a l  ( A )  a n d  m u t a n t  ( B )  r a t s  o f  
m i  
s t o c k
a t  8  m o n t h s .  
S c l e r o s i s  p e r s i s t s  i n  t h e  m e t a p h y s e s  o f  t h e  c a u d a l  v e r t e b r a e  a n d
t h e  d i s t a l  t i b i a  
( a r r o w s ) .
...
F I G U R E  4
M a r r o w  c a v i t y  s i z e  i n  n o r m a l  ( N L M )  a n d  
m i  
r a t s  e x p r e s s e d  a s  a  p e r c e n t a g e
o f  t h e  d i s t a n c e  b e t w e e n  t i b i a l  g r o w t h  p l a t e s  d u r i n g  t h e  f i r s t  f o u r  
p o s t n a t a l
w e e k s .  T h e  m a r r o w  
c a v i t y  o f  m u t a n t s  i s  s i g n i f i c a n t l y  s m a l l e r  t h a n  
n o r m a l
( p : 5 0 .
0 5 )  t h r o u g h  t h e  f i r s t  f o u r  p o s t n a t a l  w e e k s .
. (I
;: Do 60
== :: .-
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Gi 
G) 20
100
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F I G U R E  5
S c a n n i n g  e l e c t r o n  m i c r o g r a p h s  o f  t h e  a n o r g a n i c  
( m i n e r a l i z e d )  a n t e r i o r
s u r f a c e  o f  t h e  p r o x i m a l  t i b i a  o f  
o n e - w e e k - o l d  n o r m a l  ( n l m -
F i g .  4 a , e )  a n d
m u t a n t  ( m l -
F i g .  4 , f )  r a t s .  
A r e a s  o f  b o n e  
r e s o r p t i o n  a r e  i r r e g u l a r  a n d
s c a l l o p e d  a n d  a r e a s  o f  b o n e  f o r m a t i o n  a r e  s m o o t h .  T h e r e  i s  m o r e  r e s o r p t i o n
i n  n o r m a l  r a t s  t h a n  m u t a n t s  ( c o m p a r e  F i g .  4 a  a n d  b )  w h i c h  c a n  b e  c o n f i r m e d
a t  h i g h e r  m a g n i f i c a t i o n  
( F i g s .  4 c -
f ) .  F I  =  
f l a r e ;  c  =  
a n t e r i o r  t i b i a l  c r e s t ;  v
=  v a s c u l a r  s p a c e ;  r  =  s c a l l o p e d  a r e a  o f  
r e s o r p t i o n ;  f  =  a r e a s  o f  f o r m a t i o n .
b  =  2 0 X ;  c ,
f  =  
1 5 0 X .

F I G U R E  6
N u m b e r  o f  o s t e o c l a s t  p r o f i l e s  p e r  u n i t  a r e a  ( m m
)  o f  p r o x i m a l  
t i b i a l
m e t a p h y s i s  f r o m  n o r m a l  a n d  
m .  
r a t s  a t  v a r i o u s  p o s t n a t a l  a g e s .  D a t a  a r e
p r e s e n t e d  a s  m e a n  c o u n t s  p e r  u n i t  a r e a  f r o m  a t  l e a s t  t h r e e  n o n - a d j a c e n t
s e c t i o n s  f r o m  a t  l e a s t  t h r e e  r a t s  o f  e a c h  p h e n o t y p e  a t  e a c h  a g e .  O s t e o c l a s t s  i n
t h e  m u t a n t  s k e l e t o n  a r e  
s i g n i f i c a n t l y  r e d u c e d  ( p
O S )  d u r i n g  t h e  f i r s t  t w o
p o s t n a t a l  w e e k s .
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F I G U R E  7
P h o t o m i c r o g r a p h s  o f  t h e  p r o x i m a l  t i b i a l  
m e t a p h y s i s  f r o m  a  7 -
d a y - o l d
n o r m a l  r a t  ( a  a n d  c )  a n d  i t s  
m i  
l i t t e r m a t e  ( b  a n d  d )  r e a c t e d  t o  s h o w
t a r t r a t e - r e s i s t a n t  a c i d  p h o s p h a t a s e  
( T R A P )  a c t i v i t y  h i s t o c h e m i c a l l y .  I n
n o r m a l  r a t s  a t  t h i s  a g e  ( F i g .  7 a )  t h e  
p r o x i m a l  m e t a p h y s i s  ( d o u b l e - e n d e d
a r r o w )  i s  s h o r t ,  s i t u a t e d  b e t w e e n  t h e  p r o x i m a l  
e p i p h y s e a l  p l a t
( E )  a n d  t h e
m a r r o w  c a v i t y  ( M ) .  O s t e o c l a s t s  
( a r r o w h e a d s )  a r e  n u m e r o u s  a n d  s t a i n
i n t e n s e l y  f o r  T R A P  ( F i g .  7 c ) .  
I n  
m i  
r a t s  a t  t h i s  a g e  ( F i g .  7 b )  t h e
m e t a p h y s i s  i s  e x t e n s i v e  ( l o n g  a r r o w ) ,  t h e r e  i s  n o  
m a r r o w  c a v i t y  v i s i b l e  a t
t h i s  m a g n i f i c a t i o n  a n d  f e w e r ,  w e a k l y  s t a i n i n g  o s t e o c l a s t s  ( a r r o w h e a d s )  a r e
p r e s e n t  ( F i g .  7 b  a n d  d ) .  U g h t l y  
c o u n t e r s t a i n e d  w i t h  t o l u i d i n e  b l u e .  a ,
c  =
1 1 S X ;  b ,
d  =  3 0 0 X .
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F I G U R E  8
P h o t o m i c r o g r a p h s  o f  T R A P - s t a i n e d  s e c t i o n s  o f  t i b i a l  m e t a p h y s i s  f r o m  o n e -
d a y - o l d  ( F i g .  8 a ,
b )  a n d  3 0 -
d a y - o l d  ( F i g .  c ,
d )  n o r m a l  ( a  a n d  c )  a n d  
m 1  ( b
a n d  d )  
l i t t e r m a t e s .  A t  
b i r t h  o s t e o c l a s t s  i n  n o r m a l  r a t s  
( a r r o w h e a d s ,  F i g .  8 a )
s t a i n  m u c h  m o r e  i n t e n s e l y  f o r  T R A P  t h a n  t h o s e  i n  
m i  
l i t t e r m a t e s  ( F i g .  8 b ) .
B y  3 0  d a y s  t h e  
s t a i n i n g  i n t e n s i t y  o f  n o r m a l  ( F i g .  8 c )  a n d  m 1  
( F i g .  8 d )
o s t e o c l a s t s  ( a r r o w h e a d s )  d o e s  n o t  d i f f e r .  L i g h t l y  
c o u n t e r s t a i n e d  w i t h
t o l u i d i n e  b l u e .  
X 3 0 0 .
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F I G U R E  9
S e r u m  p h o s p h o r u s  a n d  c a l c i u m  c o n c e n t r a t i o n s  i n  n o r m a l  a n d  m u t a n t  r a t s  o f
m i  
s t o c k .  D a t a  a r e  
m e a n  v a l u e s  f r o m  t r i p l i c a t e  d e t e r m i n a t i o n s  f r o m  a t  l e a s t
t h r e e  r a t s  o f  e a c h  p h e n o t y p e  a t  e a c h  a g e .
,  .
Normal
mib/mib
CD 6
14 
AGE (days)i 0a
Normal
mib/mib
AGE (days)
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Part F:
Dental Manifestations of the mi Rat
Rationale
Tooth eruption is the bilaterally symmetrical, highly coordinated biological
event whereby a tooth is translocated through alveolar bone to its functional position in
the oral cavity. It has been doumented that bone resorption is a necessary and rate-
limiting component of eruption. This concept is exemplified among the congenital
mammalian osteopetroses, where a veritable spectrum of tooth eruption exists, ranging
from complete lack of erupted dentition in the most severe forms of the disease to delays
in incisor and/or molar eruption in the milder ones. As shown above, bone resorption is
reduced in m. rats in the perinatal period. We have examined the dental consequences
of this transient reduction in bone resorption.
Summary of Results and Conclusions
The mild osteopetrosis in m. rats caused incisor defects and delayed the eruption
of all teeth. Radiography and histological analyses revealed that in m. rats the apical
end of the incisor failed to extend posterior to the third molar as in normal siblings.
However, molar root and crown development was normal in m. rats. The temporary
encroachment of bone on incisor matrices leads to malformed and maloccluded incisors in
m. rats. These data supprt the hypothesis that each tooth has a "window of
opportunity" in which bone resorption must occur during tooth eruption, since
incisors--the first teeth to erupt in rodents--are most affected by the disease in
microphthalmia blanc.
Publication
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ABCT
We have examined the dental manifestations of the mild, transient osteopetrosis
in the rat mutation microphthalmia blanc (m. Eruption of all teeth was delayed in
mi rats compared to normal littermates. These delays ranged from 5 days for incisors
to 3 and 2 days for the first and secnd molars. Normal rats had straight incisors which
exhibited signs of wear, but in mi littermates the incisors were rnaloccluded, distorted
in shape, and showed no signs of wear. Radiographic and histologic examination of the
dentition of 1 and 4 week old rats revealed that the apical end of incisors in mi rats
failed to extend posteriorly to the third molar region as in normal siblings, but ended at
the first molar region. Histologic examination of longitudinal sections of mandibles
through the incisors of neonatal normal and mi rats showed that in 1 day old mutants
the incisor was closely surrounded by alveolar bone to which it was ankylosed. 
addition , the incisor body in mi rats was malformed, with an indented apical end. This
ankylosis was temporary, being resolved by 3 days. These data demonstrate that
neonatal reductions in bone resorption cause incisor defects and delay the eruption of all
teeth in mi rats. The maloccluded and distorted incisors of mi rats are likely caused
by temporary ankylosis of incisor matrices to alveolar bone. Taken together, these data
ilustrate that bone resorption is an essential and rate- limiting element of tooth
eruption.
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INTDUCON
Osteopetrosis is a rare inherited metablic bone disease in mammals marked by a
generalized skeletal sclerosis caused by reduced bone resorption (Marks, 1987; Osier
and Marks, 1992). The pathogenesis of the disease varies among the mutations, and
includes interceptions in osteoclast development and/or function; however,
osteopetrosis invariably involves reduced osteoclastic bone resorption (Marks, 1984;
1989). Although spontaneous mutations have been documented for a variety of
mammals, the nine distinct congenital osteopetroses occurring in common labratory
animals are best characterized (Seifert et aI., 1993). Common features of the disease
include a characteristic skeletal sclerosis at birth, which persists in the severe forms
of the disease but gradually diminishes in the less severe mutations, reduced or absent
marrow cavities, abnormal bone modeling and remodeling, extramedullary hemopoiesis,
and abnormal tooth eruption.
A spectrum of aberrant tooth eruption exists among the animal osteopetroses,
from complete absence of an erupted dentition in the most severe forms of the disease
(Cotton and Gaines, 1974), to delays in eruption of incisors and/or molars in the less
severe mutations (Marks, 1976). These observations suggest that tooth eruption
depends on bone resorption, a concept supported by abundant experimental evidence.
Cahil (1970; 1974) has shown that the radiographic and histologic hallmark of tooth
eruption is the timely formation of an eruption pathway, and conditons such as
osteopetrosis, which inhibit the formation of the eruption pathway, compromise
eruption. Tooth eruption is inhibited when bone resorption is blocked by local infusions
of bafilomycin A1' an antagonist to the osteoclastic proton pump (Sundquist and Marks,
1994). Tooth eruption is restored in osteopetrotic animals with treatments that
increase bone resorption, such as stem cell replacement or administration of colony-
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stimulating factor-1 (CSF-1 or M-CSF), respectively (Marks, 1981; lizuka et aI.,
1992). In addition, tooth eruption is accelerated in normal rats after injections of CSF-
(Cielinski et aI., 1994).
Microphthalmia blanc is a new osteopetrotic mutation in rats discove ed by
Moutier .and colleagues (1989). Mutant rats, hitherto referred to as .D rats, are
distinguished af birth by lack of pigmentation and a typical skeletal sclerosis, which
diminishes during the first postnatal month. We have recently reported that osteoclast
numbers are reduced in mi rats at birth and contain little of the functional enzymes
tartrate-resistant acid phosphatase (TRAP) and tartrate-resistant acid ATPase
(TrATPase) (Cielinski and Marks, 1994). However, by the fourth postnatal week
osteoclast numbers and function, as assayed by these functional enzymes, approaches
those observed in normal siblings. We describe here the dental consequences of this
temporary reduction in bone resorption in .D rats.
MATERIALS AND METHODS
Animals
Animals used in this study were offspring of tested females (+/mib) and mutant
males (miblmib) derived from breeding stock donated by Dr. Rene Moutier, Centre de
Selection et d'Elevage d'Animaux de Laboratorie, CNRS, Orleans, France. The rats were
maintained and bred at the University of Massachusetts accrding to the NIH Guide for the
Care and Use of Laboratory Animals. 1985 and the guidelines of the University of
Massachusetts Animal Advisory Committee. Homozygous microphthalmia blanc rats
(mib/mib) were identified at birth by lack of skin pigmentation. After weaning at 
days, mi rats were provided with powdered food ad libidum. as previously described for
toothless (11, osteopetrotic) rats (Cotton and Gaines, 1974).
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Tooth eruption:
Tooth eruption was defined as the age at which the given tooth first pierced
through the oral epithelium. For incisors, eruption was monitored by daily visual
inspection beginning seven days after birth. Molar eruption was determined by
palpation of anesthetized animals on alternate days (7:1 Ketamine : Zylagine at 0.
ml/Kg, intramuscularly) beginning fourteen days after birth.
Histoloay and Histochemist'Y
At birth and weekly intervals thereafter, a minimum of 5 normal and 5 mutant
animals were kiled by decapitation under anesthesia (see above) for histological and
histochemical analyses. The mandibles were rapidly removed, cleaned of excess soft
tissue, and transected posterior to the third molar to faciltate penetration of fixatives.
For histological examination, mandibles were fixed in 10% neutral-buffered formalin
at room temperature for 24 hours, demineralized in 10% EDTA in 0.1M Tris buffer,
dehydrated in a graded ethanol series, embedded in paraffin, and 5 m sections were
stained with hematoxylin and eosin. Alternatively, isolated mandibles were fixed in
5% gluteraldehyde in 0.1M cacodylate buffer (pH 7.2) containing 7% sucrose as
previously described (Cole and Walters, 1987), demineralized in 10% EDTA in 0.
Tris buffer, pH 7.0, and embedded in methyl methacrylate. Sections cut at 0. were
examined via light microscopy.
AutoradioQraphy
To study the formation rate of alveolar bone and dentin, at least 4 animals at 1,
7, 14, 21, and 28 days of each genotype (+/mib, mib/mib) were given 5. Ci 3H-
proline (New England Nuclear) per gram body weight and kiled 6 hours later (Walker,
1966; Marks, 1969). Serial sections were cut from paraffin-embedded mandibles
prepared as abve, dipped in IIford-L4 emulsion, and alternate slides were placed in dry
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chambers for 1 or 2 week exposures, respectively. Exposed slides were developed in D-
19 (Kodak) for 4 minutes, rinsed in water for 1 minute, fixed in 30% sodium
thiolsulfate for 5 minutes, and rinsed in tap water. Some sections were then
counterstained with hematoxylin and eosin.
Radiolooy
For radiographic examination of the dentition, mutant and normal siblings of 
stock were kiled by decapitation at 1 and 4 weeks after birth, and the heads bisected into
hemisections through the sagittal plane prior to radiography as previously described
(lizuka et aI., 1992).
RESULTS
The effects of the mild, transient osteopetrosis on tooth eruption in .m rats are
shown in Figure 1 and summarized in Table 1. In normal rats of this stock, the incisors
erupted 11 days after birth, and the first, second, and third molars erupted 19, 21, and
34 days after birth respectively. The eruption of all teeth was delayed in 
.m rats, and,
with the exception of the third molar, earlier erupting teeth were most affected by the
disease. Incisors erupted in .m rats between 13-21 days after birth, on average 5
days later than incisor eruption in normal siblings. Molars erupted between 21-
days, 23-25 days, and 38-40 days for first, second and third molars, respectively.
Therefore, the first molars were delayed an average of 3 days and the second molars 2
days compared to normal littermates. Figure 1 demonstrates the dramatic effect of
osteopetrosis on eruption of incisors in mi rats. While the incisors of normal rats are
well worn at 4 weeks after birth, the incisors of mi rats are maloccludedand distorted,
lacking any signs of wear.
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These observations were confirmed by radiologic and histologic analyses.
Radiologic examination of animals at 1 and 4 weeks (Figure 2) revealed that in 
rats, the apical end of the incisor failed to extend past the first molar (Fig. 2b, d),
while in normal siblings the apex of the incisor extends posterior to the third molar
(Fig. 2a, c). Molars in mutants were indistinguishable from normal in radiographs at 
weeks, with well developed crowns and roots. Low magnification histomorphology (not
shown) confirmed these observations.
To investigate the cause of the incisor abnormalities present in mi rats, we
examined longitudinal histologic sections of the lower mandible through the incisor of
young animals. At birth, the incisors of mi rats (Fig. 3b) exhibited abnormal
modeling compared to normal littermates (Fig. 3a), including an irregularly shaped
incisor body and indented incisor apex. Higher magnification of the apical end of these
teeth revealed encroachment of incisor tissue by bone matrix in mi rats (Fig. 3d),
while incisor tissue and bone matrix were clearly separated in normal siblings
(Fig. 3c). This ankylosis of bone with incisor enamel and dentin matrices was
temporary, being resolved by the 3rd postnatal day (data not shown).
Bone and dentine formation were not different in mi rats and normal siblings, as
revealed by autoradiography of mineralizing matrices (Figure 4). Radiolabeled proline
was incorprated equally into newly formed alveolar bone and dentine matrices in both
normal (Fig. 4a, c) and mi rats (Fig. 4b,d).
DISCUSSION
We demonstrate that the mild form of osteopetrosis in microphthalmia blanc rats
causes severe distortion of incisor shape and position and delays the eruption of all teeth.
Radiographic and histologic analyses revealed deficient posterior extension of the incisor
apex of mi rats and temporary ankylosis of enamel and dentine matrices to minerali
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bone surfaces at birth. This ankylosis in m. rats is similar to the odontoma-like
regions produced by permanent ankylosis of incisors in two other osteopetrotic rat
mutations, incisor-absent (ia (Schour et al., 1949) and toothless (11 (Iizuka et aI.,
1992). In 11 rats, neonatal injections of the growth factor CSF-1 stimulate bone
resorption, which corrects the apical incisor defects and allows the teeth to erupt
(lizuka et al., 1992). We believe that the natural resolution of the ankylosed incisor by
3 days in m. rats is similar to the condition brought abut by CSF-1 treatment of 
rats. In addition, this temporary ankylosis likely accunts for the occlusal defects which
persist after eruption.
It is noteworthy that the eruption and development of incisors are more affected
than other teeth by the mild and transient osteopetrosis present in mi rats. This is
understandable given the mild nature of the disease in these rats (Cielinski and Marks,
1994) and in light of the emerging concept of tooth eruption as a biological event
dependent upon bone resorption for the timely formation of an eruption pathway (Marks
et aI., 1994). Pathway formation is regulated by the dental follcle and' is precisely
timed according to each tooth (Cahil and Marks. 1980; Marks, 1987; Cahil et al.
1988; Marks et al. 1988). Since incisors are the first teeth to erupt in rodents, the
"window of opportunity" for the formation of their eruption pathway must precede that
of molars. This is supported by the recent report that treatment of 11 rats from birth
promotes eruption of all teeth, but delaying treatment by only 1 day compromises
incisor eruption (Iizukaet al. 1992). These data suggest that signals for the
development and activation of osteoclasts must be provided by the dental follcle soon
after birth for incisors to erupt. Incisors-absent Wi) is another mild osteopetrotic
mutation in the rat characterized by a neonatal sclerosis 
with dental abnormalities
confined to lack of erupted incisors. The work of Kodama et at (1991) has shown that in
the CSF-1 deficient QR(osteopetrotic) mouse, exogenous administration of CSF-1, when
164
postponed 11 days after birth, causes second molars to erupt before the first molars.
These results indicate that the critical periods for the formation of an eruption pathway
in rodents is birth for incisors, and prior to the 10th postnatal day for first molars.
Taken together, our data show that the mild and transient osteopetrosis present in
JI rats delays the eruption of all teeth and causes severe occlusal defects in incisors.
The observation that incisors are more severely affected by this mutation than later-
erupting molars is consistent with their respective critical periods for the eruption
pathways. The temporary encroachment of the mineralized matrices of the apical
incisor by bone matrix can accunt for both the delays in the eruption of these teeth and
the persistent deformities after eruption.
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F i g u r e  2  -  O r i g i n a l  r a d i o g r a p h s  o f  
n o r m a l  ( a ,  c )  a n d  
. m  
( b ,  d )  r a t s  a t  7  a n d  2 8  d a y s  a f t e r
b i r t h .  N o t i c e  t h a t  
i n  m i b  r a t s  ( b ,  d )  t h e  a p i c a l  i n c i s o r  ( a r r o w h e a d s )  e x t e n d s  p o s t e r i o r  t o
t h e  f i r s t  m o l a r  r e g i o n ,  b u t  n o t  t o  t h e  t h i r d  m o l a r  a s  i n  n o r m a l  r a t s  ( a ,  c ) .  
N o r m a l  r o o t  a n d
c r o w n  d e v e l o p m e n t  a r e  e v i d e n t  i n  o l d e r  
. m  
f i r s t  m o l a r s  
( a r r o w ,  d ) .

F i g u r e  3  -  P h o t o m i c r o g r a p h s  o f  m a n d i b u l a r  
i n c i s o r s  f r o m  n o r m a l  ( a ,  c )  a n d  
m u t a n t  ( b ,  d )
r a t s  o f  
m i  
s t o c k  a t  b i r t h .  a ,  b :
L o w  p o w e r  ( 3 S x )  p h o t o m i c r o g r a p h s  i l u s t r a t e  t h e  r e g u l a r
s h a p e  o f  t h e  i n c i s o r  o f  
n o r m a l  r a t s ,  w i t h  a  c h a r a c t e r i s t i c  a p i c a l  e n d  ( o p e n  a r r o w ,  a ) .  
T h e
m u t a n t  i n c i s o r  ( b )  i s  d e f o r m e d  w i t h  a n  
a b n o r m a l l y  i n d e n t e d  a p i c a l  e n d  ( o p e n  a r r o w )  a n d
b u l b - s h a p e d  i n c i s o r  b o d y  ( a s t e r i s k s ) .  c ,  
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b a r  ( a ,  b )  =
S m m ;  b a r  ( c ,  d )  =  0 .
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Part G:
Bone Metabolism in the Osteopetrotic Rat Mutation microphthalmia blanc (mi
Rationale
We have described the dental and skeletal manifestations of osteopetrosis in the
rat mutation microphthalmia blanc and shown that the transient, mild nature of the
disease in these rats is due to neonatal reductions in osteoclast number and function.
Calcium and phosphate homeostasis are normal in mi rats, but 1 ,2S-(OH)2D3 levels
are elevated at one week. Although reductions in osteoclast number and function in
neonatal mi rats can account for the recovering neonatal sclerosis, other possibilties
may exist. These include increased bone formation, which has been demonstrated to
compound osteopetrosis in the four mouse mutations gj, m1 and QI (Marks 1989),
and deficiencies in ruffed border formation , which are common in congenital
osteopetrosis (Marks 1984). In this study we measured bone formation and evaluated
osteoclast ultrastructure and gene expression as reflected by mRNA levels of TrATPase
and carbnic anhydrase II (CAli).
Summary of Results and Conclusions
The rate of bone formation in mi rats and normal littermates at 1, 7, 14, 21,
and 28 days after birth by quantitative analysis of the incorpration of radio labeled
proline into newly formed bone matrix (Walker 1966, Marks 1969). Bone formation
falls within normal ranges for all ages observed, with the exception of 21 days, when
bone formation is reduced to 56-60% compared to normal littermates. We interpret
this result to be a consequence of the nutritional disadvantage in mi rats at a time when
they are weaned and must switch to a diet of ground food with maloccuded incisors.
These data show that increased bone resorption does not complicate the skeletal sclerosis
in this mutation.
; .
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Ultrastructural features of osteoclasts in tibiae of normal and mutant rats of 
stock were analyzed at birth and 7 weeks. Osteoclasts of normal rats at birth and 7
weeks had the classical features of active osteoclasts including numerous mitochondria,
vacuolated cyoplasm, clear zones and elabrate ruffled borders. Ruffled bor~er were
absent or poorly developed in osteoclasts from neonatal mi rats. By 7 weeks, mutant
osteoclasts exhibit the distinct features of active osteoclasts including extensive
membrane rufflings flanked by clear zones. These results indicate that neonatal
abnormalities in osteoclast function in mi rats include inabilty to form a well-
developed ruffled border, similar to the situation in and mi mice, the rabbit, and
1a rat mutations (Marks 1984). This defect is also resolved by 4 weeks, similar to
derrangments in osteoclast numbers and function described earlier.
Osteoclastic gene expression is also deficient in neonatal mi rats, as evidence
by significant reductions in mRNA encoding TrATPase and carbnic anhydrase II. These
abnormalities normalize by 4 weeks. Therefore, mi rats exhibit neonatal reductions in
both numbers and function of osteoclasts which resolve during the first postnatal month.
These include reduce message encoding the functional enzymes TrATPase and carbnic
anhydrae II, reduce amounts of the functional enzymes TRAP and TrATPase as shown by
. histochemical staining, and inabilty of osteoclasts to form ruffled borders. All of these
abnormalities are improved dramatically by 4 weeks. or later.
Publication
This study is being prepared for publication in Bone. The key figures follow;
please refer to them for specific details.
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T r a n s m i s s i o n  
e l e c t r o n  m i c r o g r a p h s  o f  o s t e o c l a s t s  f r o m  1 -
d a y - o l d  n o r m a l  ( A )
a n d  
m .  
( B )  r a t s .  
N o r m a l  o s t e o c l a s t s  e x h i b i t  c h a r a c t e r i s t i c s  o f  a c t i v e  o s t e o c l a s t s ,
i n c l u d i n g  m i t o c h o n d r i a  ( m ) ,  v a c u o l e s  ( v ) ,  a n d  a  w e l l -
d e v e l o p e d  r u f f l e d  b o r d e r  ( R B )
s u r r o u n d e d  b y  a n  o r g a n e l l e -
f r e e  c l e a r  z o n e  ( c z ) .  
M u t a n t  o s t e o c l a s t s  ( B )  p o s s e s s
m i t o c h o n d r i a  ( m ) ,  v a c u o l e s  ( v ) ,  a n d  c l e a r  z o n e s  ( c z ) ,  b u t  
m e m b r a n e  r u f f l i n g  i s  l i m i t e d
( a r r o w s ) .  N  =  n u c l e u s ,  n  =  
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CHAPTR 5
SUMMAY AND DISCUSON
In view of the fact that the significance of all these results have already been
discussed in each of the publications above, this chapter wil be mercifully brief. Please
refer to each publication for more wide-ranging discussion of these data.
Part A:
Significant contributions of this work
1. We have shown that in the toothless rat, a mutation lacking erupted dentition
due to severely reduced bone resorption, CSF-1 promoted tooth eruption that was
delayed compared to normal rats. Eruption was accmpanied by changes in the
populations of TRAP+ mononuclear cells in the dental follcle and TRAP+ osteoclasts on
adjacent alveolar bone surfaces. These cell populations were dramatically increased in
treated mutants compared to untreated 11 rats, but the timing of their appearance was
delayed compared to normallittermates. This lag in the appearance of osteoclasts and
their precursors corresponded to the delays in eruption of first molars observed 
treated 11 rats. These data show that increased bone resorption--provided by CSF-
injections--promotes eruption in 11 rats and affirm the role of bone resorption in tooth
eruption.
2. We have demonstrated that CSF-1 accelerates the eruption of molars in
normal rats. CSF-1 increased the number of TRAP+ mononuclear cells in the dental
follcle and TRAP+ osteoclasts on adjacent alveolar bone surfaces, but had no effect on
the timing of their appearance in normal rats. These data suggest that CSF-1 stimulates
eruption of molars in rats by influencing the cellular mediators of the bone resorption
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necessary for tooth eruption. In addition, our data support the concept that bone
resorption is a necessary and rate-limiting element of tooth eruption (Marks et al.
1993. Marks 1981), agree with the proposed role of the dental follcle in 
regulating the
resorption of eruption (Cahil and Marks, 1980 ), and together with the observation
that CSF-1 is produced and secreted by cultured dental follcle cells (Wise et al. 1994),
indicate that CSF-1 plays a role in the molecular cascde which regulates eruption. The
potential clinical uses of CSF-1 in the movement and eruption of teeth must be explored.
3. Our data have revealed a differential effect on tooth eruption of the growth
factors CSF-1 and EGF. CSF-1 accelerated eruption of molars in normal rats, but had no
effect on incisor eruption. On the other hand, EGF accelerated incisor eruption , but did
not effect molar eruption in normal rats. These results agree with the original
description of EGF by Cohen (1962) as a factor causing preccious incisor eruption.
Our data show that this effect is not extended to molars and indicate that incisor and
molar eruption in rodents are governed by different molecular signals. Therefore, data
generated by observing incisor eruption as an assay for tooth eruption must be
reevaluated, and exclusive use of only this method to identify factors affecting tooth
eruption must be avoided.
4. We have also detailed for the first time the mechanism for the transient, mild
form of osteopetrosis inherited by mi rats. Mutant animals possessed a typical
sclerosis at birth, which. diminishedubut was not resolveduduring the first postnatal
month. We believe that these characteristics are caused by early reductions in
osteoclast number and function which improve to normal levels by 4 weeks. Osteoclast
numbers were severely reduced in mi rats between birth and 2 weeks, but improved to
near normal levels by 4 weeks. Neonatal abnormalities in osteoclast function included
reduced staining for the functional enzymes TRAP and TrATPase, decreased levels of
mRNA for both TrATPase and CAli, and inabilty to form a well-developed ruffled border.
- . , '
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None of these defects were apparent after the first postnatal month. It is interesting that
two mild osteopetrotic mutations in the rat, mi and ia (incisors-absent) exhibit
minimal and excessive osteoclast numbers and reactivity for TRAP , respectively
(present study, Marks 1973). This underscores the remarkable variety of cellular
manifestations of osteopetrosis--even in two mutations with early, improving sclerosis.
S. We have shown that the dental abnormalities caused by the mild. transient
form of osteopetrosis in mi rats are limited to incisor defects and delays in the eruption
of all teeth. Histologic and radiographic examination of mutant incisors revealed that,
contrary to the situation in normal rats, the apex of the incisor of mi rats failed to
extend past the first molar region to the third molar. The incisor apex of newborn 
rats was misshaped due to ankylosis of incisor matrices with alveolar bone. This
ankylosis was temporary, being resolved by the third postnatal day. We believe that the
delayed eruption of incisors in mi rats and abnormal shape and occlusion of these teeth
in older animals is a consequence of the temporary ankylosis in newborn rats. It is
noteworthy that the ia rat is another mild osteopetrotic mutation in the rat with neonatal
reductions in bone resorption and dental abnormalities limited to delayed eruption and
incisor defects. In addition, the early resolution of incisor ankylosis in mi rats is
similar to the situation in 11 rats .treated with CSF-1. Incisors are permanently
ankylosed and fail to erupt unless CSF-1 treatment is started at or soon after birth.
These observations are understandable when viewed w.ithin the emerging concept of tooth
eruption as a localized process within alveolar bone in which formation of an eruption
pathway is produced by bone resorption (Cahil and Marks 1982, Marks 1986).
Formation of this eruption pathway is controlled locally, is linked to the dental follcle,
and results in a window of opportunity for tooth eruption which occurs at a
characteristic time for each tooth.
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Part B
Future Directions
1. Can prenatal administration of CSF-1 resolve the characteristic skeletal
defect of mi fats? The hemopoietic growth factor CSF-1 has been shown to increase
osteoclast numbers and activity in both 11 rats and gg mice. CSF-1 also accelerates
eruption of molars in normal rats by increasing the number of TRAP+ osteoclasts and
their putative precursors around the erupting dentition. These data indicate that
exogenously supplied CSF-1 has a positive effect on osteolastogenesis and function. The
abilty to visually identify mm rats at birth, compared to radiographic identification of
mutants in other stocks, provides the. unique opportunity to study the prenatal effects of
CSF-1 on the skeletal defects of newborn mi rats. Given the mild, transient
osteopetrosis in mi rats. exogenously supplied CSF-1 may stimulate early recovery of
the disease as determined by skeletal radiographs and determination of osteolast
number , histochemistry, ultrastructure, and gene expression.
2. We have show that CSF-1 promotes eruption of teeth in 11 rats and acclerates
eruption in normal rats by increasing bone resorption and formation of an eruption
pathway. However, the mechanism by which EGF influences incisor eruption remains a
mystery. EGF has been shown to stimulate production of CSF'-1 mRNA and secretion of
CSF-1 protein in cultured marrow stromal cells (Abboud 1992), suggesting that EGF
may influence bone n:isorption during incisor eruption by upregulating local secretion 
CSF-1. Our observations on the differential effects of CSF-1 and EGF on molar and
incisor eruption in rats does not supprt this concept and suggests that the eruption of
these two types of teet;, are differnt. Another way to test the hypothesis that EGF plays a
role in eruption by augmenting bone resorption is to treat newbrn 11 fats with EGF and
.- .
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examine its effects on incisor eruption. Eruption of incisors in these bone resorption-
deficient rats would support this concept.
3. In the mi rat, we have identified numerous transient osteoclast defects
including reduced number and abnormal function as evidenced by histochemistry,
ultrastructure and gene expression. In the other rat mutations with congenital
osteopetrosis (J, 11, and gW, abnormal osteoblastic gene expression has been
documented (Shalhoub et al. 1991). These abnormalities are understandable in light of
the concept that the development and function of both osteoblasts and osteoclasts is
coordinated or coupled to maintain skeletal homeostasis. However, are extracellular
matrix abnormaliies in osteopetrotic rats universal, or confined to more sclerotic
mutations? Examining osteoblastic gene expression in the mi rat wil faciltate a
better understanding of this question and provide insights regarding the interactions
between the two major cellular constituents of the skeleton.
These avenues of research are logical progressions given our current
understanding of osteoclast ontogeny.
